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1.1 The role of copper in biological functions 
 
Metal ions are essential for the biological function of many proteins. Thus, at least 
one-third of all proteins encoded in the human genome appear to contain metal ions or 
need metal ions to perform their function [1]. Metal ions are used either as a structural 
component or as a catalytic co-factor [2]. The metals are implicated in various biological 
processes such as electron transfer reactions, oxygen transport, and in a large variety of 
catalytic processes. 
Metals are sometimes referred to as trace elements, but from the point of view of the 
cell, this is a misnomer. Studies of transition metal quotas of Escherichia coli, for instance, 
reveal that individual bacteria concentrate Zn and Fe by several orders of magnitude 
relative to the concentration in a typical growth medium until they achieve a quota of about 
2 × 105 atoms per cell, which is equivalent to a total concentration of about 0.1 mM [1]. 
Metals such as Cu and Mn are maintained in the 10 to 100µM range. Other metals are also 
concentrated by the E. coli cell to a narrow, fixed, total concentration as follows: K and Mg, 
108 atoms per cell, >10 mM; Ca, Zn, and Fe, 105 atoms per cell, ~0.1 mM; Cu, Mn, Mo, 
and Se, 104 atoms per cell, ~10 µM; V, Co, and Ni, low abundance [1]. 
Copper, as one of the abundant metal ions in living systems, has two oxidation states: 
cuprous Cu(I) and cupric Cu(II). Cu(II) is fairly soluble, whereas the solubility of Cu(I) is 
in the sub-micromolar range. A considerable number of enzymes in human cells use the 
redox property of copper for their functions. For example: 
i) Ceruloplasmin (CP) 
Ceruloplasmin is the primary copper carrier in serum. It is also a potent ferroxidase, 
capable of oxidizing Fe(II) to Fe(III) in the presence of molecule oxygen and accelerating 
the binding of iron by apotransferrin [3]. Oxidation of iron is important for its binding to 
transferrin. The latter oxidation step is critical for iron release from cells. In the case of 
copper deficiency, iron remains in the liver and upon addition of copper containing 
ceruloplasmin, iron is immediately released from liver into the blood [4,5].  
ii) Cytochrome c Oxidase (CcO) 
It is the terminal enzyme in respiratory chain, whose function is the conversion of O2 
to water. This enzyme anchors on the inner membrane of mitochondria. A number of metal 
cofactors are needed for its function. The metal binding sites includes two copper specific 
sites, CuA in Cox2 subunit and CuB in Cox1 subunit [6]. CuA is a binuclear, mixed valent 
center (one Cu(II) state and one Cu(I) state), located in the inner membrane space (IMS) of 
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mitochondria[7] . CuA site receives one electron from reduced cytochrome c, thus switching 
Cu(II) form to Cu(I) form. The electron is further transferred to the CuB center via two 
heme centers. CuB is located in the inner membrane of mitochondria, where O2 is reduced. 
Since the formation of two water molecule from O2 consumes four protons, a proton 
gradient is generated between IMS and the matrix. The energy stored by the proton 
gradient is subsequently utilized for ATP synthesis. The copper co-factors in this enzyme 
are critical for electron transfer and the overall catalytic reactions. 
iii) Cu/Zn superoxide dismutase 
Cu/Zn-SOD (SOD1) is a member of the SOD enzyme family, which. catalyzes the 
disproportionation reaction turning two molecules of superoxide into one molecule of O2 
and one of H2O2 [9]. The mechanism can be described as a cycling ‘ping-pong’:  
 
SOD1 is a homodimer that is largely localized in intracellular cytoplasmic spaces, but it is 
present also in the IMS [9].  
iv) Metallothioneins (MT) 
The primary purpose of this group of proteins is to sequester metal ions when they are 
present in excess [10]. Metallothioneins can bind Cu, Zn, Cd, Hg, Ag, or Ni [10]. However, 
Cu has the highest apparent affinity and can displace other metal ions [11]. It has been 
reported that metallothioneins with bound copper possess some SOD activity [11].  
v) Lysyl oxidase 
Lysyl oxidase plays an important role in development of connective tissues as it is 
required for cross-linking collagen and elastin [9,12]. In Menkes disease, connective tissue 
development is altered due to failure of lysyl oxidase [13, 14]. Due to reduced functionality of 
lysyl oxidase, patients show hyperelastic skin, hernias, and aortic aneurysms among other 
connective tissue related abnormalities [12, 15].  
vi) Other copper associated proteins and enzymes 
Copper is found in other enzymes, where it plays a role ranging from structural 
support to a redox active center, include tyrosinase, dopamine-β-monooxygenase, α-
amidating enzyme, diamine oxidase, angiogenin, some matrix metalloproteinases such as 
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secreted protein acidic and rich in cysteine (SPARC), and blood clotting factors V and 
VIII[9,16]. Disruption of copper homeostasis can have effects on all of these enzymes and 
their activities as well as the development of toxic levels of the metal and reactive oxygen 
species. 
1.2 Copper trafficking in human cell 
 
Although copper is a kind of nutrient metal ion, it is also toxic for both eukaryotes and 
prokaryotes. Free copper ions contribute to produce reactive oxygen species (ROS). 
Furthermore, oxidative stress carried out by reactive oxygen species (ROS), could be 
amplified by copper reactivity, leading to the impairment of essential molecules such as 
lipids, proteins and DNA [17]. Thus biological systems have developed various copper 
homeostasis systems, ranging from copper storage to translocation, controlled by specific 
proteins.  Free copper concentration in cell is indeed lower than 10-18M [8].  
Some homeostasis and translocation system for copper cargo in eukaryotic cells have 
been characterized. Copper is transported inside the eukaryotic cell by the protein family, 
called CTR. In Saccharomyces cerevisiae, depending on extracellular copper 
concentrations, copper is transported by two high-affinity copper transporters Ctr1 and 
Ctr3 (Km for copper ~1–5 µM), or by a low-affinity Cu/Fe-transporter Fet4 (Km for 
copper ~35µM) [19]. Prior its uptake, copper, which is present in the extracellular space in 
the Cu(II) form, is thought to be reduced to Cu(I) by one or more cell-surface Fe(III)/Cu(II) 
reductases encoded by the FRE1 genes [20]. The mechanism for cupric ion reduction prior to 
uptake remains unknown. Unlike other high affinity metal transporters (such as ATP7A 
and ATP7B), Ctr1 proteins do not require ATP for copper import [21].  
The delivery of copper to target enzymes depends on specific and continuous complex 
systems (Fig.1). One of these copper translocation pathways was consisted of a small 
copper chaperone, called HAH1 or Atox1, and its partners. HAH1 transfers copper cargo to 
gene product of ATP7A (MNK protein) or ATP7B (WLN protein), both of which are 
important protein for copper homeostasis (also see section 1.4)  
The second copper chaperone, CCS, is a protein required for the delivery of copper to 
SOD (Fig.1). CCS is a homodimer with 35-kDa subunits and 3 functional domains. 
Domain II is highly homologous to SOD, and heterodimer pairs of SOD and CCS subunits 
were observed, which could form to facilitate copper transfer [22]. Domain I contains the 
copper-binding site, but essential cysteines in domain III are involved in the transfer of 
copper to apo-SOD. 
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Copper translocation in mitochondria requires quite complex process (Fig.1). Several 
proteins are indeed involved in the correct copper binding of CcO, including Cox17, Sco1, 
Sco2, Cox11, Cox19 and Cox23. Cox17, which is only a 69-residue protein, acts as the 
copper chaperone in mitochondria. The overall fold of Cox17 is composed of two helixes 
and a flexible N-terminus [23]. In vitro studies showed that Cox17 is able to bind up to 4 
copper ions by six Cys residues [24]. Cox17 is encoded by nucle DNA and leads to be 
imported into IMS by the TOM protein, located in the outer membrane of mitochondria. In 
cytosol, all six Cys resides of Cox17 are in the reduced state, since a large amount of 
reduced glutathione (GSH) is present. In mitochondria, four Cys residues of Cox17 are 
specifically oxidized by Mia40 to form two disulphide bonds. The remaining two reduced 
Cys residues are able to bind one copper ion. Because Cox17 is imported to mitochondria 
in the apo form, the mechanism by which copper was transported into mitochondria is still 
unknown.  
 
 
 
1.3 Copper and diseases 
 
The alteration of copper homeostasis leads to errors of metabolism and damage to 
cells, resulting in pathological conditions. Such conditions are well exemplified by two 
inherited diseases of copper metabolism in humans, Menkes and Wilson syndromes: in 
both cases, the impairment by mutation of two homologous copper transport ATPases, 
ATP7A and ATP7B, which are selectively expressed in different tissues, leads either to the 
decrease or to the overload of copper in the cells. 
Menkes disease (MD) is a fatal X-linked copper deficiency disorder. About one in 
200,000 males are born with this devastating genetic disorder. Its symptoms include 
 
Fig 1: Copper transport in hepatocytes, neurons, and astrocytes. Reprinted from Prohaska, J. R. et al. J. Nutr. 2004 
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profound mental retardation, and connective tissue (collagen) abnormalities that result in 
soft bones and cartilage and weakened artery walls [12,13,25]. The pathophysilogy of this 
disease are mutations on the ATP7A gene (MNK). The latter defect creates a systemic 
copper deficiency since MNK is primarily responsible for absorbing copper through diet. 
The copper content is particularly low in the brain of the patients with mutated ATP7A, 
because this protein is also expressed at the blood-brain barrier [26,27]. The current treatment 
of Menkes disease is administration of copper-histidine to the patient. Individuals affected 
by MD usually die in early childhood. 
Wilson’s disease (WD) is an autosomal recessive hereditary disease, with an 
incidence of about 1 in 30,000 in most parts of the world and a male preponderance. 
Symptoms usually appear around the ages of 10 to 21 years. The mutant form of ATP7B 
expressed in people with Wilson's disease inhibits the release of copper into bile, leading to 
liver failure as a result of the very high concentrations of copper accumulated in this organ. 
The disease is treated with lifelong use of chelating agents such as D-penicillamine or 
trienine hydrochloride, drugs that help remove copper from tissue. Patients will also need 
to take vitamin B6 and follow a low-copper diet, which means avoiding mushrooms, nuts, 
chocolate, dried fruit, liver, and shellfish [27]. 
Disorders due to respiratory chain deficiency determine also fatal diseases, leading to 
death at an early age as well. Isolated CcO deficiency represents one of the most 
commonly recognized causes of respiratory chain defects in humans associated with a wide 
spectrum of clinical phenotypes, primarily affecting those organs with high-energy demand 
such as the brain, skeletal, muscle and heart [28]. A number of mutations in genes encoding 
CcO assembly factors (Sco1, Sco2, Cox15, Cox10, Surf) have been described as a frequent 
cause of CcO deficiency and have been assigned with specific clinical symptoms.  
Moreover, the imbalance of copper homeostasis have been linked to some 
neurodegenerative diseases as Alzheimer’s disease (AD) [29], Creutzfeldt-Jakob disease, 
Parkinson’s disease (PD)[30] and Amyotrophic Lateral Sclerosis disease (ALS)[31].  
It is probable that aberrant reactivity of copper is a major source of production of ROS, 
which in turn is responsible for the more global oxidative stress parameters observed in 
these diseases. These disorders may all be classified as “conformational” in that they all 
show, as hallmarks, conformationally altered proteins, which precipitate, form aggregates, 
and may be responsible of cell damage. Direct interaction between copper and the proteins 
that are the pathological hallmark of these diseases has been reported, and thus, redox 
activity of the metal may also be involved in the process of protein misfolding. The 
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molecular mechanisms leading to neurodegeneration in all these diseases are still unknown. 
However, metal-mediated oxidative stress could induce a cascade of events, including 
mitochondrial dysfunction that may be responsible for cell death. 
 
1.4 The functional and structural components of MNK and WLN 
 
As described in section 1.2, the gene products of ATP7A (MNK) and ATP7B (WLN) 
are involved in one of the major intracellular copper translocating pathway. Moreover, 
these two proteins are also essential for copper homeostasis regulation in the body. An 
adult need 1mg copper per day. The dietary copper is absorbed in intestine. Protein Ctr1 
imports the copper to the intestinal cells by passing the apical membrane. Copper is 
exported from the intestinal epithelium into the blood by MNK (Fig.2) in a process that 
involves trafficking of the transporter towards the basolateral membrane [32,33]. In other 
tissues, MNK and WLN are also responsible for copper homeostasis. But the expression 
patterns of ATP7A and ATP7B are somewhat complementary, with ATP7A expressed in the 
majority of tissues except for the liver, and ATP7B expressed primarily in the liver, but 
also in the kidney and placenta, and at lower levels in brain, heart and lungs. The excess 
copper is excreted into bile (Fig.2). Thus, in Wilson disease patients, copper release into 
the bile is greatly impaired, resulting in marked accumulation of copper in the liver while 
the mutations in ATP7A induces copper deficiency on other tissues like brain. 
 
 
 
Fig. 2 Simplified scheme of copper distribution in the body. Reprinted from Lutsenko et al., Physiol. Rev. 2006 
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Inside the cells, both these two proteins reside at the trans Golgi-network, where 
copper is transported for incorporation into copper-dependent enzymes such as lysyl 
oxidase in fibroblasts (mediated by MNK) or ceruloplasmin in hepatocytes (mediated by 
WLN) (Fig.1). When intracellular copper levels rise, the proteins are redistributed to 
different vesicular compartments close to the plasma membrane and excess copper are 
excreted. Both MNK and WLN proteins are large membrane proteins, composed by about 
1500 amino acids. They are highly similar proteins, with significant primary sequence 
homology (50–60% identity).  Recent studies have already established that both MNK and 
WLN are P-type ATPases, which use energy of ATP hydrolysis to transport copper ion 
across the membrane [34]. Fig.3 shows the general architecture of MNK and WLN and their 
domains. The proteins are composed of eight trans membranes and several soluble domains, 
all of which extended into cytosol.   
 
 
In the N-terminal part, there are six soluble metal binding domains (MBDs), each 
harboring the sequence motif GMT/HCxxCxxxIE (Fig.3C). Each of six MBDs can bind 
one reduced copper ion via two Cys residues in this motif. Structural information shows 
that the overall fold of individual MBDs is organized in a  "ferredoxin"-like    -fold. 
Though in vitro studies showed that all the six MBDs could bind one copper ion, the 
functional properties of each MBDs are not equal. Recent studies suggested that the MBD5 
and MBD6, the closest to the membrane, are important for the copper incorporation in the 
TGN [35]. Indeed, it was believed that one of these two domains transfer copper ions to the 
CPC motif in the trans membrane helices. In vitro studies showed that MBD5-6 of WLN 
protein are unable to receive any copper ion from HAH1, but MBD4 and MBD1 are the 
copper downstream mediated by HAH1 [36].  This data suggest that the copper transferring 
chain is starting from MBD1 or MBD4 to MBD5-6, CPC motif receiving copper ion from 
 
 
Fig. 3 Domain organization and catalytic cycle of human Cu-ATPases. Reprinted from Lutsenko et al., Physiol. Rev. 2006 
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MBD5-6 and, finally, supplying the target enzymes in TGN. However, recent studies on 
MBD1-6 of Menkes protein indicate that MBD6 can be metallated by Cu(I)HAH1 directly 
[64]
. The copper transfer still takes place after the Cys residues of domains 1 to 4 are 
mutated to alanine [64]. However, the function of all the MBDs is not well understood yet. It 
is predicted that copper binding and consequent changes in domain-domain interactions 
allow MNK or WLN to adopt specific conformations and/or interact with proteins 
necessary for the intracellular trafficking of these transporters [37].  
Like the other ATPases, the activity of WNK and WLN is most likely mediated 
through coordinated action of the A-domain and the ATP-binding domain (Fig.3B and 3C). 
The latter domain consists of two portions: N-domain and P-domain. The site of catalytic 
phosphorylation and the signature motifs for the P-type ATPase (DKTG, TGDN, 
GDGxND) reside in the P-domain and N-domain, respectively. A-domain contains the 
TGE sequenct motif, which is essential for enzymatic function of P-type ATPase. Several 
mutations in this region of ATP7A were linked to the Menkes disease phenotype. The 
COOH terminal tail contains 80-100 residues. In a recent study, it was shown that this 
domain is necessary for protein stability [38]. But the precise function of this domain is not 
yet understood.  
 
1.5 Copper delivery to Cytochrome c oxidase 
 
As mentioned in section 1.1, Cytochrome c oxidase (CcO) is the terminal enzyme in 
the energy transducing respiratory chain. This enzyme is located in the inner mitochondrial 
membrane, where it catalyses reduction of molecular oxygen to water and pumps protons 
across the membrane [39,40,41]. The energy stored by the proton gradient is subsequently 
utilized for ATP synthesis. Human CcO is composed of 13 subunits (Fig 4), 10 of which 
are encoded by nuclear genes [42,43]. Two of the nuclear subunits (VIa and VIIa) have 
tissue-specific isoforms. The three mtDNA-encoded subunits (Cox1-Cox3) form the 
catalytic core of the enzyme. Beside the two copper sites, it also has two hemes (a and a3), 
one magnesium and one zinc ion [7]. It has been reported that more than 30 proteins are 
important for the assembly of CcO [44].  The function role of these accessory factors in the 
assembly of CcO can be classified to the assembly of subunits, the formation and insertion 
of heme A, the delivery and insertion of metal ions to the CcO in the mitochondria, and 
final maturation of the complex. Several proteins are important for the assembly of metal 
ions. Little is known about the delivery of Zn and Mg ions to the mitochondrion or whether 
specific accessory factors are necessary for the insertion of these ions into CcO.  
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In the eukaryotic cell, four proteins (Cox11, Cox17, Sco1 and Sco2) have been 
implicated in the copper ion loading of CcO. Cox17 has been supposed to be the key 
mitochondrial copper ion shuttle, whereas Cox11 and Sco1 function downstream. Yeast 
lacking COX17 (COX17∆ yeast) are respiratory-deficient due to a complete lack of CcO 
activity [45]. It can be restored by the addition of 0.4% copper salts to the growth medium. 
This result is consistent with Cox17 functioning in copper delivery to CcO. The simple 
prediction was that Cox17 would shuttle Cu(I) into the IMS to be used in the assembly of 
CcO. This theory was strengthened by the observation that Cox17 is a copper binding 
protein [61]. However, Cox17 tethered to the mitochondrial inner membrane by a fusion to 
the transmembrane domain of the inner membrane protein Sco2 was able to reverse the 
respiratory defect of cox17∆ cells and restored normal CcO activity [62]. These results 
suggest that the function of Cox17 is confined to the mitochondrial intermembrane 
space[63]. 
 
 
 
 
 
 
Fig.5 Scheme of Cu metalation of Cox1 and Cox2 mediated by Cox11 and Sco1, respectively. Reprinted from Carr H. and 
Winge DR., Acc. Chem. Res.2003 
 
 
Fig.4 The structure of bovine CcO and the metal cofactors. Reprinted from Carr H. and Winge DR., Acc. Chem. Res.2003 
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Sco1 was suggested to function in copper delivery to CcO (Fig.5) by the observation 
that the respiratory deficient phenotype of a COX17-∆ strain could be suppressed by over 
expression of SCO1 or a related gene designated SCO2 [45]. Yeast strains lacking SCO1 
also are respiratory deficient, and an excess of copper and or overexpression of either 
Cox17 or Sco2 cannot compensate for the Sco1-associated CcO deficiency [45]. The 
absolute requirement of Sco1 in the activation of CcO indicates that Sco1 functions 
downstream from Cox17 in the delivery of copper to CcO. Indeed, in vitro Sco1 can 
receive copper from the copper chaperone Cox17 [46]. It also appeared that Sco1 is 
important for formation of the CuA site in Cox2. Yeast Sco1 was shown to interact with 
Cox2 [47]. 
Sco1 and Sco2 are highly similar proteins. Both proteins contain a single trans 
membrane helix in the N-terminal segment of the proteins, anchoring of these two proteins 
to the inner mitochondrion while the C-terminal segment of Sco proteins is soluble and 
extended into IMS. A highly conserved CXXXC motif and a conserved His have been 
proposed to be the copper ligands. Mutation of any one of these conserved residues in Sco1 
abrogates function, resulting in a nonfunctional CcO complex, which means that the 
function of Sco1 correlates with Cu(I) binding. Although Sco2 is highly similar to Sco1, 
studies with immortalized fibroblasts from Sco1 and Sco2 patients suggest that human 
Sco1 and human Sco2 have nonoverlapping but cooperative functions in CcO assembly [48]. 
Recently, it was shown that human Sco2 is also the downstream mediator of the balance 
between the utilization of respiratory and glycolytic pathways and has a regulatory role in 
the maintenance of cellular copper homeostasis [49]. 
Cox11 is the co-metallochaperone for the CuB site (Fig.5). Recently, Hiser et al. 
demonstrated that the CuB site is absent in CcO purified from Rhodobacter sphaeroides 
lacking COX11 gene [50]. Moreover, Tzagoloff et.al. [51] have shown that some Cox11 
mutants lack CcO activity; however, RNA and protein synthesis of the core subunits I and 
II are normal, suggesting that Cox11 functions post-translationally to generate active 
CcO[51]. 
Yeast Cox11 is a 34kDa protein that resembles Sco1, with a single transmembrane 
helix of about 24 aminoacids just downstream of the N-terminal mitochondrial anchored 
targeting sequence. The C-terminal domain protrudes into the inner membrane space and, 
as with the soluble C-terminal domain of Sco1, binds a Cu(I) ion. Recently, the first 
structure of Cox11 family has been solved [52]. The fold of C-terminal domain of Cox11 is 
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organized into a novel type of Immunoglobulin-like Fold. The protein binds one copper 
atom per molecule. 
Similar to eukaryotic cell, a number of proteins are essential for the assembly of metal 
cofactors of CcO of prokaryotic cell. A genome-wide search in all prokaryotic genomes 
combined with genomic context reveals that only Sco and Cox11 have orthologs in 
prokaryotes, whereas Cox17 orthologs are found only in eukaryotes[65]. As predicted from 
genomic contexts analysis, a protein of unknown function, called Hyp1, has been 
suggested to have a role of copper trafficking in prokaryotes. The latter is a soluble protein 
mostly occurring in the periplasm of Gram-negative bacteria, and consisting of about 150 
amino acids. All Hyp1 sequences share a conserved Hx14Mx21HxM consensus motif, 
which could bind copper(I) ion. Recently, the first structure of Hyp1 protein from 
Deinococcus radiodurans (DR1885) showed that the fold of this class of proteins 
organizes in cupredoxin-like fold, which is similar to more studied protein CopC, involved 
in copper homeostasis[66].  
Although Sco proteins are widespread proteins found in many prokaryotic organisms, 
it appears that the physiological function of Sco proteins goes beyond assembly of the CuA 
cofactor. Extensive analysis of completely sequenced prokaryotic genomes reveals that 
18% of them contain either Sco proteins but not CuA-containing proteins or vice versa. In 
addition, in several cases, multiple Sco-encoding genes occur even if only a single 
potential Sco target is encoded in the genome[67]. 
 
1.6 CcO deficiency linked to HSco1/2 pathogenic mutations 
 
Mutations in human SCO1 and human SCO2 genes cause severe, tissue-specific CcO 
deficiencies owing to a failure in CcO assembly: Human Sco2 (HSco2) mutations are 
predominately associated with early-onset hypertrophic cardiomyopathy and ence-
phalopathy [53-55], whereas one missense mutation (P174L) in HSco1 is founds to be 
associated with fatal infantile hepatoencephalomyopathy [56], a progressive neonatal 
disorder predominantly affecting the liver. Pro174, adjacent to the conserved CXXXC 
motif of HSco1, is completely conserved in eukaryotes. It has been shown that the 
pathogenicity of the mutant does not result from its instability, but rather from an impaired 
function [57]. 
In HSco2, the E140K pathogenic mutation is adjacent to the postulated CXXXC 
conserved hypothetical copper binding motif. Also S225F pathogenic mutation is adjacent 
to the conserved His224, while the R171W mutation is close to a DXXXD conserved motif, 
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which is also spatially close to CXXXC motif. These observations suggest that the 
mutations probably impair the copper binding on HSco2 and/or the copper transfer process. 
On the other hand, using a policonal antibody against HSco2, severely decreased level of 
HSco2 in fibroblast and myoblast from patients with different Sco2 mutations were 
observed suggesting an unstable gene product [55]. Both HSco1 and HSco2 are ubiquitary 
expressed and the reason for "tissue specificity" in the disorders is unknown. Remarkably, 
CcO deficiency in cells from patients with HSco2 mutations [58,59] can be rescued by the 
addition of copper to the growth medium, but the mechanism by which this rescue occurs 
is unknown.  
 
1.7 Aims and topics of the research 
 
During the three years of PhD my research was focused on the investigation of the 
function of the proteins involved in the copper homeostasis and CcO assembly pathway, 
particularly, focusing on the proteins related to the diseases induced by copper disorder. 
My focus was on two systems: one was the sixth soluble copper binding domain of Menkes 
protein (MNK6), the other was the functional role of HSco1 and HSco2 in CcO assembly. 
 MNK6 is the closest domain to membrane, so it could be responsible to transfer 
copper to CPC motif in the trans membrane helix. One pathogenic mutation A629P in the 
last β-strand of MNK6 is linked to the Menkes disease and this is the only missense 
mutation in all the six soluble domains of MNK. Therefore, the aim of our research was to 
investigate the molecular reason of the pathogenic mutation, by comparing the structures 
and dynamic properties between wild type and its mutated protein. 
The other interesting topic was the function role of HSco1 and HSco2 in CcO 
assembly. Copper incorporation in Cox2 is mediated by HSco1 and HSco2. However, it is 
still not clear yet about their specific functional role. Totally, six pathogenic mutations in 
this two proteins are linked to the CcO deficiency disease. All these six mutations are 
spatially close to the CXXXC motif based on structural model derived from the known 
similar fold. Thus, CcO deficiency induced by these mutations could be linked to copper 
binding properties. Therefore, the aim of this project is to investigate the function of 
HSco1/2 protein and discern the mechanism by which pathogenic mutations causes fatal 
diseases, by solving the solution structures of HSco1 and HSco2 and of a HSco1 related 
mutant (P174 HSco1) in different forms, i.e. apo and copper ion loaded, and studying their 
dynamics properties. Investigations of interaction of these two proteins with chaperone 
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Cox17, of their copper binding affinity and of their redox properties have been 
characterized to understand the functional aspects of these proteins.  
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Obviously, NMR spectroscopy has already been one of the most important tools for 
protein structure determination. Up to now, about 15% structures, deposited in protein 
structure database, are solved by NMR spectroscopy. Considering that body fluids such as 
blood, stomach liquid and saliva are protein solutions where these molecules perform their 
physiological functions, NMR has obvious advantage to closely mimic a given 
physiological fluid.  
Furthermore, in addition to protein structure determination, NMR applications include 
investigations of dynamic features of the molecular structures (see section 2.2), as well as 
studies of structural, thermodynamic and kinetic aspects of interactions between proteins 
and other solution components [1-4]. Here, this work will focus on the discussion of 
structure determination, dynamic properties studies and the characterization of protein-
metal interaction by NMR spectroscopy. 
 
2.1 Structure determination by NMR spectroscopy 
 
The standard protocol for NMR structure determination includes the preparation of a 
homogeneous protein solution, the recording and handling of the NMR datasets, the 
structural interpretation of the NMR data. Typically, uniformly 13C and 15N labelled 
proteins are used for structure determination. Triple labelled sample, 2D, 13C and 15N, is 
necessary for protein with larger size (more than 30kDa). The protocol of resonance 
assignments of double (15N and 13C) labelled proteins using 3D experiments is based on a 
number of experiments where show cross peaks among these relative nuclei of the 
backbone or the side chain [5]. 
 
2.1.1 Sample preparation 
The first critical parameter for obtaining good quality NMR spectra is the amount of 
sample available. Typically, a molar concentration of 0.5mM is close to a minimal 
requirement for structural characterizations. Several techniques for protein expression and 
purification have improved dramatically in the past decade. Currently, the E. coli 
expression system is the most widely used for NMR purpose, which requires the 
production of high yield of labeled 15N and 13C samples. Considerable efforts are also 
underway to make alternative hosts more accessible and affordable, and eukaryotic systems 
including mammalian, yeast and insect cell expression are becoming easier and less 
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expensive to be used. In this work, all the proteins were expressed in E.coli system, by 
using competent E.coli BL21-Gold (DE3) cells. The 15N-labeled and 15N 13C-labeled 
proteins were obtained by growing cells in minimal medium (M9) containing 3g/l 13C-
Glucose and 1g/l 15N-(NH4)2SO4 whereas LB medium was used for the non-labelled 
protein. 
Copper proteins, in many cases, bind copper ion by Cys residues. In this work, Sco 
family proteins bind copper ions via CXXXC motif and one highly conserved His residue. 
The sixth soluble domain of Menkes protein (MNK6) binds copper ions via CXXC motif. 
When these samples were exposed into air, SH groups of Cys residues are easily to be 
oxidized by O2, forming disulphide bonds. Moreover, the re-oxidation of the Cys residues 
could also induce unspecific intra-molecular disulfide bonds formation, which could 
induce protein aggregation and precipitation. Therefore, it is necessary to perform 
disulphide reduction on the sample prior to NMR measurement on the apo form and as 
well to the metallation of the sample. The reducing agent applied in this work is 
dithiothreitol (DTT). Glutathione and ascrobic acid are also widely used reducing agents. 
Protein reduction and metallation were carried out under nitrogen atomophere in an 
anaerobic chamber to prevent re-oxidation of the Cys residues. The excess DTT were 
removed by using PD-10 desalting column. All the NMR samples were prepared in Pi 
50mM pH=7.2 buffer.  
In order to obtain Cu(I) and Ni(II) metallated protein, progressive titration, monitored 
by UV-vis or 1H-15N HSQC experiments were performed, using the metals respectively in 
the [Cu(I)(CH3CN)4]PF6 and NiCl2 forms. The titration was performed using a maximum 
protein concentration of 0.2mM, in order to avoid the unspecific binding of metal ions on 
the protein surface. Excess metal ions were removed by dialysis overnight prior to the 
sample concentration. 
 
2.1.2 Resonance assignments 
After acquiring spectra on a protein sample, the peaks of the spectra have to be 
identified. Off diagonal peaks, called cross peaks, correspond to an interaction between 
two or more nuclei. The interaction is mainly of two different types: through space 
interactions and interactions through chemical bonds. Table 1 listed the pulse sequences 
used for the backbone assignments and side chain assignments in this thesis. 
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Backbone assignment experiments  Side chain assignment experiments 
HNCA HBHA(CBCACONH) 
HN(CO)CA hCCH-TOCSY 
CBCA(CO)NH 2J 1H-15N HSQC 
HNCACB  
HNCO  
HNHA  
Table 1. NMR experiments performed for backbone and side chain assignments.  
 
The assignment usually starts with the identification of the HN-N pairs in the 
backbone of the amino acid residue sequence of the protein. After identification of the HN-
N pairs, spectra from different sequential experiments are used to sequentially connect one 
with the other. After amino acid residues have been connected into chains, the chains are 
placed into amino acid sequence. Placing on the chain on the amino acid sequence is 
usually base on the chemical shifts of Cα and Cβ, which are dependent on amino acid type. 
Side chain nuclei are usually identified using TOCSY type experiments, correlating the 
side chain nuclei to the already known backbone nuclei in the same residues. In principle, 
all the nuclei should be assigned, but line-broadening effect induced by chemical exchange 
phenomenon could make the resonance too weak to be identified, such as N-terminal 
residues and residues located in flexible loops.  
In the case of proteins with a molecular weight larger than 30 kDa, the use of 
TROSY-type experiments is necessary. TROSY experiments can reduce the signal loss [6], 
which is the direct consequence of the slower correlation tumbling of large molecules that 
results in faster relaxation and consequently broader lines in the NMR spectrum. 
TROSY uses constructive interference between different relaxation mechanisms and 
works best at the highest available magnetic field strengths in the range of 700 to 900 MHz 
proton resonance frequencies. With TROSY the molecular size of proteins accessible for 
detailed NMR investigations has been extended several fold. The TROSY technique 
benefits a variety of triple resonance NMR experiments as the 3D HNCA and HNCOCA [7] 
and the TROSY-based NOESY experiments [8] for the collection of structural constraints 
are also available. CRINEPT-TROSY is another recently developed technique for even 
larger proteins. By combining INEPT with cross-correlated relaxation-induced polarization 
transfer, CRINEPT-TROSY can yield a further significant gain in sensitivity for molecular 
sizes above 200kDa[9,10]. The best magnetic field strengths for CRINEPT-TROSY are in 
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the range 900-1000MHz proton resonance frequencies. 
 
2.1.3 Conformational constrains 
Protein structure determination using NMR is mostly based on local distance and 
angle constrains, which could be derived from experimental data. Distance constrains are 
acquired from NOE spectroscopy (NOESY).  Angle information is mainly obtained from 
chemical shifts and spin-spin interaction through bonds.  
  
2.1.3.a Distance constrains 
The NOE reflects the transfer of magnetization between spins coupled by the dipole-
dipole interaction. The intensity of a cross peak in NOESY spectrum is mainly 
proportional to the distance between nuclei to the two power of minus six. The intensity is 
also dependent on the global and internal motions of the molecule. It is generally assumed 
that there exists a single rigid conformation that is compatible with all NOE data 
simultaneously, provided that the NOE data are interpreted in a conservative semi-
quantitative manner. 
Because the intensity of the cross peaks are also affected by motions of the molecule, 
NOE data are usually treated as upper bounds (UPL) on inter atomic distances instead of 
precise distance restraints. For the same reason, the absence of an NOE is in general not 
interpreted as a lower bound on the distance between the two interacting spins. 
 
2.1.3.b Angle restrains 
The structure quality will be much improved, if performed with additional torsion 
angle restraints beside distance restraints. Two techniques are widely used to obtain 
backbone angle constraints: Chemical Shift Index (CSI) [11] and 3J coupling constants [12]. 
CSI method relies on the fact that the chemical shifts of the different nuclei in the 
protein backbone are related both to the type of amino acid and to the nature of the 
secondary structure they are located in. By comparing the actual chemical shift for a 
nucleus in a specific amino acid with a reference value, it is possible to predict in what 
secondary structure element the nucleus resides. Several programs are available for the 
prediction of the secondary structure elements, such as TALOS  [13] and PREDICTOR [14], 
by using a complete set of backbone chemical shifts for all Hα, Cα, Cβ and CO resonances. 
In the latter program, the χ1 angle could be also predicted. 
Vicinal scalar coupling constants, 3J, can also be used for torsion angle prediction, 
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according to Karplus equations [15]. 3J HNHα coupling constants are obtained from the ratio 
between the intensity of the diagonal peak and that of the cross peak of the HNHα map. The 
Karplus equations are periodic, and thus more than one angle could be possible for a 
certain scalar coupling. The angular information is therefore included in the structure 
calculation as favored and less favored region instead of specific angles. 
 
 2.1.4 Structure calculation 
After convert the experimental data to NMR conformation restraints, structures 
calculations are usually done with either one of three methods, simulated annealing [16,17], 
distance geometry [18] or torsion angle dynamic [19]. A number of programs are also 
available for automatically assignment and structure calculation either staring from 
chemical shifts and integrated peaks, such as AUTOSTRUCTURE [20], and CANDID [21], 
or starting from chemical shifts and NOESY spectra, such as ATNOS-CANDID [22]. The 
efficiency of structure determination was largely improved by the latter kind of programs, 
since the most time consuming work could be performed by program automatically. In this 
thesis, all the calculation works have been done by DYANA-1.5 or ATNOS-CANDID 
coupled with CYANA-2.0 by using torsion angle dynamics algorithm. In this algorithm, 
the molecular dynamics simulation uses torsion angles as degree of freedom, while bond 
lengths, angles, and backbone peptide plane angles are fixed. During the integration time 
steps, the favored conformation was searched by minimizing the deviation between 
constrains and obtained conformations. Compared with other algorithms, torsion angle 
dynamics provides at present the most efficient way to calculate NMR structures. 
 
2.1.5 Structure refinement 
At the end of the structure calculation, an important question is whether the structure 
calculation was “successful”. There are two important features, i) whether the calculated 
structures fulfill the given restraints, ii) whether the calculations are converged. The first 
feature could be described by statistical report of the target function. In each calculation, 20 
or 30 conformers, among 200 or 350 conformers, with lowest final target functions were 
chosen to represent the solution structures. The average values of target function of the 
represent structures should be smaller than 1Å2 and each single violation should be smaller 
than 0.3Å2. The second feature was judged by RMSD (root mean square deviation) 
between these models. Only the family structure with backbone RMSD values close or less 
than 1 Å will be considered as “good”. 
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The “good” structures obtained from torsion angle dynamics finally should be refined 
in AMBER program [23]. In the final refinement, force field parameters are also considered. 
The refinement in explicit water box after the refinement in vacuum makes the structure 
qualities further improved. 
 
2.1.6 Structure validation 
The solved structures could be flawed or present a wrong fold, even though RMSD 
and target function values are accepted. The defect could be induced by only a few wrong 
assigned NOEs or other local constraints. Thus the validation protocol is critical to 
understand the quality of the structures. The validation of protein structures contains two 
aspects: 1) validation of coordinate data and 2) validation of experimental data.  
 
2.1.6.a Validation of coordinate data 
The validation of coordinate data measures the match between many aspects of the 
geometry and the expected range of permissible values for each geometric parameter. In 
this thesis, all the validation works of coordinate data were performed by using programs 
PROCHECK [24], PROCHECK_NMR [25] and WHAT IF [26]. In WHAT IF package, output 
files contains two classes of Z-scores: structure Z-scores and RMS Z-scores (Table2 as an 
example). RMS Z-scores check many stereochemical properties of proteins, including bond 
lengths, bond angles, tetrahedral geometry and planar group. Since these properties, are 
implemented in structure refinement programs as constraints, these scores are always good 
in practice. The only parameter that should be checked carefully for each residue is the 
chirality of individual group, which is not implemented in the refinement programs. 
Structure Z-scores, positive is better than average: 
  1st generation packing quality   :    -2.774 
  2nd generation packing quality  :    -2.213 
  Ramachandran plot appearance :    -2.996 
  chi-1/chi-2 rotamer normality    :   -2.651 
  Backbone conformation             :   -2.375 
 
 RMS Z-scores, should be close to 1.0: 
  Bond lengths                              :     0.668 
  Bond angles                               :     1.215 
  Omega angle restraints              :     1.595 (loose) 
  Side chain planarity                   :     1.308 
  Improper dihedral distribution   :     0.970 
  Inside/Outside distribution         :     1.052 
Table2: Output of WHAT IF on Cu(I)HSco2 structure after refinement in water box.  
Typically, Z-scores below –3 were considered poor,   
those below –4 were considered bad 
Structure Z-scores from WHAT IF package check dihedral-angle preference and 
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packing of structures. These scores are important to check the quality of the structures. 
Typically, Z-scores below –3 were considered poor, those below –4 were considered bad. 
Among these values, Ramachandran plot appearance checks backbone dihedral angels, φ 
and ϕ, whose combinations should represent in the theoretically allowed angle ranges. 
Similarly, PROCHECK_NMR also constructs dihedral angles mapping in defined four 
areas based on a great number of observations from high-quality of structures: most 
favoured, additionally allowed, generously allowed, and disallowed. For a good structure, 
the total percentage of residues occurring in the most favoured and additionally allowed 
should be more than 90%. In addition to backbone dihedral angles, χ1/χ2 rotamor normality 
scores are indicators for quality of side chain conformations. And scores of packing 
qualities could evaluate the packing qualities of atoms, thus, possibly, finding bad contacts.  
 
Since the determination of solution structures are mainly based on distance restrains 
which are derived from NOESY spectrum, sometimes, it is unlikely to get well-defined 
local conformations when chemical exchange phenomenon is present, resulting in severely 
line broadening. Those residues, whose backbone assignments were missing or the number 
of NOEs was much less than other residues, were excluded in the statistics data.  
 
2.1.6.b Validation of experimental data 
The validation of experimental data consists two parts: NOE violations and NOE 
completeness. As discussed in section 2.1.5, single violation should be smaller than 0.3 Å2. 
Large NOE violation could indicate a wrong assignment and the assignment to 
Fig 6. Ramachandran plot of the minimized 
mean structure of Cu(I)TTHA1943  
81.7% residues occurs in the most favored 
region 
16.1% in additional allowed region 
1.1% in generally allowed region  
1.1% in disallowed region. 
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corresponding cross peaks should be checked. In some cases, average values of target 
function of family structures are very small. In that situation, the scaling constant used for 
calibration of NOESY spectrum should be checked again. That value could be 
overestimated so that the NOE restrains are too loose to define a tight structure.  
The completeness of the NOEs is another important parameter to understand whether 
experimental data is enough to define a high quality structure. In this thesis, all the NOE 
completeness work has been done via online AQUA program [27] 
(http://www.nmr.chem.uu.nl/users/jurgen/Aqua/server/). The input files of AQUA program 
consist of a NOE constrain file and a structure file. Theoretical NOE constrains will be 
predicted from the structures combined with user defined maximal observable distance, 
which is usually set to 4.0 or 5.0 Å. The average completeness for maximum distances of 
4.0 and 5.0 Å for NMR protein structures was 48 +/- 13 and 26 +/- 9 %, respectively.  
 
2.2 Dynamic properties characterization by NMR on different time scales  
 
Function in biological systems is exquisitely dependent on spatial and temporal 
changes in proteins. Innumerable biological processes ultimately rely on transduction of 
information through conformational changes in proteins associated with folding and 
assembly, ligand binding and molecular recognition, and catalysis. A central problem in 
understanding biological processes at a molecular level is the elucidation of how the active 
conformation of proteins is achieved on time scales necessary for function. NMR 
spectroscopy has a unique capacity to investigate dynamic properties of molecules over a 
range of different time scales.   
Interpretation of relaxation parameters of R1, R2 and NOE data of 15N nuclei in 
protein is the most widely used technique to characterize the dynamic properties of protein, 
because local motions on both ps-ns and µs-ms time scale can be studied. Other techniques, 
such as Hydrogen/Deuterium exchange rate (H/D exchange rate) [28], scalar coupling 
constants [29], and residual dipole coupling constants [30], are also well established for the 
investigation of exchange phenomenon. In this thesis, interpretation of relaxation 
parameters and H/D exchange rate are used to investigate the dynamic properties of protein. 
 
2.2.1 the nature of 15N relaxation parameters  
Relaxation rate constants for nuclei in proteins depend upon a large number of factors, 
including: overall rotational correlation times, internal motions, the geometrical 
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arrangement of nuclei, and the relative strengths of the applicable relaxation mechanisms. 
For spin 1/2 nuclei (1H, 13C and 15N) in protein molecules, the dominant relaxation 
mechanisms are the magnetic dipolar and anisotropic chemical shift (CSA) mechanisms [31]. 
Other relaxation mechanisms, such as quadrupolar, scalar coupling interactions and so on 
[31]
, are of minor importance. If the overall correlation time and the three-dimensional 
structural coordinates of the protein are known, relaxation rate constants can be calculated 
in a relatively straightforward manner using redfield relaxation matrix approach. This 
approach introduces the spectral density function, J(ω), which represents the relative 
intensities at which a given frequency is contained within the full spectrum of random 
magnetic background oscillations. The 15N relaxation parameters of a 15N spin of an HN 
amide bond in protein can be obtained by following equations [32]:  
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In eqs. (4) and (5), µ0 = 4π × 10-7 kg m s-2 A-2, h = 6.6262 × 10-34 erg • s, where h is 
Planck’s constant; γH and γN are the gyromagnetic ratios of 1H and 15N respectively 
(2.6753 × 108 rad • s-1 • T-1 and -2.71 × 107 rad • s-1 • T-1); ωH and ωN are the Larmor 
frequencies; ∆σ is the anisotropy of the chemical shift tensor of the 15N spin (160ppm or 
170ppm); rHN is the length of the HN bond (1.02 × 10-8 cm); τc is the correlation time for 
molecular tumbling. In general, τc is proportional to the molecular weight. 
 
2.2.2 determination of overall correlation time 
The first step in data interpretation is the determination of τc. In general, the apparent 
(1) 
(2) 
(3) 
(4) 
(5) 
(6) 
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τc,app for a given spin could be calculated from the ratio of R2/R1. In the case of isotropic 
tumbling, R2/R1 values are, approximately, proportional to ωN2τc2. Ideally, the molecular 
correlation time τc could be obtained from averaging over relaxation data from all the 
resolved residues. However, the τc,app value for a single spin could be much higher or 
smaller than the overall correlation time by two factors: i) the presence of fast local 
motions (ps-ns) will make τc,app smaller than overall correlation time; ii) the line 
broadening contribution to R2 (Rex in µs-ms time scale) will make τc overestimated. 
Therefore residues whose internal mobility is not negligible are excluded to the 
measurement of τc, by two criteria:  
i) the 15N relaxation data of all the residues with a 15N-NOE significantly below the 
maximum (usually with values < 0.65) should be removed from the calculation lists;  
ii) residues with values of [(<R2>- R2) / < R2> - (<R1>- R1) / < R1>] > 1.5 times the std. 
should be removed from the calculation lists 
In the case of anisotropic tumbling, R2/R1 ratio is also affected by the shape of 
globular proteins. A 3×3 diffusion tensor D could be fitted together with 3D-coordination 
structures, instead of a single τc value. In this thesis, the anisotropic diffusion tensors of 
proteins are calculated by using TENSOR2 program [33]. 
 
2.2.3 internal motions determined by reduced spectra density mapping 
Relaxation rate constants are linear combinations of J(ω) sampled at the given 
frequencies of the spin system. Consequently, discrete values of J(ω) can be obtained by 
inverting the systems of Eqs. (1-3). However, three measurable relaxation parameters are 
insufficient to determine uniquely the values of the spectral density function at the five 
frequencies (0, ωH-ωN, ωH +ωN, ωH, ωN). In practice, the linear combinations of J(ωH-ωN), 
J(ωH) and J(ωH+ωN) first order by a single term of the form αJ(βωH), in which α and β 
are constants [34-36]. This approach is called reduced spectral density mapping. In such 
manner, Eqs.(1-3) could be derived to: 
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There are several ways for further approximation on the constant β1, β2 and β3 in 
(7) 
(8) 
(9) 
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order to obtain the spectra density function. The works in this thesis applied the approach 
by neglecting ωN terms (β1=β2 =β3=1). Consequently, the reduced spectral density function 
values at the frequencies of interest are given by 
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J(0) values obtained could be overestimated, if contributions to R2 from chemical 
exchange process, which arises from µs-ms time scale, are present. Thus, from sequential 
plot of the J(0)eff, spins with conformational exchange could be identified by the much 
higher values than average. Similarly, much higher J(ωH) values than average ones 
indicate fast local motions (ps-ns) on those residues. 
The above approximation makes the data analysis easier and convenient to reveal the 
local motions. The limitation for this approach is the fact that the global shape of globular 
protein is always supposed to be spherical. In some systems, the wrong “interpreted 
motions”, in fact, are the consequence of anisotropic tumbling.  
 
2.2.4 internal motions determined by MODEL free approach 
A different approach is called MODEL free approach introduced by Lipari and 
Szabo[37].  Given a protein with isotropic overall rotaional correlation time, the form of the 
corresponding MODEL free spectra density function is a Lorentzian: 
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In the anisotropic rotation case, the J(w) can be written in the form 
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where τc is the overall correlation time. Furthermore, it is assumed that the correlation 
function for the internal motion can be approximated by a single decaying exponential with 
a time constant of τe and decays to a value of S2. The generalized order parameters S2 can 
be interpreted as a measure of the spatial restriction of the internal motion, and the 
effective correlation time τe as a measure of the timescale of the internal motion. It satisfies 
(10) 
(11) 
(12) 
(13) 
(14) 
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the inequality 0<S2<1 and lower values indicate larger amplitudes of internal motions.   
Furthermore, it is occasionally necessary to invoke motion on two widely-separated 
time scales to adequately fit the data, resulting in the so-called “extended model-free” 
spectral density of Clore et al [38]. In this thesis, MODEL free approach was applied to 
analysis the internal motion of protein TTHA1943 and its copper adduct (result 3.5). The 
calculations are performed by TENSOR2 program. 
 
2.2.6 Cross-correlated relaxation rates combined with R2 values provide another hints 
for conformational exchange. 
Undoubtedly, data interpretation of R1, R2 and NOE of 15N nucleus of the isolated HN 
vectors in protein, by different approaches, is the most powerful tool to unravel the local 
motions. There are several convenient programs, such as TENSOR2 and MODEL free, by 
which one can perform detailed analysis 15N relaxation parameters, obtain diffusion tensors 
and get internal dynamic information in different time scales. One can also predict τc value 
and relaxation rates from the known 3D-coordination structure by the programs, like 
HYDRONMR [39], by using rigid body assumption. However, these approaches are good 
only for the rigid system coupled with localized motion, for example, only a few residues 
in the sequence are flexible while the rest residues are rigid. In some unusual cases, which 
is really rare, proteins are fluctuating among all the peptide sequence [40]. In the latter cases, 
conformational exchange (Rex) contributes significantly to R2 values among the whole 
sequence. Thus, the determined τc values are overestimated if following the above 
approaches. Moreover, it is incorrect to interpret data by reduced spectra density mapping 
or MODEL-free approach, since Rex terms could be different from residue to residue. 
In order to determine the τc and estimate Rex values, one can perform experiments for 
measuring the cross-correlated relaxation rate, ηxy. As described above, the dominant 
mechanisms of 15N relaxation in proteins are the dipole-dipole interaction and anisotropic 
chemical shift (CSA)[41]. Beside the single spin relaxation rate, for instance, Nz (R1) and 
Nx (R2), and cross relaxation rate (NOE), these two mechanisms are also the dominant 
mechanisms for the relaxation rates of the coupled spin state, for instance, HzNz, HzNx, 
HxNz and HxNx, and cross correlated relaxation rate Nx-NxHz as well. Different from 
single spin relaxation rate, the transverse cross correlated relaxation rates, ηxy, are not 
affect by conformational exchange. Similarly, ηxy values could be obtained by redfield 
relaxation matrix, with given τc and three-dimensional structure, according to the following 
equation: 
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where  is the angle between the unique axes of the CSA and dipolar tensors; ∆N is the 
difference of the two principal components of the axially symmetric 15N chemical shift 
tensor.  
The quantitative measurement of cross correlation relaxation rates was performed by 
using the pulse scheme designed by Tjadra et al [42]. The ηxy values of well resolved 
residues were also extracted by following the approach in the same article. From the fitted 
ηxy value, τc,app for each residues could be obtained by Eqs. (15). The  values in this work 
were uniformly assumed to be 17o; and ∆N values were assumed to be 160ppm. These 
correlation times are independent from the conformational exchange. Consequently, the 
R2,calc values could be back calculated according to Eqs. (8), assuming no chemical 
exchange contributes to the R2 values. The difference of R2,calc and R2,expt is the value of Rex. 
Since τc,app for each residues could be obtained independently from motions, this 
approach has an advantage in characterization the dynamic properties of wholly fluxional 
system. But the drawback of this approach resides in that several assumptions have to be 
used for data fitting and the sensitivity of the experiments is quite less than the classical R1, 
R2 and NOE measurements.  
  
2.2.6 H/D exchange 
Hydrogen/Deuterium exchange technique can also be used to study protein stability 
and dynamic properties. For a protein that is dissolved in D2O, the H/D exchange can be 
described as in Eqs. (18) [43],  
 
where kop and kcl are the rate constants for opening and closing events in the protein, and 
krc is the rate constant for the H/D exchange at the amide group.  
Under conditions favoring the folded state (i.e., kcl >> kop), the observed exchange 
(16) 
(17) 
(18) 
(15) 
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rate, kex, is given by 
rccl
rcop
ex kk
kk
k
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=
 
Depending on the ratio of krc to kcl, the following two limiting conditions may be 
encountered:  
(i) If  kcl << krc, each opening fluctuation leads to an isotope exchange, and Eqs. 19 
simplifies to 
opex kk =  
In this case, the exchange is limited by the opening rate, kop. Obviously, HN exchange 
measurements under these conditions provide readily interpretable data that can be 
correlated with a key feature of internal protein motility.  
(ii) If kcl >> krc, the intrinsic exchange is the rate-limiting step, and Eqs. 19 reduces to 
rcopex kKk =  
Here, Kop = kop / kcl is the equilibrium constant for the conformational transition between 
the folded and the unfolded states. In this case, the rate of H/D exchange is slow enough to 
detect the kex values. By following the intensities of resonances in 1H-15N HSQC spectra in 
different time, kex can be described by 
0
ln1
I
I
t
kex −=
 
where I is the peak intensity at time t, and I0 is the initial intensity when t is equal to 0. It 
has already been well established to investigate folding and unfolding equilibrium by using 
kex values. In this thesis, this technique was applied to study the stability of β-sheet of 
A629P MNK6. It was found that the kex values of the residues in the last β-strand of A629P 
MNK6, where mutant residue reside, and the residues in the first β-strand, which forming 
H-bonds net work with the last one, are two folder faster or more than those of wild type 
one. This indicates that the stability of the secondary elements is much decreased due to the 
mutation.  
 
2.3 Investigating the metal binding of proteins by NMR spectroscopy 
Identification of the metal-binding sites in proteins and mapping the structural and 
dynamic changes upon metal binding are important for our understanding of the biological 
function of metal-dependent proteins.  
(19) 
(20) 
(21) 
(22) 
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2.3.1 monitoring metal ion binding in protein by NMR 
The binding of diamagnetic metal ions to proteins can be studied by chemical shift 
perturbation caused by the metal ion binding. This approach is also called “chemical shift 
mapping”. The chemical shift perturbations can be followed in titration experiments, where 
the concentration of the diamagnetic metal ion is increased gradually. 
If the exchange rate between metal free and metal bound form are much smaller than 
the chemical shift difference between two forms, two separate peaks will be detected 
during titration experiments. This phenomenon is called “slow exchange”. On the contrary, 
if the exchange between the metal-free and the metal-bound form of the protein is fast 
compared to the chemical shift difference between the two forms, a single exchange-
averaged signal is observed [44]. The chemical shift of the exchange-averaged signal will 
depend on the metal ion concentration. In this thesis, MNK6 protein, Sco family proteins 
and TTHA1943 bind copper ion in a process of slow exchange. The residues, whose 
chemical shifts are significantly different (> 0.2ppm) between apo and holo form, are ones 
close to the binding sites. To consider the chemical shift change on both 1H and 15N 
dimensions, composite chemical shifts are used in the mapping according to Eqs. 23. Fig 7 
shows an example of chemical shift variation between apo and copper form of TTHA1943. 
2
)5/()(
22 NHHN δδδ ∆+∆=
       (23) 
0 20 40 60 80 100 120
0.0
0.2
0.4
0.6
0.8
1.0
Co
m
po
sit
e
 
Ch
e
m
ica
l S
hi
ft 
Va
ria
tio
n
(pp
m
)
Residue number
 
In addition to sulfur atom of Cys residues, nitrogen atom of the aromatic side chain of 
His residues and sulfur atom of Met residues are also potential copper binding ligands.  
Typically, if copper ion is bound to the sulfur atom of Met residues, chemical shift 
Fig 7: combined chemical shift variation between 
apoTTHA1943 and Cu(I)TTHA-1943. Copper ion 
was bound to His 46, Met 59, His 85 and Met 85 
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variation of methyl group (Cε) should be detected in the 1H-13C HSQC. The chemical shift 
changes of His side chains could be followed by a 1H-15N HSQC experiments tailored to 
the detection of 2J 1H-15N coupling. In the latter spectra, three or four patterns represent 
one aromatic side chain of His residues. 
  
2.3.2 Measuring copper binding affinity 
Since the change of signal intensities or positions for the residues around the metal 
binding sites is easily followed in the 1H-15N HSQC with different metal/protein ratio, 
NMR is also a good technique to determine the dissociation constant (KD). But sometimes 
the metal binding affinity is so high that the KD value is unlikely to detect directly with the 
titration between metal and protein. In the slow exchange process, dissociation constant is 
in nM range, with a few exceptions. In this thesis, the KD values of copper proteins were 
measured by copper competition experiments between copper load form of protein and 
copper chelator (DTT). Since copper exchange between protein and DTT is also in a 
process of slow exchange, peak intensities, which represent the same residues in apo and 
copper loaded form, are followed in different DTT/protein ratio. Provided that the reaction 
is in the equilibrium: 
 
The equilibrium constant   
]Pr)(][[
]Pr][)([
oteinICuDTT
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can be fitted according to following equations: 
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where y is the ratio of peak intensities of a residue between copper loaded form and apo 
form (y=[Cu(I)Protein]/[apoProtein]) and x is the ratio between total concentration of DTT 
and total concentration of protein. KD values of protein can be extracted by 
)(DTTDeqD KKK ×=  
where KD(DTT) is 6.31×10-12 M [45] 
If the exchange process of metal binding is very fast, there is, even during the titration, 
only a single set of resonances whose chemical shifts are the fractionally weighted average 
(24) 
(25) 
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of the free and bound chemical shifts. Here the resonances of nuclei close to the binding 
sites move in a continuous fashion during the titration. It is often observed for weaker 
interactions (in µM range), when the interaction is in the process of fast exchange. Within 
the latter range, KD values can be determined directly by fitting chemical shift in different 
metal/protein ratio. Provided a protein binds one diamagnetic metal according to the 
following equilibrium: 
 
KD values can be fitted according to following equations: 
)2(/)4( 2 aabBB −−−∆=∆
∞
δδ
  
where  
)( DKbaB ++−=  
and a and b are the total concentrations of protein and metal ion, respectively. ∆δ is the 
chemical shift change of a protein residue upon addition of metal ion, and ∆δ∞ is the 
estimated chemical shift change for the state where b/a → ∞. 
(26) 
(27) 
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3 
RESULT 
  
 
40 
 
During the three years of the PhD course, I mainly focused my work on protein 
structures determination, protein dynamic properties characterization, metal binding 
affinity measurements and metal mediated protein-protein interactions. All these work 
have been performed by NMR spectroscopy. All the structures mentioned in this thesis 
have been deposited in RCSB PDB. Specifically:  
As discussed in the introduction section, Menkes disease is a fatal disease that can be 
induced by various mutations in the ATP7A gene. One of the disease causing mutations, 
A629P, occurs in the last of the six copper(I) binding soluble domains (MNK6). In order to 
understand why this apparently minor amino acid replacement is pathogenic, solution 
structures of MNK6 and A629P-MNK6 were determined in both apo and copper(I) loaded 
forms. Totally, four structures were obtained. The structure difference induced by mutation 
is subtle. Comparing H/D exchange rates of wild type and mutant proteins, it was shown 
that A629P mutation makes the protein β-sheet more solvent accessible, possibly resulting 
in an enhanced susceptibility of ATP7A to proteolytic cleavage and/or in reduced 
capability of copper(I)-translocation. A small reduction of the affinity for copper(I) was 
also observed. Detailed results were reported in result section 3.1 
In order to understand the function role of HSco1 in CcO assembly, solution 
structures of apo, Cu(I), and Ni(II) human Sco1 have been determined. The protein passes 
from an open and conformationally mobile state to a closed and rigid conformation upon 
metal binding as shown by NMR data. The metal binding ligands are two Cys residues of 
the CXXXCP motif and one highly conserved His residue. Crystals of the Ni(II) derivative 
were also obtained with the Ni(II) ion bound to the same His residue and to the two 
oxidized Cys residues of the CPXXCP motif (The work about crystal structure of 
Ni(II)HSco1 has been done by Dr. Vito Calderone). From the various structures solved, 
two functional roles could be assigned to HSco1 protein: i) copper chaperone for CcO and 
ii) thioredoxin function. Detailed discussions were reported in result section 3.2. 
Mutant P174L of HSco1 The pathogenic mutant (P174L) of human Sco1 produces 
respiratory chain deficiency associated with CcO assembly defects. The position of this 
mutant is the proline residue of CXXXCP binding motif. In order to compare with the wild 
type structure, I solved the solution structure of Cu(I)-P174L-HSco1. It is shown that Leu-
174 prevents the formation of a well packed hydrophobic region around the metal-binding 
site and causes a reduction of the affinity of copper(I) for the protein. KD values for 
Cu(I)WT-HSco1 and Cu(I)P174L-HSco1 are ~10-17 M and ~10-13 M, respectively. The 
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latter value for copper donor to HSco1, Cu(I)1Cox172S-S, is ~10-15 M, indicating that Cox17 
has higher copper affinity than mutant HSco1 but lower than that of WT-HSco1. Thus we 
could conclude that mutant P174L induces less well packed hydrophobic region, decreases 
the copper binding affinity, thus impairs the copper transfer from Cox17 to HSco1. 
Detailed works were shown in result section 3.3. 
The solution structure of copper(I) loaded human Sco2 (Cu(I)HSco2) has also been 
determined. Although the overall fold of Cu(I)HSco2 is highly similar to HSco1 homolog, 
the dynamic properties and the conformational disorder are quite different when the apo 
forms and the copper(I)-loaded forms of the two proteins are compared separately. 
Comparing R2 values and ηxy values of Cu(I)HSco2, it was shown that certain degree of 
fluxionality is present through all the peptide sequence. This property is absent in HSco1 
protein. Such different are accounted for in terms of the different physicochemical 
properties in strategic protein locations. Detailed description was shown in result section 
3.4.  
As discussed in introduction section, the physiological function of Sco proteins in 
prokaryotes go beyond assembly of the CuA of CcO and could be different from organism 
to organism, although Sco proteins are widespread proteins found in many prokaryotic 
organisms. And a new protein, called Hyp1, has been suggested to have a role of copper 
trafficking in prokaryotes.  In order to unravel the function of Hyp1 protein and Sco protein 
in different prokaryotic organisms, the solution structures of Hyp1 protein in T. 
thermopiles, the gene product of TTHA1943, were solved by NMR in both apo and 
copper(I) binding forms. Copper binding affinity was also determined by competition 
experiments, showing a dissociation constant of KD=2.2 ± 0.6×10-13M. Protein-protein 
interactions with Sco protein of T. Thermophillus (TTSco) and CuA have been also 
performed. From various protein-protein interaction data, it is suggested that TTSco might 
function as a thioredoxin, instead of copper chaperone, whereas TTHA1943 is a copper(I) 
chaperone for CuA site. This work has not been published yet and the paper is in 
preparation. Detailed works were shown in section 3.5. 
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Copper is an essential heavy metal involved in
various cellular processes, being required as a
cofactor in several enzymes. Although essential,
copper is toxic when it accumulates beyond an
acceptable level. Since dietary copper intake gener-
ally exceeds the trace amount required, organisms
have evolved mechanisms for the absorption,
delivery, and removal of copper to achieve homeo-
stasis.1–3 The occurrence of human disorders that
disrupt copper homeostasis demonstrates the need
for stringent regulation of intracellular copper
levels: Menkes disease (MD)1 is a disorder associ-
ated with tissue copper deficiency, often leading to
death in the first decade of life, whereas Wilson
disease (WD) results from copper overload and is
more treatable than MD with patients often seekinglsevier Ltd. All rights reserve
disease; WD, Wilson
ation Database; WT,
omain of Menkes
in of Menkes protein;
nkes protein; HSQC,
rence spectroscopy.
ing author:the first medical advice between the second and the
third decade of life.
MD is an X-linked copper deficiency syndrome,
first characterized in 1962.4 It has been shown that
MD is caused by mutations in the gene ATP7A.5–7
This gene encodes a 1500 amino acid residue
copper-translocating P-type ATPase, which is an
integral membrane protein with various soluble
domains, including a long N-terminal cytosolic tail
containing six putative metal-binding domains.
Copper(I) is delivered to the N-terminal metal-
binding domains of the ATPase for subsequent
translocation by a small protein, HAH1, which
functions as a so-called metallochaperone.8 Each of
the six N-terminal domains of ATP7A can bind a
single copper(I) ion by coordinating it to two
cysteine side-chains.9 ATP7A is expressed in most
tissues, including heart, lung, skeletal muscle, skin,
colon, lymphoblasts, fibroblasts, and, at a low level,
pancreas, kidney and stomach (see expression
profile at UniGene†). ATP7A has two important
cellular functions: (i) to facilitate the export of
copper from non-hepatic tissues and its absorptiond.
† http://www.ncbi.nlm.nih.gov/UniGene/ESTProfile-
Viewer.cgi?uglistZHs.496414
410 The Pathogenicity of an ATP7A Mutantinto circulation, and (ii) to deliver copper to the
secretory pathway for incorporation into copper-
dependent enzymes.10 To carry out both functions,
ATP7A must be correctly localized within distinct
subcellular compartments, which is achieved
through a copper-dependent trafficking of the
polypeptide within the cell.11 Under low copper
conditions, ATP7A is localized within the trans-
Golgi network; copper stimulation results in the
redistribution of ATP7A to the plasma membrane
for copper transport into circulation.
The clinical features of MD can be attributed to
the malfunctioning of one or more copper-requiring
enzymes,12 such as lysyl oxidase, cytochrome c
oxidase, and dopamine b-hydroxylase, caused by
the copper deficiency resulting from the absence of
ATP7A activity.13 The clinical features of the disease
are hypopigmented hair and pili torti (kinky hair
syndrome), resulting from reduced keratin cross-
linking, connective tissue fragility (aortic aneur-
ysms, fragile bones) and severe neurological
defects. On the other hand, the mechanisms
accounting for the prenatal cerebral and cerebellar
degeneration remain unknown, implying the exist-
ence of as yet unidentified copper-requiring
enzymes, which play an essential role in neuronal
growth and differentiation in the developing
human fetus.13 ATP7A mutations leading to MD
show great variability. In particular, point
mutations have been reported in a number of
patients, (see the Human Gene Mutation Database
(HGMD)†, and His & Cox14). The various types of
point mutations are represented almost equally
among ATP7A mutations (deletions/insertions
39.1%, missense and nonsense mutations 37.9%,
splice-site mutations 23%). The large majority of the
mutations result in truncation of the protein. Gross
genomic deletions of ATP7A have also been
reported.15 There are very few point mutations
within the N-terminal metal-binding domains
causing MD, with only one missense mutation
reported in the HGMD. This is the Ala629Pro
mutation,16 which is located in the last strand of
the b-sheet of the sixth domain of ATP7A (MNK6
hereafter). A comparison between the disease-
causing mutations of ATP7A and its human paralog
ATP7B (leading to WD) reveals some differences in
their distribution throughout the two genes.14 In
particular, mutations in the region between MNK6
and the first trans-membrane helix are found in
many MD patients, compared with only 3% of WD
patients.14 Notably, mutagenesis of the ATP7B gene
shows that its sixth metal-binding domain is
sufficient but not essential for function.17 These data
suggest that the integrityof theboundarybetween the
cytoplasmic tail and the trans-membrane region,
which has been proposed to be important for proper
interaction between the soluble copper-binding
domains and the remainder of the ATP7A protein
chain,18 may be critical for MD. It is however quite†www.hgmd.orglikely that there is not a single mechanism by which
amino acid substitutions cause MD (or WD), as
different disease-causing variants may show or not
changes in ATP7A localization19 as well as may
retain or not copper(I)-translocation capabilities.20
Indeed, the mutation investigated here is partly
functional when inserted in a yeast strain lacking
the copper(I)-transporting ATPase Ccc2.21 The
present investigation thus contributes to the
accumulating evidence that amino acid substi-
tutions may lead to pathological states by means
of very subtle changes in the behaviour of a protein
in solution rather than by means of disruption of
protein structure or of abrogation of catalytic
activity.22–25 Such effects are difficult to predict
also with respect to their effect on the phenotype.
In this respect it is worth noting that MD is
characterized by a poor correlation between
mutations and phenotype.19,26Results
Protein characterization and structural
calculations
Wild-type (WT) and A629P-MNK6 bound one
copper(I) ion per protein molecule, and were
monomeric in solution in both the apo and
copper(I) forms. Backbone assignments were
obtained using standard strategies based on triple
resonance experiments (Supplementary Data, Table
S1) and are given in the Supplementary Data
(Tables S2–S5). The resonances of the amide
moieties of residues 2 and 16–17 (residues have
been numbered from 1 to 76, rather than starting
from 561, for the sake of simplicity; with this
numbering, the mutated position 629 corresponds
to 69) were not detectable. Combined chemical shift
variations between the apo and copper(I) forms of
WT and A629P-MNK6 are highly similar and
localized around the metal-binding loop (Figure
S1). Combined chemical shift differences between
WT and A629P-MNK6 (Figure 1(a) and (b)) show
that the mutation affects mainly residues 4–6, 9–11,
37, 43, 48, 58, 62–64, 67–68, 70 in the apo form and
residues 4–6, 10–11, 48, 62, 67–68, 70 in the copper(I)
form (taking as significant a variation of at least
0.1 ppm). Residue 11 is in both forms the most
affected by the mutation. In apo-MNK6, these
residues map mainly to the strands b1 and b4,
and the C-terminal part of helix a2 (Figure 1(c)).
However, perturbations extend also to strand b3,
which is H-bonded to b1, and to one residue in b2.
The restraints used in the four structure calcu-
lations performed are in Tables S6–9. Backbone
RMSD values were in all cases around 0.65(G0.10)
A˚. Target function values were satisfactory in all
cases (see Supplementary Data), with no distance
constraint violation above 0.30 A˚. The percentage of
residues in the most favourable regions of the
Ramachandran plot was about 80%. An analysis of
various features of the structures obtained is given
Figure 1. Combined chemical shift variations of
backbone amide moieties between WT and A629P-
MNK6 for both the apo (a) and copper(I) forms (b) of
the protein. The mutation is located at position 69 in the
present numbering scheme. (c) Structure of apo-WT-
MNK6 colour-coded to highlight residues whose back-
bone amide moieties experience combined chemical shift
variations of at least 0.1 ppm (in black). The mutated
residue 69 is identified by a white star. The side-chains of
the metal-binding cysteine residues are also shown.
The Pathogenicity of an ATP7A Mutant 411in Tables S6–9. Table S10 reports the secondary
structures elements identified by PROCHECK.27
Figure 2 shows a comparison of the four structures.
It appears immediately that the mutation does not
affect the fold of the protein, and in particular the
structure of the b-sheet within which the mutated
residue is located (being the last-but-one residue in
the fourth strand). An analysis of the superpositionof the mean structures identifies only the loop
region (residues 49–54) between the third b-strand
and the second a-helix as a stretch with some
difference between the WT and mutant structures.
This region, which is distant from the mutation, has
the higher local RMSD in all structures, suggesting
that the small difference observed is not significant.
The structure of the metal-binding loop region is
instead essentially unaffected by the mutation, even
though residue 16 is not involved in helix a1 in
some structures of apo-A629P-MNK6. Indeed,
variations in the geometry and structural features,
e.g. H-bond patterns, of this loop between apo and
copper(I)-MNK6 are relatively small and do not
follow a defined trend. The same is true when
comparing the structures of A629P-MNK6 and WT-
MNK6.
The temperature dependence of CD and hetero-
nuclear single quantum coherence (HSQC) spectra is
similar for WTand A629P-MNK6. CD spectra are for
both systems only marginally altered between 293 K
and 363 K, indicating that the fraction of unfolded
protein is very small even at the highest temperature.
Instead, A629P-MNK6 is slightly more easily
denatured by guanidinium chloride than WT-MNK6,
as qualitatively demonstrated in Figure 3, which
shows that at 3.5 M [guanidinium] A629P-MNK6 is
completely unfolded, while WT-MNK6 is still partly
folded. Indeed in the spectrum of the latter, peaks
from both the folded and the unfolded protein are
detected, while the spectrum of the former contains
only peaks from the unfolded protein (Figure 3).
Protein dynamics
15N relaxation measurements show that the
protein dynamics on the sub-nanoseconds as well
as microseconds–milliseconds time-scales is essen-
tially the same in all four systems studied here. The
N and C termini are quite flexible on the sub-
nanosecond time-scale, while mobility on the ms–ms
time-scale is observed in the metal-binding loop
region and for the loop between the first a-helix and
the second b-strand, similarly to MNK2.28
The kinetics of H/D exchange up to 20 h has been
measured for the apo and copper(I)-forms of WT
and A629P-MNK6. For both proteins, the variation
in the kinetics of H/D exchange between the apo
and copper(I) forms is small all over the sequence,
with the exception of residues 22–23, 65 and 67,
which are in contact and form a small hydrophobic
cluster. On the other hand, residues in the mutated
protein exchange as fast as or faster than the
corresponding residues in theWT protein. In strand
b4, where the A629P mutation is located, only
residue 68, which precedes in sequence the
mutation, can be compared, as Ser70 exchanges
too fast to be detected in all four systems. Residue
68 in A629P-MNK6 exchanges so fast that its
signal in the first 1H–15N HSQC, taken immediately
after dissolving the sample in 2H2O, is already not
detectable, while the corresponding signal in
WT-MNK6 decays with a half-life of the order of
Figure 2. Comparison of the
structures of apo (right) and cop-
per(I) (left) WT-MNK6 (top) and
A629P-MNK6 (bottom). The metal
site is shown (cysteine bonds in
green; copper(I) ion in pink). The
yellow arrow indicates the pos-
ition of the mutation. The N and C
termini are also labelled, only for
copper(I)-WT-MNK6. The metal
coordination is shown in the
insets.
412 The Pathogenicity of an ATP7A Mutant10–15 min. The same behaviour is also observed
only for residue 11 (Figure 4), which is H-bonded to
residue 68. The other residues featuring significant
(i.e. a twofold or more) variations of their kinetic
constants with respect to the WT-MNK6 are mainly
located in strands b1 and b3, and in part in strand
b2 (Figure 5 and Table S11).
Interaction with HAH1
The interaction of WT and A629P-MNK6 with
HAH1 was studied by titrating the 15N-enrichedFigure 3. Comparison of the 1H–15NHSQC spectra of apo-A
guanidium chloride, showing that A62P-MNK6 is completel
protein are still observable for WT-MNK6. The residues boxe
protein, while no signals from the folded protein can be observ
from folded apo-WT-MNK6 have been boxed (i.e. there are oth
because they are very close to or in overlap with the signalsapo-protein with unlabelled copper(I)-HAH1. The
process was followed through 1H-15N HSQC
spectra. No variation in the chemical shifts of the
amide signals in MNK6 could be observed at any
stage of the titration. Instead, the intensities of apo-
protein signals decreased with increasing HAH1
concentration. Concomitantly, signals correspond-
ing to copper(I)-MNK6 (Met13, Thr14, Cys15, Ser17,
Cys18, Val19 and His20, which are the only ones
clearly distinguishable between the apo and the
copper(I) forms) appeared and increased in inten-
sity along the titration (Figure S2 of Supplementary629P- (right) andWT-MNK6 (left) in the presence of 3.5 M
y unfolded, while well-dispersed signals from the folded
d in the 1H–15N HSQC of WT-MNK6 belong to the folded
ed in the case of A629P-MNK6. Only well-resolved peaks
er peaks from the folded protein that have not been boxed
of the unfolded protein).
Figure 4.Comparison of the first 1H–15NHSQC spectrum taken after dissolving in 2H2O (from left to right) apo-A629P
and WT-MNK6, and copper(I)-A629P and WT-MNK6.
The Pathogenicity of an ATP7A Mutant 413Data). No additional signals from a possible
intermediate could be detected. These results are
analogous to those observed for the MNK2 and
MNK5 domains.29
The above data thus indicate that there is no
formation of an adduct between MNK6 and HAH1
at detectable concentration, while copper(I) is
transferred between the two proteins. The latter
process is slow on the chemical shift time-scale,
setting an upper limit for the equilibration rate
around 102–103 sK1. The molar fraction of apo and
copper(I)-MNK6 as a function of the MNK6:HAH1
molar ratio can be fitted with an equilibrium
constant for the transfer of copper(I) from HAH1
of 8.7(G2.6) for WT-MNK6 and 6.5(G1.1) for
A629P-MNK6, similar to MNK2 and MNK5.29Figure 5. Average solution structure of apo-WT-MNK6
coloured as a function of the variation in H/D exchange
rates between apo-WT-MNK6 and apo-A629P-MNK6.
Residues in grey exchange too fast in both systems to be
detected in HSQC experiments. Residues in blue have the
same exchange rates, within error, in the two proteins,
while residues in red feature at least a twofold variation in
exchange rate. The mutated residue A629P is in green.To define the relative affinity for copper(I) of WT
and A629P-MNK6, an equimolar mixture of apo-
WT-MNK6 and copper(I)-A629P-MNK6 was pre-
pared. The interaction between apo-WT-MNK6 and
copper(I)-A629P-MNK6 is slow on the time-scale of
the NMR chemical shift, and reaches equilibrium
within a few minutes frommixing (i.e. the system is
already at equilibrium in the first HSQC spectrum).
The ratio of the integrals of selected amino acids
displaying well-resolved peaks for the apo and
copper(I)-forms, indicates that the apparent ratio
between the two copper(I) binding constants’
affinity for copper(I) of WT-MNK6 and A629P-
MNK6 is 1.3(G0.2) (WT/A629P). Note that this
value matches the value expected from the ratio of
the equilibrium constants for the transfer of
copper(I) from HAH1 to MNK6 (8.7/6.5Z1.34).
The latter constants have been independently
measured in separate experiments, giving confi-
dence in the observed, albeit small, effect.Discussion
The structural properties of MNK6 are not
significantly altered by the disease-causing A629P
mutation. The same is true for its dynamic proper-
ties on the sub-nanosecond and ms–ms time-scales.
A number of examples have accumulated where
disease-causing mutations are found to marginally
affect the global fold of the protein. In mutants of
superoxide dismutase causing familial amyotrophic
lateral sclerosis (fALS), such as G93A, G37R, the
tertiary structure of the enzyme is essentially
conserved.23 Some small differences have been
detected in protein dynamics.23 Other seemingly
similar subtle mutations associated with fALS still
do not change the fold but induce protein poly-
merization, resulting in the formation of fibres
containing an essentially correctly folded protein.25
This is similar to what is observed in sickle cell
disease, where a mutation of the b-subunit of
hemoglobin induces the formation of fibres
414 The Pathogenicity of an ATP7A Mutantinvolving hemoglobin tetramers, which can be
rescued by the interaction with chains containing
other mutations.30,31 Finally, in the case of Wilson
disease, it has been proposed that the fold of the
common H1069Q mutant (His1069 is located in the
nucleotide-binding domain of ATP7B) is the same
as that of the WT protein at the level of resolution
provided by CD spectroscopy.32 Nevertheless, the
H1069Q mutant has been shown to be degraded
more rapidly than the WT protein.33
Here, a significant difference between WT-MNK6
and A629P-MNK6 is observed for the kinetics of
H/D exchange, both in the apo and copper(I) forms.
Under non-denaturing conditions, the mechanism
for H/D exchange in well-folded proteins involves
an equilibrium between a so-called closed state
(which is not competent for exchange) and an open
state (which is the one allowing the amide proton to
exchange). H/D exchange takes place from the
open state, with an intrinsic kinetic constant that
depends only on the primary sequence and the pH
of the solution.34 The experimental kinetic constant
is equal to the product of the equilibrium constant
and the intrinsic kinetic constant. The opening
reaction for each residue can be interpreted as a
folding/unfolding equilibrium involving that par-
ticular residue.34,35 Coordinated opening of more
than a single amide group is often detected, leading
to the concept of the existence of “cooperative
folding units” within proteins.35
Calculations of the intrinsic exchange rates with
well-established methods36 predict that, except for
residue 70, they are not affected by the mutation.
Consequently, the ratio of the H/D exchange
kinetics constants measured for each backbone
amide in WT and A629P-MNK6 is equal to the
ratio of the corresponding equilibrium constants for
the opening reaction. The experimental exchange
rates in A629P-MNK6 are equal to or, particularly in
the protein b-sheet (Figure 5), higher than the rates
observed for WT-MNK6. Thus, it can be concluded
that for the mutant protein the equilibria between
folded and unfolded conformations are shifted
towards the unfolded state(s), i.e. the b-sheet is
more often transiently exposed to the bulk solvent.
This is in agreement with the finding that denatura-
tion by guanidinium is more easily induced for
A629P-MNK6 than for WT-MNK6 (Figure 3). The
most dramatic evidence for increased propensity
towards unfolding is observed for residues 11 and
68 (Figure 4). In addition, several other residues
mainly in the b-sheet are characterized by enhanced
H/D exchange rate in the mutant (Figure 5),
indicating that the weakening introduced in the
connection between the first and the last strands
makes the entire element of secondary structure
more prone to opening, i.e. makes partially
unfolded states more easily populated under native
conditions. This is also suggested by inspection of
Figure 1, showing that combined chemical shift
variations, which can be taken as indicative of slight
changes in inter-atomic contacts and/or H-bonds,
are largest close (in space) to the mutation site, butextend through the b-sheet as well as helix a1.
Comparison of Figures 1(c) and 5 additionally
shows that residues experiencing variation in
exchange rates often correspond to or are adjacent
to residues whose amide moieties have combined
chemical shift variations larger than 0.1 ppm.
From the structural point of view this is due to the
mutation causing some minor rearrangements by
affecting the packing of side-chains. Indeed, the
impact of the mutation on the structure is expected
to be small as the side-chain of the Ala in
WT-MNK6 does not form close contacts with
other residues. Therefore, given the similar polarity
and size (the Pro side-chain volume is ca twice that
of Ala), a Pro residue should be accommodated in
the same position with relative ease. On the other
hand, in the various soluble domains of ATP7A
(and ATP7B as well), the position corresponding to
Ala629 is always occupied by an alanine, but in the
third domain. The small repacking associated with
the mutation, while leaving essentially unaltered
the protein fold, weakens significantly the H-bond
pattern connecting strands b1 and b4, which then
acts as a “nucleation seed” for enhanced transient
unfolding of the b-sheet. As discussed at the
beginning of this section, in fact subtle changes in
interatomic contacts may affect significantly the
behaviour in solution of various proteins, leading to
or modulating the phenotype of pathological states.
The present data show that HAH1 is capable of
transferring copper(I) to both WT and A629P-
MNK6. The affinity for copper(I) of the protein is
marginally lowered by the mutation, as competition
experiments indicate that the WT has a binding
constant 20–30% higher than that of the A629P
protein. This is the only other observable difference,
in addition to the loosening of the b-sheet discussed
above, between WT and A629P-MNK6. The vari-
ation in copper(I) affinity observed is however well
within the expected span of the affinity constants of
each individual metal-binding domain, as
suggested by data for human ATP7B.37 The relative
contribution of the other five soluble domains to
transferring copper(I) from the cytoplasm to the
binding site in the trans-membrane part of ATP7A
is unknown, while for ATP7B it has been shown
that a mutant in which the cysteine residues
of the sixth domain only had been removed
could deliver copper to Fet3p as well as normal
ATP7B.17
It can be proposed that the mechanism by which
the A629P mutation causes MD is linked to two
factors. The first one is that the increased readiness
of the sixth domain to expose its backbone might
render the protein more susceptible to degradation,
i.e. may increase the turn-over rate of the protein,
ultimately leading to a decreased concentration on
the membrane surface. Indeed, it is known that
unstructured regions serve as the initiation site for
degradation, being hydrolysed first, after which the
rest of the protein is digested sequentially.38 In
agreement with the present proposal, degradation
of the Wilson disease-causing H1069Q mutant is
The Pathogenicity of an ATP7A Mutant 415faster than for theWT protein.33 A second factor is a
slightly decreased metal-binding ability of the sixth
soluble domain, possibly leading to decreased
efficiency in transporting copper(I) across the
membrane. These two factors could actually work
synergistically in causing MD, by making
mutant ATP7A an enzyme that is both less
efficient and more quickly recycled than the WT
protein. Enhanced proteolysis of the ATP7B protein
could play a role in the onset of Wilson disease,
where various disease-causing missense mutations,
mapped to the metal-binding domains 2, 5 and 6,
have been reported.14 A similar contention has
been proposed for the H1069Q mutation.33 Note
that domain 2 in ATP7B is a proposed
preferential entry point for copper(I) delivered by
HAH1.39,40
Here, it is shown that the A629P mutation
produces subtle effects on the properties of
MNK6. This may be in agreement with the
observation that A629P-ATP7A produces reduced
(with respect to normal ATP7A) but still detectable
levels of functional (i.e. copper-containing) Fet3p in
yeast lacking Ccc2 (ccc2D) at variance with other
two ATP7A mutants, P1001A and H1086Q, which
are not able to restore copper incorporation into
Fet3p.21 Notably, the study in ccc2D-yeast21 indi-
cates that the onset of alterations in copper(I)
homeostasis induced by the A629P mutation is
not, or only partly, dependent on re-localization of
ATP7A from the trans-Golgi network to the plasma
membrane, because this process is absent in yeast.
Note that the re-localization and transport proper-
ties of ATP7A can be uncoupled, leading to MD
mutations retaining copper(I) transport function
but with detective re-localization.20 In particular,
this has been demonstrated for a deletion of the
sequence between Ser624 and Gln649, encoded in
exon 8, which comprises the last b-strand of MNK6
and a part of the linker between MNK6 and the
first trans-membrane helix.20 This mutation
responded well to copper replacement therapy.20
On the other hand, incorrect localization is not
necessarily the only molecular mechanism under-
lying MD.19
As in the case of other diseases (such as fALS,
sickle cell anemia, and the related WD),
mutations causing MD can induce a variety of
different subtle effects at the molecular level
leading to the pathological phenotype. In par-
ticular, protein structure as well as catalytic
function may be little affected, and other factors
such as propensity to aggregation or thermo-
dynamic stability are determinant for the onset
of disease. The relative importance of the effects
induced is quite variable among the different
mutations, even in the presence of similar
phenotypes. The present data, together with
available studies in ccc2D-yeast,21 suggest that
reduction in copper(I) affinity and, perhaps more
importantly, enhanced protein turn-over are
involved in the mechanism by which the A629P
mutation induces MD.Materials and Methods
The protocol adopted to express and purify WT-MNK6
and A629P-MNK6 was essentially the same as that
previously used by us to produce MNK2.28 The
expression plasmid for WT-MNK6 was obtained as
described for MNK2, while the expression plasmid for
A629P-MNK6 was obtained from that of WT-MNK6
through the Quickchange (Stratagene) mutagenesis kit.
The poly-His tag was removed from MNK6 protein
samples used for assignments and structure calculations.
Copper(I)-containing samples were prepared by incubat-
ing the apo-protein with a slight excess of the acetonitrile
complex of copper(I). Recombinant protein characteriz-
ation, NMR frequency assignments and solution
structure determinations were carried out as done for
MNK2.28 A table summarizing the NMR experiments
performed on WT-MNK6 and A629P-MNK6 is given
in the Supplementary Data (Table S1).
Variations in the position of signals between apo and
copper(I)-MNK6 are quantified through the combined
chemical shift variation.41 This is calculated from the
experimental 1H and 15N chemical shift variations
(Dd(1H) and Dd(15N), respectively) measured between
corresponding peaks in the two forms, through the
following equation:
DdcombinedZ
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ðDdð1HÞÞ2C 125 ðDdð15NÞÞ2
2
s
HAH1 samples were produced as described, always
without poly-His tag.42 The procedure used to investigate
the interaction between WTor A629P-MNK6 with HAH1
was the same as reported for the interaction between
MNK2 and MNK5 with HAH1,29 by adding copper(I)-
HAH1 to apo-MNK6 directly in the NMR tube (under N2
atmosphere). Titrations were carried out up to
MNK6:HAH1 ratios of 1:1.4, and could be fit to an
equilibrium constant for copper(I) exchange, according to
the following equation:
copperðIÞHAH1Capo MNK6$apo HAH1
CcopperðIÞMNK6
To investigate the exchange of copper(I) between WT
and A629P-MNK6, we prepared an equimolar solution of
unlabelled copper(I)-A629P-MNK6 and 15N labelled apo-
WT-MNK6, and measured the relative intensities of
signals in the 1H-15N HSQC spectrum of apo and
copper(I)-WT-MNK6. The above procedure is equivalent
to mixing one equivalent of each apo-protein with only
one equivalent of copper(I).
The thermodynamic stability of apo, WT and A629P-
MNK6 was determined (i) by titrating the proteins with
guanidinium chloride (pH 7), up to 3.5 M, followed
through 1H–15N HSQC spectra; (ii) through variable
temperature CD experiments using a JASCO J-810
spectrometer and a Peltier temperature controller; (iii)
through variable temperature 1H–15N HSQC spectra.Protein Data Bank accession codes
The structures and NMR constraints have been
deposited in the RCSB PDB (codes 1YJR, 1YJT, 1YJU,
1YJV).
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The solution structures of apo, Cu(I), and Ni(II) human Sco1 have
been determined. The protein passes from an open and confor-
mationally mobile state to a closed and rigid conformation upon
metal binding as shown by electrospray ionization MS and NMR
data. The metal ligands of Cu(I) are two Cys residues of the CPXXCP
motif and a His residue. The latter is suitably located to coordinate
the metal anchored by the two Cys residues. The coordination
sphere of Ni(II) in solution is completed by another ligand, possibly
Asp. Crystals of the Ni(II) derivative were also obtained with the
Ni(II) ion bound to the same His residue and to the two oxidized Cys
residues of the CPXXCP motif. We propose that the various struc-
tures solved here represent the various states of the protein in its
functional cycle and that the metal can be bound to the oxidized
protein at a certain stage. Although it now seems reasonable that
Sco1, which is characterized by a thioredoxin fold, has evolved to
bind a metal atom via the di-Cys motif to act as a copper chaperone,
the oxidized form of the nickel-bound protein suggests that it may
also maintain the thioredoxin function.
cytochrome c oxidase  NMR  x-ray  assembly factor
Sco is a family of proteins ubiquitous to all kingdoms of life.Ortholog and paralog genome browsing has shown that one or
more representative of this class are present in most bacterial and
eukaryotic genomes (1, 2). In the bacterial operons, Sco proteins
often are associated with copper enzymes, suggesting that they are
involved in the maturation or functioning of such enzymes (1).
Eukaryotic genomes contain two paralogs, Sco1 and Sco2 (3, 4),
both involved in copper-dependent assembly of cytochrome c
oxidase (CcO) (5).CcOcontains two functional copper ions located
in the binuclearCuA site and one located in the binuclearCuB-heme
a3 site (6). CcO is a multimeric enzyme complex embedded in the
inner mitochondrial membrane of all eukaryotes and in the plasma
membrane of prokaryotes, and it functions as terminal enzyme of
the respiratory chain (7). Sco1 was first suggested to be involved in
copper ion delivery to the CcO complex based on the observation
that, in the presence of high copper concentrations, overexpression
of either Sco1 or the homologous Sco2 can restore the CcO activity
of Saccharomyces cerevisiae strains lacking the gene of the mito-
chondrial copper chaperone Cox17 (8). Yeast strains lacking Sco1
also are respiratory deficient, and an excess of copper andor
overexpression of either Cox17 or Sco2 cannot compensate for the
Sco1-associated CcO deficiency (8). The absolute requirement of
Sco1 in the activation of CcO indicates that Sco1 functions down-
stream fromCox17 in the delivery of copper toCcO. Indeed, in vitro
Sco1 can receive copper from the copper chaperone Cox17 (9).
Human Sco1 (HSco1) is a 301-residue polypeptide anchored
through a single helix to the inner mitochondrial membrane of
eukaryotes (10). The functional part of the Sco1 protein is com-
posed of a single soluble domain, located in C-terminal region,
whereas the N terminus contains a mitochondrial-targeting se-
quence followed by a transmembrane helix (11). The structure of
the soluble domain was first resolved by NMR for apoSco1 from
Bacillus subtilis (12). The structure revealed a potential metal
binding site constituted by two Cys residues present in a conserved
motif CPXXCP and a fully conserved His residue, in agreement
with earlier extended x-ray absorption fine structure investigations
of yeast Cu(I)Sco1 (13). Besides extended x-ray absorption fine
structure data many other spectroscopic data on the human, yeast,
and B. subtilis Sco proteins have confirmed that the protein binds
Cu(I), Cu(II), and other metal ions (14–17). The fold of apoSco1
protein, which contains four -helices and seven -strands orga-
nized in two -sheets (12), is atypical for a metal chaperone given
that it resembles the fold of thioredoxins, which are enzymes
specialized for the reduction of protein disulfides (18). Also, the
x-ray structures of the apo forms of the B. subtilis Sco1 and HSco1
proteins have been determined (16, 19). Some crystals of B. subtilis
apoSco1 contained Sco1 with SOS bonds, thus supporting a role of
the protein in redox processes. In addition, it has been recently
suggested on the basis of the extreme sensitivity of the yeast
sco1-null mutant to hydrogen peroxide that HSco1 might function
as a mitochondrial redox signaling molecule (19). Thus, the specific
role of Sco1 in maturation of CcO, either as a copper chaperone or
connected with redox processes, is still elusive.
To date there are no structures available for anymetallated forms
of Sco1 proteins. The structure of the metal adducts is, however,
crucial for understanding the mechanism of Sco-mediated copper
insertion into CcO. We have succeeded in preparing a human
Cu(I)Sco1 derivative [hereafter referred to as Cu(I)HSco1] in vitro
and have determined its solution structure through NMR. We also
have investigated the structure of the Ni(II) derivative of HSco1 as
a model for the binding of bipositive metal ions like Cu(II). We
would like to stress that NMR solution structure determination of
metalloproteins is a difficult challenge as far as the protein metal-
binding mode is concerned because NMR does not provide direct
information on protein–metal interaction. In contrast, it is also
common that the crystallization procedures might provide deriva-
tives different than the physiological ones. Still, these derivatives
may be significant as models of transient species and for the
mechanism of action. Indeed, the x-ray structure of human
Ni(II)Sco1 [hereafter referred to as Ni(II)HSco1], also reported
here, displays a completely different metal binding with respect to
the solution structure, being the metal bound to the SOS bond of
the oxidized HSco1. Structural information for different conform-
ers of the same protein is extremely valuable because individual
structures often mimic transient species, which enable elucidation
of the mechanism of protein action.
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Here, we propose that the Cu(I)HSco1 species act as chap-
erones for copper ion delivery and that the specific oxidation of
metal-ligating thiolates of HSco1 could have a role in the transfer
of copper ions to CcO.
Results
Two truncated forms of the HSco1 gene have been engineered,
both lacking the N-terminal mitochondrial targeting sequence
and the single-transmembrane helix (Fig. 1). The two truncated
forms differ by a 14-aa segment at the N-terminal side. This
14-aa segment is rich in positively and negatively charged
residues and is predicted to be unstructured. Size-exclusion
chromatography equipped with multiangle light scattering shows
that the shorter apoHSco1 construct eluted in fractions corre-
sponding to a monomeric state for the protein, whereas the
longer construct eluted as a dimer (see Fig. 6, which is published
as supporting information on the PNAS web site). This obser-
vation suggests that the residues separating the transmembrane
helix from the folded domain are essential to promote dimer-
ization. In vivo studies also have shown that this N-terminal
region is crucial for yeast Sco1 function and cannot be replaced,
even by its Sco2 counterpart (20).
For the structural and electrospray ionization (ESI)-MS char-
acterization, the short construct of 170 aa (corresponding to
residue segment 132–301) of the HSco1 gene was used. Addi-
tionally, this construct contains an additional 4-aa segment
(GSFT), corresponding to the tobacco etch virus protease
recognition site at the N terminus (Fig. 1), thus producing a final
construct of 174 aa whose identity was confirmed by ESI-MS
analysis. The ESI-MS spectrum of the oxidized apoWT-HSco1
showed two main peaks corresponding to 9 and 10 ions, and
the deconvolution of the spectrum gave the expected molecular
mass of 19,741.3 Da. Incubation of oxidized HSco1 with 1 mM
DTT increased molecular mass by 2.3 Da (molecular mass 
19,743.9 Da), which indicates that the disulfide bridge in HSco1
could be reduced easily by 1 mM DTT.
Reconstitution of Fully Reduced HSco1 with Metal Ions.We are able
to prepare HSco1 containing Cu(I) ions at 1:1, a ratio suitable
for structural studies. Mass spectra of fully reduced HSco1
reconstituted at pH 7.5 with increasing concentrations of Cu(I)
ions, are presented in Fig. 7, which is published as supporting
information on the PNAS web site. Addition of one equivalent
of Cu(I) ions to reduced HSco1 generates a new peak in MS
spectrum, which corresponds to Cu1HSco1 (Fig. 7). Addition of
further equivalents of Cu(I) ions leads to a slight additional
increase of the Cu1HSco1 peak but does not induce metal-
loforms with higher metal stoichiometry (Fig. 7). We also
showed that oxidized HSco1 does not form complex with Cu(II)
ions in an ESI-MS experiment (Fig. 7), which indicates that such
a complex, even if present in solution, is weak and dissociates
during the ESI process. Accordingly, addition of Ni(II)Cl2 to
oxidized 15N HSco1 does not affect the 1H–15N heteronuclear
single quantum correlation (HSQC) spectrum. However, we
have prepared the Cu(II) and Ni(II)HSco1 derivatives of re-
ducedHSco1 in a 1:1 metalprotein ratio. The ultravioletvisible
(UVVIS) and EPR spectra of Cu(II)HSco1 are identical to
those recently reported (15). Similar UVVIS spectra also were
reported for bacterial Sco homologues (12, 14, 17) and Cu(II)
nitrosocyanin (21, 22). In addition, the UVVIS spectrum of
Ni(II)HSco1 (Fig. 8, which is published as supporting informa-
tion on the PNAS web site) is similar to that reported for the B.
subtilis and Rhodobacter sphaeroides homologues (14, 17), with
two weak bands at 380 and 540 nm, respectively, correlating with
the two low-energy bands of the Cu(II)HSco1 spectrum al-
though shifted to lower energy (Fig. 8). The intense thiolate-
Ni(II) charge transfer band (23) is also red-shifted at 304 nmwith
respect to the Cu(II)HSco1 spectrum (Fig. 8).
The aggregation state and the conformational properties of
the Cu(I) and Ni(II)HSco1 forms have been investigated by
multiple techniques, including size-exclusion chromatography,
ESI-MS, and NMR. In NMR, 15N relaxation rates are modulated
by the correlation time for the protein tumbling (m), which is
directly related to the molecular weight of the protein, thus
monitoring its aggregation state (24). The correlation times of
Cu(I)HSco1 and Ni(II)HSco1 proteins (at millimolar concen-
trations) are 14.5  1.1 ns and 15.6  1.2, respectively, as
expected for a protein of this size in a monomeric state. These
values also are similar to the m of apoHSco1 (13.8  1.6 ns),
which reorients in solution as a monomeric protein as shown by
size-exclusion chromatography and multiangle light scattering
experiments. ESI-MS experiments conducted at a 1.8 M con-
centration of protein did not detect any higher aggregates for
apoHSco1 or Cu1HSco1. ESI-MS spectra and, especially, the
charge-state distribution of ions also can yield information about
the conformational states of proteins under a variety of condi-
tions (25). Upon the binding of Cu(I), the charge state distri-
bution of Cu1HSco1 species shifted toward ions with lower
charges (9 and 8), which indicates that binding of metal
induces a conformation change of the protein to a more compact
state (Fig. 7).
Cu(I), Ni(II), and apoHSco1 Solution Structures. The solution struc-
tures of Cu(I)HSco1 and Ni(II)HSco1 (Fig. 2) were determined
by using distance and angle restraints as obtained from 2D and
3D heteronuclear NMR experiments (Table 1, which is pub-
lished as supporting information on the PNAS web site). The
overall fold of Cu(I)HSco1 and Ni(II)HSco1 structures is the
same as that of the crystal structure of apoHSco1 (19) and
contains four -helices and nine -strands organized into the
thioredoxin fold. The solution structure of apoHSco1 also
displays the same global thioredoxin fold. However, the -hair-
pin present in the extended, solvent-exposed loop-8 region does
not form anymore (Fig. 2).
Cu(I) is coordinated by the two Cys residues of the CPXXCP
conserved motif, shared by the third loop and helix 1, and by
the conserved His-260 (Fig. 2), located in the seventh -strand,
as shown by 2JNH coupling-based 1H–15N HSQC experiments
Fig. 1. Diagram of the protein sequence and cloned constructs of HSco1. The positions of the mitochondrial target sequence (MTS), transmembrane helix (TM),
and the soluble fragment of HSco1 are orange, blue, and yellow, respectively. The N terminus of HSco1 protruding into the mitochondrial matrix is green. The
soluble fragments used in the present study are named long and short truncated constructs. The truncates lack only the mitochondrial target sequence and
transmembrane helix. The essential CPXXCP motif, the tobacco etch virus protease recognition site (GSFT), and the 14-aa segment (red dotted box) at the N
terminus side are indicated in bold. The positively and negatively charged amino acids are represented in blue and red, respectively.
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(Fig. 9, which is published as supporting information on the
PNAS web site). From these experiments, it appears that, in
Cu(I)HSco1, His-260 acquires a preferential conformation
where N1 is protonated and N2 is coordinated to the metal ion.
The involvement in the metal binding of residues from two
different regions of the protein produces a compact state of
protein with respect to the apo form, in agreement with obser-
vations in ESI-MS experiments. Backbone NH resonances of
three regions comprising residues 166–180, 202–204, and 244–
264 are indeed not detected in the 1H–15N HSQC spectrum
of apoHSco1, although they are present in both Cu(I) and
Ni(II)HSco1 spectra. These three regions comprise the
CPXXCP metal-binding motif and the surrounding loops 5 and
8, the latter containing the third ligand, His-260. The inability to
detect the backbone NH signals listed above is because of their
fast exchange with the bulk solvent or because of the presence
of multiple backbone conformations in the metal-binding area of
apoHSco1, whereas the metal binding is able to ‘‘freeze’’ these
regions in a more rigid conformation. In particular, the large
conformational variability of the long loop 8 observed in the
apoHSco1 solution structure (no long-range nuclear Overhauser
effects are detected in loop 8) indicates that backbone structural
changes are necessary to locate the metal ligand His-260 in the
vicinity of the other two ligands, Cys-169 and Cys-173 (Fig. 2).
Analysis of backbone dynamics (Fig. 10, which is published as
supporting information on the PNAS web site) also is in agree-
ment with the latter picture and demonstrates that both metal-
lated forms of HSco1 do not display extensive motions on both
milli- to microsecond andor nano- to picosecond time scales,
with the exception of the C and N termini.
When reduced, HSco1 binds a divalent cation, as Ni(II), and
the metal is still bound by the two Cys residues of the CPXXCP
motif and by His-260 through the N2 atom (Fig. 2), as confirmed
by 2J 1H–15N HSQC NMR experiments. Because Ni(II) is
expected to be at least four-coordinated, it is feasible that a forth
ligand is completing its coordination sphere. This ligand could be
a water molecule or a residue donated by the protein. The
solution structure of Ni(II)HSco1 shows that two acidic groups
(Asp-171 and Asp-259) could complete the Ni(II) coordination
sphere, but our data do not allow discrimination between these
two possibilities.
Ni(II)HSco1 Crystal Structure. Crystals of the Ni(II)HSco1 deriva-
tive also were obtained in aerobic conditions. The overall
structure of the Ni(II)HSco1 complex is essentially superimpos-
able with that of apoHSco1 [Protein Data Bank (PDB) ID code
1WP0] (19), which was used as the model in the molecular
replacement. The main exception is the solvent exposed a region
involving residues 240–260 (loop 8 and the -hairpin), ending
with the metal-binding His-260. This loop indeed acquires a
more ordered conformation as a consequence of the metal
binding, according to the behavior in solution; this greater
stability is confirmed by the good quality of the electron density
map in that region for both molecules in the asymmetric unit,
which is indeed better than that observed in the apoHSco1
crystal structure (19). A further confirmation is the significantly
lower temperature factors of the atoms belonging to the above-
mentioned loop in the structure of Ni(II)HSco1 with respect to
those of the crystal structure of apoHSco1 (19).
The coordination sphere of Ni(II) in the crystal structure of
Ni(II)HSco1 is quite odd and unexpected. In this structure, the
Fig. 3. The distorted square planar coordination of nickel as present in the
x-ray structure of oxidized Ni(II)HSco1. Bonding distances between nickel and
the coordinating moieties are shown in green along with the distance be-
tween the two Cys residues. The distance between the nickel ion and the OH
oxygen of Tyr-163 is also shown in magenta, and it is too large to be considered
a bonding interaction.
Fig. 2. Solution structures of human Cu(I), Ni(II), and apoSco1. (Left) The
superimposition of 20 structures of Cu(I), Ni(II) and apoHSco1 are shown.
-helices and -strands are colored in red and cyan, respectively. (Right) The
average structures of the lowest energy ensemble are shown. The metal-
binding residues Cys-169, Cys-173, and His-260 are shown in yellow and blue,
respectively. Cu(I) and Ni(II) ions are depicted as orange and pink spheres,
respectively.
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two metal-binding Cys residues are oxidized and form a disulfide
bond (Fig. 3; see also Fig. 11, which is published as supporting
information on the PNAS web site) and therefore not capable of
binding the Ni(II) ion as thiolates. Still, the metal ion remains in
contact with the SOS bridge with a NiOS distance of 2.0–2.2 Å,
suggesting the formation of bonds with the available lone pairs
of sulfur atoms (Fig. 3). The coordination sphere of Ni(II) is
completed by His-260 (N2ONi, 2.03–2.45 Å), in agreement with
the solution structure of Ni(II)HSco1, and a water molecule or
more likely an anion such as Cl arranged in a distorted square
planar geometry.
We have been able to trace one case only in the PDB of a
nickel ion coordinated to Cys residues (PDB ID code 1FRF) that
are at bonding distance; in this case, the metal-binding site is
dinuclear (iron and nickel) and is made of four Cys residues
pointing toward two metal ions that are at a distance of 3.2 Å
from each other. Cys-75 and Cys-546 are at interaction distance
(2.4 Å), whereas Cys-72 and Cys-543 are farther apart (3.0 Å)
(26). The distances between nickel and the four sulfur atoms are
as follows: Cys-72–Ni, 2.15 Å; Cys-543–Ni, 2.11 Å; Cys-75–Ni,
1.61 Å; and Cys-546–Ni, 2.44 Å.
Discussion
The solution and crystal structures of the metal derivatives of
HSco1 are completely superimposable along the entire amino acid
sequence (Fig. 4) (backbone rms deviation to the new structure
within 0.8 Å). These structures also are very similar to the solution
structure of apoHSco1 with the exception of loop 8, which displays
a different backbone conformation in apoHSco1, positioning the
imidazole ring of His-260 at 10 Å from the sulfur atoms of the
metal binding Cys residues (Fig. 4). In addition, helix 2, which
encompasses the CPXXCP metal-binding site at its N terminus, is
tilted in the apo solution structure with respect to the structure of
themetallatedHSco1 (Fig. 4). From theNMRstructures, it appears
that the apo form is highly disordered around themetal binding site,
sampling more open conformations than in the metallated forms
(Fig. 2). This observation also agrees with the results of confor-
mation analysis byESI-MS. In the x-ray structure of apoHSco1 (19),
however, the protein is frozen in a specific conformation that does
not reflect the real condition in solution. Therefore, metal binding
is accompanied by a relatively large, albeit localized, effect on the
protein structure, mainly involving loop 8: From an open confor-
mation with local disorder, the structure converts into a well
defined, compact state in which a metal ion is bound. In particular,
the presence of the His ligand, suitably located in loop 8 to
coordinate both divalent and monovalent metal ions, is important
to modulate the order and disorder state of loop 8 observed in the
metallated and apo forms, respectively. Also taking into account
that disordered regions in protein structure often are engaged in
protein–protein interactions (27), one may speculate that loop 8
modulates association–dissociation of HSco1 with its partner, the
Cu(I) chaperone Cox17. For example, it is possible that, once
Cu(I)Cox17 interacts transiently with apoHSco1 and donates its
copper cargo to HSco1, loop 8 structurally rearranges and allows
His binding and concomitant formation of the compact Cu(I)H-
Sco1 structure, which might not exchange copper with Cox17. The
formation of the stable, compact Cu(I)HSco1 state could thus
constitute the important driving force of the copper transfer from
Cox17 to HSco1.
Biological Context. The debate on whether HSco1 is a metal-
loprotein or a thioredoxin can significantly be advanced in light
of the structural results presented here. HSco1 forms 1:1 com-
plexes with the Cu(I) and Ni(II) ions by exploiting the same
metal binding ligands, which confirms that HSco1 is suitable for
binding both monovalent and divalent metal ions (15). Reduced
HSco1 also can bind one equivalent of Cu(II); however, the
reconstituted Cu(II)HSco1 complex shows two different coor-
dination environments with different populations (15). Similar
results on Cu(II)Sco1 complexes also were obtained for the B.
subtilis and yeast proteins (12, 15). It is therefore reasonable to
assign a copper chaperone role to HSco1, the metal ion being
coordinated by two Cys residues and one His residue. A similar
metal-binding site also is found in another copper chaperone,
i.e., the ATX1 from Synecocystis (28). Similarly to the latter
system, themetal-donating and themetal-receiving coordination
sites are different, thus overcoming the condition that ‘‘donor’’
and ‘‘recipient’’ protein partners in metal transfer processes need
metal-binding sites similar in structure, as recently suggested
(29). The presence of three ligands, one of each being a
‘‘f lexible’’ His residue, also makes the site suitable for the
binding of divalent metal ions. Indeed, Cu(II), Ni(II), and,
presumably, Zn(II) (14) can bind at the same site of HSco1. In
the case of a divalent metals, the coordination can be completed
by an additional exogenous ligand, e.g., H2O, or by a protein
carboxylate. The latter hypothesis is supported by the observa-
tion that the affinity of HSco1 for the Cu(II) ion is reduced if
Asp-259 is mutated (15).
The fold of HSco1 is similar to that of redox-active proteins
like thioredoxins and peroxiredoxins, with themetal-binding Cys
residues located at the same positions as the conserved catalytic
Cys residues in thioredoxins. This feature became apparent when
the first structure of a Sco1 homolog was solved (12). Therefore,
a thioredoxin fold has evolved as a metal chaperone to bind the
metal atom via the di-Cys motif, and one may speculate that the
thioredoxin function is still maintained. Indeed, apoHSco1 can
be easily oxidized to form SOS bonds. In this research, we also
have shown that, in the oxidized form, the protein has low
affinity for metal ions because their addition did not affect the
1H–15N HSQC spectrum of oxidized apoHSco1, and no metal
adduct has been detected by ESI-MS experiments. In the PDB,
only one example of a metal ion bound to an oxidized SOS bond
is reported (26). Therefore, it is feasible that the present crystal
structure of the nickel derivative of oxidized HSco1 represents
the transient copper-delivery complex, which might exist just
before the copper is transferred to the CuA site of the COXII
subunit. Indeed, biochemical and genetic studies on yeast Sco1
Fig. 4. Overlay of the backbone of apo (blue), Cu(I) (green), and Ni(II) (red)
HSco1 solution structures and of Ni(II) (black) HSco1 x-ray structure.
8598  www.pnas.orgcgidoi10.1073pnas.0601375103 Banci et al.
demonstrated its ability for direct interaction with the COXII
subunit (30, 31). Because numerous proteins in the mitochon-
drial intermembrane space have disulfide bonds (32–34), the two
Cys residues of the CuA site of COXII may also require reduction
before metal transfer. The same requirement applies to the
bacteria in which the COXII subunit is exposed to oxidizing
periplasmatic or extracelluar environments. Therefore, it may be
argued that Sco1 participates, along with metal transfer, in the
reduction of the CuA site of COXII and its metal-transfer
mechanism might include the following steps: (i) CuHSco1
interacts with the oxidized COXII and reduces the Cys residues
of the CuA site as a thioredoxin, and (ii) the oxidized HSco1
protein transfers Cu to the reduced CuA site (Fig. 5). The
oxidized apoHSco1 could be reduced before the next metal
transfer and its reduction can be performed by another thiore-
doxin-like protein, such as HSco2, which is known to play a key
role in CuA formation (35), or by cytochrome c, an electron-
transfer protein that is found in the same operon of Sco1
homologs in some bacteria or is fused to some Sco1 paralog
proteins (1). The copper delivery process therefore seems to
involve several proteins in a complex molecular mechanism that
requires further investigation. Interestingly, a dual functional
role in the assembly mechanism of the copper enzyme super-
oxide dismutase has been similarly proposed for its copper
chaperone CCS, which is, along with the copper donation,
involved in the formation of an intramolecular disulfide essential
for superoxide dismutase activity (36).
Concluding Remarks. We have succeeded in preparing Cu(I) and
Ni(II) derivatives of HSco1 and determined their solution
structures. The solution structure of apoHSco1 also has been
determined. The structures confirm that the metal ions are
bound by two Cys residues and one His residue, and they show
the transition from a locally disordered apo protein to a compact
metallated form, as confirmed by ESI-MS studies. We also
obtained crystals of Ni(II)HSco1, which suggest the binding of
the metal ion to the oxidized form of HSco1. This species may
represent a transition state of the copper transfer from HSco1
to the CuA site of COXII. This transient species may present a
missing link that integrates the metal transfer and thioredoxin
functions already proposed for this fascinating protein. A similar
mechanism of copper transfer also has been previously suggested
for the bacterial Sco1 homologue PrrC from Rhodobacter spha-
eroides (17).
Methods
Protein Preparation and Characterization. Long and short soluble
domains of HSco1 (lacking the first 351 and 393 bp, respectively,
corresponding to residues 1–117 and 1–131) were amplified by
PCR, cloned into the Gateway Entry vector pENTRtobacco etch
virusD-TOPO (Invitrogen), and subcloned into pETG-30A (Eu-
ropean Molecular Biology Laboratory Protein Expression and
Purification Facility) by Gateway LR reaction to generate N-
terminal, His-GST fused proteins. The proteins were expressed in
Escherichia coli BL21-Gold(DE3) cells (Stratagene), which were
grown in LB and minimal medium [(15NH4)2SO4 andor [13C]-
glucose] for the production of labeled samples. Purification was
performed by using a HiTrap chelating HP column (Amersham
Pharmacia Biosciences) charged with Zn(II). His-GST tag was
cleaved with AcTEV, and separated from the C-terminal domain
with a second purification step. After this purification, the protein
preparations showed a single component by SDSPAGEwith5%
of copper bound to the protein, as checked through ESI-MS
spectrometry. DTT was added to the apoprotein in a 10 mM
concentration to reduce the Cys residues of the CPXXCP motif
before metal reconstitution. The Cu(I), Cu(II), Ni(II) metallated
forms were obtained by addition of stoichiometric amounts of the
metal ions {as [Cu(I)(CH3CN)4]PF6, CuSO4, and NiCl2} to diluted
protein solutions in 50 mMphosphate buffer at pH 7.2, followed by
protein concentration under nitrogen atmosphere. The metal con-
tent was finally determined by inductively coupled plasma MS.
Electronic spectra on the metal derivatives were recorded
on a Cary 50 spectrophotometer (Varian). EPR spectra on
Cu(II)HSco1 were recorded at 180 K on an Elexsys E500
spectrometer (Bruker) equipped with a X-band microwave
bridge (microwave frequency, 9.45 GHz) and an ER 4131 VT
unit for temperature control. To investigate the aggregation
state of HSco1, 0.5–1 mM protein samples were run on a
Superdex75 HR-1030 size-exclusion column on an AKTA-
FPLC system (Amersham Pharmacia Biosciences) connected
with a multiangle light scattering (DAWN-EOS, Wyatt Tech-
nologies, Santa Barbara, CA) coupled with quasielastic light-
scattering detectors.
Before ESI-MS experiments, purified apoHSco1 protein was
brought into 50 mM ammonium acetate buffer (pH 7.5) by using
a HiPrep2610 desalting column (Amersham Pharmacia Bio-
sciences). In MS experiments, 1.8 M protein samples were
infused by a syringe pump at 15 lmin into an Ettan API
ESI-TOF mass spectrometer (Amersham Pharmacia Bio-
sciences). Mass spectra were recorded during 2–3 min at a
capillary exit voltage of 150 V. apoHSco1 was reduced by
addition of 0.5 or 1.0 mM DTT at 25°C. Reconstitution of
apoHSco1 with copper was conducted as follows. First, Cu(II)
acetate was dissolved at 150 M concentration in argon-
saturated 50 mM ammonium acetate, pH 7.5, and Cu(II) was
reduced to Cu(I) by addition of 0.5 mM DTT. Different equiv-
alents of freshly prepared Cu(I)DTT complex were added to the
apoHSco1 samples (protein concentration, 1.8 M), the mixture
was incubated for 1 min at 25°C, and ESI-MS spectra were
recorded as described above.
Solution Structures Determination. NMR spectral assignment and
structure determination were obtained through the experiments
listed in Table 1, which also indicates the magnetic fields at which
they were collected. Overall, the resonances of 95% of carbon
atoms, 97% of nitrogen atoms, and 90%of protons were assigned
in Cu(I)HSco1 and Ni(II)HSco1 (deposited in the Protein Data
Bank database). In the case of apo form, the resonances of 85%
of carbon atoms, 80% of nitrogen atoms, and 80% of proton
Fig. 5. Proposed mechanism for copper transfer from HSco1 to the COXII
subunit of CcO. This model implies that HSco1 may form a transient species
characterized by an oxidized SOS moiety still able to interact with a copper
ion. This state might exist just before the copper is transferred to the CuA site
of CcO. In the metal transfer mechanism, HSco1 also can work as a thioredoxin
in the reduction of the Cys residues in the CuA site of COXII. At this stage, the
oxidization state of copper during the metal transfer cannot be assessed. The
CuA site of the COXII subunit can indeed accept both Cu(I) and Cu(II) ions from
HSco1. Broken lines indicate the metal coordination bonds.
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atoms were assigned. The 1H, 13C, and 15N resonance assign-
ments of the apo, Cu(I), and Ni(II)HSco1 forms are reported,
respectively, in Tables 2–4, which are published as supporting
information on the PNAS web site. The His ring protons were
assigned through a 1H–15N HSQC experiment tailored to the
detection of 2J 1H–15N couplings and from the analysis of
the 13C-NOESY-HSQC spectra. For all His residues, all of the
nonexchangeable protons were assigned in Cu(I)HSco1 and
Ni(II)HSco1. The exchangeable proton of the metal-binding
ligand, His-260, also was detected in both metallated forms. R1
and R2 15N relaxation rates and 1H–15N nuclear Overhauser
effects (with and without 1H saturation) (Table 1) were mea-
sured at 298K on Avance 500 and 600 MHz Bruker spectrom-
eters and then analyzed by using a standard procedure (37).
After conversion of the NMR data in structural constraints
[3,035, 2,776 and 2,066 meaningful proton–proton distances,
together with 85  and 83  angle constraints for Cu(I)HSco1,
Ni(II)HSco1, and apoHSco1, respectively], the structures were
calculated using the program DYANA (38). The best 30 structures
of the DYANA family were then subjected to restrained energy
minimization with AMBER 8.0 (39). The force-field parameters for
the metal ions were adapted from similar systems (40, 41). The
statistical analysis of the restrained energy minimization family
of apoHSco1, Cu(I)HSco1, and Ni(II)HSco1 structures are
reported, respectively, in Tables 5, 6, and 7, which are published
as supporting information on the PNAS web site. The programs
PROCHECK and PROCHECK-NMR (42, 43) were used in the eval-
uation of the quality of the structures.More than 90% of residues
were located in the allowed regions of the Ramachandran plot.
Crystallization, Data Collection, and Structure Solution. Crystals of
Ni(II)HSco1 grew at 20°C from a 0.1 M TrisHCl30% polyeth-
ylene glycol 6000 solution at pH 8.5 by the vapor diffusion
technique. The final protein concentration was10 mgml. The
data set was collected by using synchrotron radiation at beamline
ID-29 (European Synchrotron Radiation Facility, Grenoble,
France) at 100 K, with the crystal cryocooled, in the presence of
10–15% of ethylen glycol. The Ni(II)HSco1 crystal diffracted up
to 2.5-Å resolution and belongs to space group P212121 (a 
51.46 Å, b  52.44 Å, c  136.41 Å) with two molecules in the
asymmetric unit, a solvent content of 47.1%, and a mosaicity of
0.7°. The structure was solved by using the molecular replace-
ment technique, with the structure of the apoHSco1 (PDB ID
code 1WP0) as starting model.
The Ramachandran plot of the refined model shows that
97.5% of residues are in allowed regions of the plot, 2.5% of
residues are in generously allowed, and no residues are in
disallowed regions. Table 8, which is published as supporting
information on the PNAS web site, reports the data collection
and refinement statistics.
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Corrections
IN THIS ISSUE, MEDICAL SCIENCES. For the ‘‘In This Issue’’ summary
entitled ‘‘Mammary tumors arrested in mice by deleting Notch’’
appearing in issue 24, June 13, 2006, of Proc.Natl.Acad. Sci.USA
(103, 8907–8908), the title of the summary appeared incorrectly
and should read ‘‘Mammary tumors arrested in mice by deleting
Myc.’’
www.pnas.orgcgidoi10.1073pnas.0605124103
CHEMISTRY. For the article ‘‘A hint for the function of human Sco1
from different structures,’’ by Lucia Banci, Ivano Bertini, Vito
Calderone, Simone Ciofi-Baffoni, Stefano Mangani, Manuele
Martinelli, Peep Palumaa, and Shenlin Wang, which appeared in
issue 23, June 6, 2006, of Proc. Natl. Acad. Sci. USA (103,
8595–8600; first published May 30, 2006; 10.1073pnas.
0601375103), the authors note that, due to a printer’s error, the
first sentence of the Discussion on page 8598, ‘‘The solution
and crystal structures of the metal derivatives of HSco1 are
completely superimposable along the entire amino acid se-
quence (Fig. 4) (backbone rms deviation to the new structure
within 0.8 Å),’’ should read: ‘‘The solution and crystal structures of
the metal derivatives of HSco1 are completely superimposable
along the entire amino acid sequence (Fig. 4) (backbone rms
deviation to the mean structure within 0.8 Å).’’ This error does
not affect the conclusions of the article.
www.pnas.orgcgidoi10.1073pnas.0605020103
EVOLUTION. For the article ‘‘Naked corals: Skeleton loss in
Scleractinia,’’ by Mo´nica Medina, Allen G. Collins, Tori L.
Takaoka, Jennifer V. Kuehl, and Jeffrey L. Boore, which
appeared in issue 24, June 13, 2006, of Proc.Natl. Acad. Sci.USA
(103, 9096–9100; first published June 5, 2006; 10.1073
pnas.0602444103), the caption for the issue cover image ap-
peared incorrectly, due to a PNAS error. The online version has
been corrected. The corrected cover caption appears below.
Cover image: Oral view of the naked coral Discosoma sp.
(Cnidaria: Anthozoa: Hexacorallia: Corallimorpharia). This
coral species inhabits shallow tropical waters in the Indo-
Pacific Sea. Corallimorpharians like this one appear to be
scleractinian stony corals that, during the Cretaceous period,
lost the ability to precipitate a calcium carbonate skeleton. See
the article by Medina et al. on pages 9096–9100. Image
courtesy of Mo´nica Medina and David Keys (Joint Genome
Institute, Walnut Creek, CA).
www.pnas.orgcgidoi10.1073pnas.0604989103
MEDICAL SCIENCES. For the article ‘‘Anomalous levels of Cl
transporters in the hippocampal subiculum from temporal lobe
epilepsy patients make GABA excitatory,’’ by E. Palma, M.
Amici, F. Sobrero, G. Spinelli, S. Di Angelantonio, D.
Ragozzino, A. Mascia, C. Scoppetta, V. Esposito, R. Miledi, and
F. Eusebi, which appeared in issue 22, May 30, 2006, of Proc.
Natl. Acad. Sci. USA (103, 8465–8468; first published May 18,
2006; 10.1073pnas.0602979103), the authors note that the last
sentence of the Abstract, ‘‘We conclude that the anomalous
expression of both Cl transporters, KCC1 and NKCC2, in TLE
hippocampal subiculum probably causes altered Cl transport in
the ‘epileptic’ neurons, as revealed in the microtransplanted
Xenopus oocytes, and renders GABA aberrantly ‘exciting,’ a
feature that may contribute to the precipitation of epileptic
seizures,’’ should read: ‘‘We conclude that the anomalous ex-
pression of both Cl transporters, NKCC1 and KCC2, in TLE
hippocampal subiculum probably causes altered Cl transport in
the ‘epileptic’ neurons, as revealed in the microtransplanted
Xenopus oocytes, and renders GABA aberrantly ‘exciting,’ a
feature that may contribute to the precipitation of epileptic
seizures.’’ This error does not affect the conclusions of the
article.
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MICROBIOLOGY. For the article ‘‘Two major classes in the M
protein family in group A streptococci,’’ by Paul O’Toole, Lars
Stenberg, Marianne Rissler, and Gunnar Lindahl, which ap-
peared in issue 18, September 15, 1992, of Proc. Natl. Acad. Sci.
USA (89, 8661–8665), the author name Paul O’Toole should
have appeared as Paul W. O’Toole. The online version has been
corrected. The corrected author line appears below.
Paul W. O’Toole, Lars Stenberg, Marianne Rissler,
and Gunnar Lindahl
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The pathogenic mutant (P174L) of human Sco1 produces respira-
tory chain deficiency associated with cytochrome c oxidase (CcO)
assembly defects. The solution structure of the mutant in its Cu(I)
form shows that Leu-174 prevents the formation of a well packed
hydrophobic region around the metal-binding site and causes a
reduction of the affinity of copper(I) for the protein. KD values for
Cu(I)WT-HSco1 and Cu(I)P174L-HSco1 are 1017 and 1013, re-
spectively. The reduction potentials of the two apo proteins are
similar, but slower reduction/oxidation rates are found for the
mutant with respect to the WT. The mitochondrial metal-
lochaperone in the partially oxidized Cu1(I)Cox172S-S form, at
variance with the fully reduced Cu4(I)Cox17, interacts transiently
with both WT-HSco1 and the mutant, forming the Cox17/Cu(I)/
HSco1 complex, but copper is efficiently transferred only in the
case of WT protein. Cu1(I)Cox172S-S indeed has an affinity for
copper(I) (KD 1015) higher than that of the P174L-HSco1 mutant
but lower than that of WT-HSco1. We propose that HSco1 muta-
tion, altering the structure around the metal-binding site, affects
both copper(I) binding and redox properties of the protein, thus
impairing the efficiency of copper transfer to CcO. The pathogenic
mutation therefore could (i) lessen the Sco1 affinity for copper(I)
and hence copper supply for CcO or (ii) decrease the efficiency of
reduction of CcO thiols involved in copper binding, or both effects
could be produced by the mutation.
cytochrome c oxidase  mass spectrometry  NMR  copper chaperone 
respiratory chain deficiency
Cytochrome c oxidase (CcO) is the terminal enzyme of therespiratory chain, embedded in the inner mitochondrial
membrane of all eukaryotes and in the plasma membrane of
many prokaryotes. In eukaryotes, a large number of nuclear
genes are required for the proper assembly and function of the
CcO complex, among which at least six proteins (Cox17, Cox23,
Cox19, Sco1, Sco2, and Cox11) are involved in the delivery and
insertion of copper into the binuclear CuA and CuB-heme a3 sites
of CcO (1–3). Sco1 and Sco2, which are anchored to the inner
mitochondrial membrane through a single transmembrane helix,
are specifically implicated in the assembly of the CuA site of CcO
(4–7). Sco1 and Sco2 are both metal-binding proteins capable to
bind either copper(I) or copper(II) in the same metal-binding
site (8, 9); mutations of the ligands that abrogate their copper-
binding ability drastically compromise CcO activity (9, 10). The
mitochondrial copper chaperone Cox17 is capable of donating
copper(I) to Sco1 (11), implying that it might transfer copper to
Sco1, which, in turn, inserts it into the CuA site. According to this
mechanism, Sco1 was shown to interact with the CuA-containing
COXII subunit of CcO (6).
Important insights on the function of this class of proteins also
recently were obtained from a genome-wide search for all
available prokaryotic genomes (12). This search showed the
presence of several Sco paralogs adjacent to copper and/or redox
proteins, thus suggesting that Sco proteins can have multifunc-
tional properties involved in different physiological processes.
The structure of Sco proteins is characterized by a thioredoxin
fold (13–15), and, from the first structural characterization (13),
it was suggested that the protein also may fulfill a redox function.
Recently, we have solved the solution structures of the demet-
allated, the copper(I), and the nickel(II) derivatives of human
Sco1 (HSco1 hereafter) as well as the crystal structure of a
nickel(II) derivative (16). The structural analysis showed that
Cu(I) is coordinated by ligands located in two distant protein
regions: Cys-169 and Cys-173 of the CXXXC conserved motif in
loop 3 and His-260 in loop 8. In the structure of the apo protein,
the latter loop is highly disordered and mobile in solution (16),
suggesting that the metal binding is able to ‘‘freeze’’ this loop in
a more rigid conformation, thus representing an important step
in the metal-binding process of HSco1. In the crystal structure
of oxidized Ni(II)HSco1, the two metal-binding cysteines are
oxidized and form a disulfide bond, still with the metal ion
interacting with the S-S moiety. This metal environment showed
that the protein can have a peculiar mode of interaction with a
metal ion, suggesting that cysteine oxidation of HSco1 also might
play a role in the metal release to CuA site of CcO (16). These
structural data further support our initial suggestion that Sco1
can act both as a copper chaperone and a thioredoxin (13).
Human SCO1 and SCO2 genes can experience pathogenic
mutations that produce respiratory chain deficiency associated
with CcO assembly defects (17). The missense mutation in
human Sco1 gene of a proline into a leucine, P174L, is associated
with a fatal neonatal hepatopathy when the second allele also is
nonfunctional (18). This finding implies that the pathology is
caused by a loss of normal Sco1 function rather than gain of some
aberrant action of the mutant protein. This proline, adjacent to
the conserved CXXXC domain of HSco1, is completely con-
served in eukaryotes. Introduction of the P174Lmutant chimeric
HSco1 protein in Sco1-null yeast mutants impaired CcO assem-
bly and induced loss of CcO activity (19). WT protein and P174L
mutant chimera are present in comparable concentrations in
mitochondrial extracts, thus indicating that the pathogenicity of
the mutant does not result from its instability but rather from an
impaired function (19). During the preparation of our work, a
paper on the same P174L-HSco1 mutant came out indicating
that the mutation compromises Cox17-dependent metalation
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without impairing copper binding (20). In the present research,
we have explored at the molecular level the effect of the
mutation on the Sco1 function by solving the solution structure
of the P174L-HSco1 mutant, characterizing the metal-binding
and redox properties of the P174L-HSco1 mutant with respect
to WT HSco1 (WT-HSco1 hereafter), and investigating the role
of Cox17 in the copper transfer to both WT and mutant HSco1
proteins. Our work demonstrates that the P174L mutation alters
hydrophobic interactions around the metal-binding site, thus
affecting both the copper-binding and the redox properties of
HSco1 and, therefore, determining a reduction of the copper
transfer efficiency from Cox17 to HSco1. We also learned that
the partially oxidized Cu1(I)Cox172S-S and not the fully reduced
Cu4(I)Cox17 are the preferential species delivering copper to
HSco1.
Results
Structural Properties of the Pathogenic Mutant P174L-HSco1.
ApoP174L-HSco1 at millimolar concentration is a well folded
protein as it appears from the 1H-15N heteronuclear single
quantum correlation (HSQC) spectrum [see supporting infor-
mation (SI) Fig. 5], which also is similar to that of apoWT-
HSco1. Accordingly, the mutant maintains the same fold of
WT-HSco1, featuring indeed the same content of -strands
(21%) and -helices (26%) as derived from circular dichroism
spectra. Fluorimetric thermal unfolding assay (SI Fig. 5) shows
that the thermal stability of apoP174L-HSco1 also is the same as
that of apoWT-HSco1, both having a melting temperature of
54°C. These data show that the pathogenic nature of the
mutation does not originate from fold and/or stability differ-
ences of apoP174L-HSco1 with respect to the WT protein. This
conclusion also is consistent with in vivo results, which showed
that comparable concentrations of either WT or P174L mutant
protein are present in mitochondrial extracts (19).
ApoP174L-HSco1, as apoWT-HSco1, is able to bind Cu(I)
ions, when the latter is provided as Cu(I) acetonitrile complex.
The metalation of both proteins, followed through 1H-15N
HSQC spectra in the presence of 1 mM DTT (SI Fig. 6),
however, shows meaningful differences. Indeed, although 1 eq of
Cu(I) fully metallates WT-HSco1, complete metalation of
P174L-HSco1 is not achieved even when 3 eq of Cu(I) are added,
as 20% of P174L-HSco1 is still in the apo form (SI Fig. 6). In
the latter experiment, Cu(I) thus competes between the mutant
and the DTT chelator, allowing us to determine the dissociation
constant (KD) of the Cu(I)P174L-HSco1 complex. Following the
relative ratio of apo and copper(I) forms, as obtained from the
1H-15N HSQC spectra of the mixture during the titration steps
[the interaction between the protein and Cu(I)DTT complex is
slow on the chemical-shift time scale], KD of the Cu(I)P174L-
HSco1 complex is estimated to be 3.2  0.6  1013 M. This
value is much higher than the KD 1017 of theWT protein (see
Transfer of Copper from Cox17 to HSco1). When copper(I) is
added in the absence of DTT, 1.5 eq are enough to fully
metallate the mutant.
Copper binding to WT-HSco1 induces major conformational
changes to the protein, which passes from an open state in the
apo form to a closed, compact one upon copper binding (16).
This change clearly is evident from the solution structures of
these two states of WT-HSco1 and also can readily be assessed
from the charge state analysis of electrospray ionization
(ESI)-MS spectra. Conformational analysis by ESI-MS is based
on observation that, during the ESI, tightly compact proteins
acquire only a narrow range of low-charge values, whereas open
conformations produce a more heterogeneous and highly
charged population (21). Charge-state distribution of
Cu(I)P174L-HSco1 (Int9/Int10  1.6; Fig. 1) is similar to that
of apoP174L-HSco1 (Int9/Int10  1.7) and apoWT-HSco1
(Int9/Int10 1.4), indicating that all these systems have a more
open conformation than Cu(I)WT-HSco1, in which the lower
9 state was more populated (Int9/Int10  3.8; Fig. 1). These
data therefore show that Cu(I) binding to apoP174L-HSco1 is
unable to induce the compact conformation as it occurs in the
WT protein.
In the 1H-15N HSQC spectrum of the fully metallated P174L-
HSco1 (Cu1(I)P174L-HSco1), 34 residues show a splitting in two
or, in a few cases, three NH cross-peaks, indicating the occur-
rence of structural heterogeneity, which is absent in Cu1(I)WT-
HSco1. The twomajor species are present in a ratio of 60:40. The
relative intensity of the resonances of the two species is
temperature-dependent, indicating that there is an equilibrium
between the two. The solution structure of Cu1(I)P174L-HSco1
(determined from the more abundant species) shows the same
thioredoxin-like fold of the WT protein (Fig. 2) with an average
backbone rmsd of 1.30 Å. The only significant structural differ-
ence is in loop 8, which contains the His copper ligand. In the
mutant, this loop does not have the short -hairpin (Fig. 2),
similarly to what occurs in the apoWT-HSco1 solution structure
but at variance with the Cu1(I)WT-HSco1 structure (16). Be-
cause no apo form of the mutant is present in the NMR sample
(see Methods), the latter less defined secondary structure could
be the consequence of the structural heterogeneity in this region,
which in turn could induce a weaker copper-affinity in the
mutant. Several residues with double conformations are located
in helix 2, which is in contact with the metal-binding CXXXC
Fig. 1. Binding of copper ions to human Sco1 and mutant P174LSco1. ESI-TOF
mass spectra of WT-HSco1 (0.8 M) and P174L-HSco1 (1.2 M) reconstituted
with Cu(I)DTT complex in 50 mM ammonium acetate, pH 7.5. (A) apoWT-
HSco1. (B) WT-HSco1  1 eq of Cu(I) in the presence of 1.0 mM DTT. (C)
apoP174L-HSco1. (D) P174L-HSco1  1 eq of Cu(I) in the presence of 1.0 mM
DTT. (E) P174L-HSco1 1 eq of Cu(I) 3 eq of Cox172S-S in the presence of 1.0
mM DTT. Charge state 8, 9, and 10 ions are presented and numbers on
the peaks denote the metal stoichiometry of the complex.
16  www.pnas.orgcgidoi10.1073pnas.0606189103 Banci et al.
region through hydrophobic interactions involving Leu-174 or
Pro-174 and Leu-177 (helix 1), and Tyr-216 and Phe-220 (helix
2). Although Pro-174 has extensive hydrophobic contacts with
both Tyr-216 and Phe-220 in Cu1(I)WT-HSco1, thus forming a
compact hydrophobic patch, in the mutant, the bulkier Leu side
chain prevents the optimal packing with the two aromatic side
chains (Fig. 2), which indeed display double conformation.
Leu-174 essentially interacts only with Phe-220 (Fig. 2) and is
more solvent-exposed (25%) than Pro-174 is (12%). The lack of
a well organized hydrophobic core on this side of the metal-
binding region also causes the presence of a double conforma-
tion for His-260, located in loop 8. Two patterns for the aromatic
ring of this His are observed in the 2JNH coupling-based 1H-15N
HSQC spectra (SI Fig. 7). One pattern, belonging to the minor
species, fully matches the shifts of His-260 in Cu1(I)WT-HSco1,
whereas the other has different shifts but still is indicative of
copper(I) coordination through N2 as in theWT protein. In the
major species, His-260 lacks NOEs contacts with the CXXXC
metal-binding region that are present in the WT form. A
decreased number of NOEs with respect to WT protein also is
observed in the metal-binding loop 3 and in the surrounding
loops 5, 7, and 8, likely reflecting the effect of the observed
conformational disorder. From this structural investigation, we
thus can conclude that the mutation (i) perturbs the hydrophobic
interactions and (ii) induces conformational heterogeneity
around the copper-binding site, with both effects overall reduc-
ing the affinity of the protein for copper(I).
Redox Properties of the Pathogenic Mutant P174L-HSco1. Based on
its thioredoxin fold, it has been suggested that the two Cys
residues of the CXXXC conserved motif in Sco protein family
can be involved in redox reactions (13–15), perhaps in the
reduction of the oxidized cysteines in CuA site of CcO (16).
Oxidized and reduced forms of apoHSco1 are characterized by
different fluorescence spectra (Fig. 3). Trp-159 and, to a lesser
extent, Tyr-163 are the residues principally contributing to the
difference of florescence intensity upon change of the oxidation
state of the protein (see SI Text for details), as assessed by
comparing the fluorescence spectra of W159F, W159F/Y163F,
and Y216F mutants with that of WT-HSco1 (SI Fig. 8). Tyr-163
is close to the CXXXC motif, whereas Trp-159 is far but still
belonging to the same -strand of Tyr-163. From the difference
in fluorescence of the two redox states of the protein, the
reduction potential of the two cysteines for WT- and P174L-
HSco1 in their apo forms can be determined. The measured
reduction potentials at pH 7.2 are 0.277  0.030 V and
0.275  0.028 V for WT-HSco1 and P174L-HSco1, respec-
tively (Fig. 3), falling in the standard state redox potentials range
of the thioredoxin family of thiol-disulfide oxidoreductases
(124 to 270 mV) (22), consistently with a possible function
of HSco1 as a thioredoxin. The similar reduction potentials of
WT-HSco1 and P174L-HSco1 also indicate that the pathogenic
mutation does not significantly affect the thermodynamic equi-
librium between reduced and oxidized HSco1. However, the
kinetic rates of disulfide bond formation and reduction are
significantly different in WT-HSco1 and P174L-HSco1 forms.
Air oxidation of cysteines in apoWT-HSco1 has an half-life time
of4 h. Oxidation of apoP174L-HSco1 is a much slower process,
because 70% of the reduced form still is present after 4 h of
air exposure (SI Fig. 9). Reduction of the disulfide bond in
oxidized apoHSco1, by 1 mMDTT, also has different rates in the
two proteins, being much faster in WT-HSco1 than in the
mutant. In the former, the reduction of the disulfide bond is
completed already after 1 min (SI Fig. 10); however, after the
same period, only 20% of oxidized apoP174L-HSco1 is reduced,
and, after 5 min, a reduction level of only 55% is reached (SI Fig.
10). In summary, P174L-HSco1 mutant has a similar redox
potential as compared with WT protein but significantly slower
reduction and oxidation rates.
Fig. 2. SolutionstructureofCu1(I)P174L-HSco1mutant. (A)Backboneatomsare
represented as a tube with variable radius, proportional to the backbone rmsd
value of each residue for Cu1(I)P174L-HSco1 and Cu1(I)WT-HSco1. The side chains
of Cys-169, Cys-173, His-260, and the copper(I) ions are shown in yellow, green,
and orange, respectively. The secondary structure elements also are indicated:
-strandsare incyanand-helices in red. (B) Side-chainpacking involvingPro-174
or Leu-174 (in yellow) and Tyr-216 and Phe-220 (in green) is shown on the WT and
P174L mean minimized solution structures. The mutant protein was copper-
saturated resulting in a 1:1 copper:protein complex.
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Fig. 3. Redox properties of WT-HSco1 and P174L-HSco1. (A) Fluorescence
emission spectra of 5 M WT-HSco1 (black) and P174L-HSco1 (blue) recorded
under native conditions of the oxidized (50 mM phosphate buffer, pH 7.0, 0.01
mM GSSG; dotted lines) and the reduced (50 mM phosphate buffer, pH 7.0, 200
mM GSH; solid lines) protein after excitation at 280 nm. (B) Redox equilibrium
of WT-HSco1 and P174L-HSco1 with different [GSH]2/GSSG ratios as followed
by measuring fluorescence emission at 327 nm. After nonlinear regression,
values of Keq  17.70  2.23 mM and of 15.66  1.86 mM (correlation
coefficient: 0.986 and 0.996) were obtained for the WT-HSco1 and P174L-
HSco1/glutathione systems, corresponding to a redox potentials of0.277
0.030 V and0.275 0.028 V, respectively, by using the glutathione standard
potential of 0.240 V at pH 7.0 and 298 K.
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Transfer of Copper from Cox17 to HSco1.After the characterization
of the structural and redox properties of the P174L-HSco1
mutant, we also addressed and analyzed the mechanism of
copper acquisition from the copper chaperone Cox17, which also
could be affected by the mutation. For this analyses, we have
used porcine Cox17, which differs from human Cox17 only in the
first four amino acid residues. Cox17 could exist in three
different oxidation states, which have different metal-binding
properties (23). In oxidative environment, a completely oxidized
form with three disulfide bonds (Cox173S-S hereafter) is present
that is unable to bind copper. In the presence of 1 mM DTT,
Cox17 is partially oxidized with two disulfide bonds (Cox172S-S)
and two reduced Cys residues, which bind one Cu(I) ion
[Cu1(I)Cox172S-S hereafter]. In more reducing conditions, Cox17
exists in the fully reduced state, which binds cooperatively four
Cu(I) ions forming a tetracopper-thiolate cluster [Cu4(I)Cox17
hereafter] (23). In principle, both metallated forms of Cox17
could transfer metals to HSco1 protein.
To test which form of Cox17 can transfer Cu(I) to WT-HSco1,
we have produced amixture of Cu4(I)Cox17 and Cu1(I)Cox172S-S
forms and mixed it to reduced apoWT-HSco1. ESI-MS data of
the Cox17 mixture showed metalation of apoWT-HSco1 with
one Cu(I) ion and the concomitant decrease of the peak of
Cu1(I)Cox172S-S, whereas that of Cu4(I)Cox17 remains unaltered
(SI Fig. 11). This finding indicates that Cu1(I)Cox172S-S prefer-
entially transfers Cu(I) to apoWT-HSco1. All of the subsequent
NMR and ESI-MS experiments thus have been performed with
the Cu1(I)Cox172S-S form.
Competition experiments for Cu(I) between the Cox172S-S
protein and the Cu(I) chelator DTT were carried out with
ESI-MS technique as described in ref. 23. From these data, it
results that Cox172S-S bind one Cu(I) ion tightly with a KD value
of 6.4  0.6  1015 M (SI Fig. 12).
When 15N-labeled apoWT-HSco1 is titrated with increasing
amounts of unlabelled Cu1(I)Cox172S-S in the presence of 1 mM
DTT, the intensity of someof itsNH signals decreases in the 1H-15N
HSQC spectra, and, concomitantly, NH signals of the Cu(I)WT-
HSco1 species appeared with increasing intensities along the titra-
tion (SI Fig. 13). No additional signals from a possible (transiently
populated) intermediate could be detected at any point of the
titration. ApoWT-HSco1 reaches 90% of its metalation upon
addition of 1 eq of Cu1(I)Cox172S-S, indicating a lower limit of the
equilibrium constant of 102. Considering the latter value and theKD
value of Cu1(I)Cox172S-S (KD  6.4  0.6  1015 M), KD of
Cu(I)WT-HSco1 is estimated to be 1017 or lower, thus WT
protein displaying a higher affinity for Cu(I) compared with the
mutant (KD 3.2 0.6 1013M).The rotational correlation time
(13.2  0.9 ns) of WT-HSco1 in the 1:1 mixture with
Cu1(I)Cox172S-S is not higher than that of isolated apo orCu(I)WT-
HSco1 (13.8  1.6 and 14.5  1.1 ns, respectively), indicating that
no complex is present at detectable concentrations. The copper(I)
transfer process is slow on the chemical-shift time scale, setting a
lower limit for the equilibration rate of102 s1 [determined by the
smallest chemical-shift difference between apoWT-HSco1 and
Cu(I)WT-HSco1 that can be detected, i.e.,0.1 ppm at 800MHz].
The comparison of the 1H-15N HSQC spectra of the Cu(I)WT-
HSco1metalated viaCu1(I)Cox172S-S with that ofCu(I)WT-HSco1
metallated via Cu(I) acetonitrile complex (SI Fig. 14) shows that a
fewNH resonances (residues 164, 243, 245, 258, and 260–262) close
to the metal-binding site are missing, broader, or having two
conformational states in the former spectrum, indicating that
Cox17 is transiently interacting with this region of WT-HSco1
producing conformational exchange processes of these NH
resonances.
ESI-MS spectrometry confirms the NMR data, showing that, by
adding an excess of apoCox172S-S, the apoWT-HSco1/Cu(I)WT-
HSco1 ratio does not change (SI Fig. 15C versus B), indicating that
Cu(I) ion is bound to WT-HSco1 with higher affinity than to
Cu1(I)Cox172S-S. According to the different metal-binding affini-
ties, from ESI-MS experiments, we also established that even 10
mM DTT cannot extract Cu(I) from Cu(I)WT-HSco1, whereas
already 5mMDTTextracts40%of copper fromCu1(I)Cox172S-S.
Therefore, Cox172S-S does not compete with WT-HSco1 for Cu(I)
ions, but vice versa, it contributes to metalation of WT-HSco1
protein as it follows from the fact that Cox172S-S shifts the meta-
lation equilibrium of HSco1 toward the Cu(I)WT-HSco1 form
more than the Cu(I)DTT complex does (SI Fig. 15A and B). These
data are in agreement with the copper content of human Sco1,
determined from the cytoplasmof yeast cells overexpressing human
Sco1 in the presence and absence of co-overexpression of human
Cox17 (9).
ESI-MS spectra also indicate that, in the absence of metal ion,
WT-HSco1 and Cox17 proteins do not form any complex.
However, in the presence of 1 eq of Cu(I) there are two minor
twin-peaks in the ESI-MS spectra (SI Fig. 15D) whose decon-
volution yields molecular masses of 26,497 and 26,562 Da, which
correspond to WT-HSco1/Cu1(I)/Cox172S-S and WT-HSco1/
Cu2(I)/Cox172S-S complexes (theoretical Mr 26,499.8 and
26,563.4 Da, respectively). These peaks have very low intensity,
indicating that these complexes are transient and not highly
populated states, in agreement with NMR results obtained at
millimolar concentration. However, the relative intensity of
these minor peaks increases at higher concentration of proteins,
indicating that an equilibrium between free proteins and protein
complexes is present. Moreover, at substoichiometric concen-
trations of Cu(I) ions, WT-HSco1/Cu1(I)/Cox172S-S is prevalent,
whereas at higher Cu(I) concentrations, the WT-HSco1/Cu2(I)/
Cox172S-S form prevails. This is another example of formation of
a metal-mediated protein–protein complex, also observed in
the case of other copper chaperones (24–26). As a whole, the
ESI-MS results indicate that WT-HSco1/Cu1(I)/Cox172S-S is
the transient intermediate involved in metal transfer from
Cu1(I)Cox172S-S to WT-HSco1. At higher metal concentrations,
WT-HSco1/Cu2(I)/Cox172S-S complex also exists, which suggests
that the WT-HSco1/Cox172S-S complex can accommodate two
Cu(I) ions.
When Cu1(I)Cox172S-S is added to apoP174L-HSco1, differently
fromwhat happens forWT-HSco1, no copper transfer occurs at 1:1
Cu1(I)Cox172S-S/P174L-HSco1 ratio, as judged by the 1H-15N
HSQC spectrum of the mixture. By increasing the Cu1(I)Cox172S-
S/P174L-HSco1 ratio up to 2:1, copper transfer occurs slowly on the
chemical-shift time scale, similarly to the WT protein, but only
20% of P174L-HSco1 is metallated, accordingly to the higher
affinity of Cox172S-S for copper(I) [KD  6.4  0.6  1015 M for
Cu1(I)Cox172S-S; KD  3.2  0.6  1013 M for Cu(I)P174L-
HSco1]. ESI-MS spectra also show that the addition ofCox172S-S up
to 3 eq does not improve the metalation of P174L-HSco1 (Fig. 1 E
versusD), which is different fromwhat occurs with theWTprotein.
Addition of Cox172S-S also does not change the charge-state dis-
tribution of Cu(I)P174L-HSco1 (SI Fig. 16), which remains similar
to that of apoP174L-HSco1 (Fig. 1E). Similarly to WT-HSco1, no
protein–protein complexes are observed in ESI-MS spectra in the
absence of metal, and a minor twin peak, corresponding to P174L-
HSco1/Cu1(I)/Cox172S-S and P174L-HSco1/Cu2(I)/Cox172S-S com-
plexes, is detected inESI-MS spectrum in presence ofCu(I) ions (SI
Fig. 16), which indicates that transient protein–protein complexes
with 1 and 2 Cu(I) ions also do exist in case of the mutant protein.
All of the data indicate that, even if Cox17 is still capable of
interacting and exchanging copper(I) with the P174L-HSco1 mu-
tant, the latter is not efficientlymetallated into a compact copper(I)
form, at variance with what occurs in WT protein.
Discussion
Copper incorporation into CcO is biologically crucial; it is,
however, an extremely complex process, which is tightly regu-
lated and requires a large array of proteins, each of them with
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a specific, in most of the cases, nonreplaceable role. The
comprehension and description of these processes are still in
their infancy, and only now knowledge about the structure and
functional role of the assisting proteins has begun to become
available. Many lines of evidence show that copper insertion into
CuA site of COXII subunit is not a simple, passive copper
transfer from Cox17 to Sco1/2 proteins and finally to COXII, but
redox reactions are interlinked with the process of copper
transfer (12, 15, 16, 27).
In this work, we have shown that the P174Lmutation in HSco1
significantly affects the redox and metal-binding properties of
this protein. Structurally, the mutation produces the lack of well
organized hydrophobic contacts and a structural heterogeneity
in the vicinity of the metal-binding region. The local structural
changes induced by the point mutation decrease the copper(I)
affinity of the mutant, thus negatively affecting the cometal-
lochaperone function of HSco1 in the CuA assembly. The
mutation also determines that the oxidation and reduction rates
of the disulphide bond of the mutant are much slower than those
of the WT protein. It is likely that introduction of the bulky
Leu-174 disturbs the mutual orientation of cysteines and slows
down the local conformational changes necessary for disulfide
bond formation and disruption. The thioredoxin role of HSco1,
proposed for maintaining the receiving CuA site in the suitable
reduced state (15, 16), therefore is significantly perturbed be-
cause the mutation could slow down the reduction of the
copper-binding cysteines in CuA site of CcO. Overall, these
alterations induced by the mutation on copper-binding and
redox properties of HSco1 can sizably decrease the efficiency of
the copper transfer from Cu(I)HSco1 to the CuA site of CcO.
Our results also provide a detailed understanding of the
metalation process of HSco1 by Cox17 and show how the
mutation at position 174 of HSco1 affects this process. ESI-MS
data demonstrate that Cu1(I)Cox172S-S, but not Cu4(I)Cox17, is
capable of transferring Cu(I) to apoWT-HSco1 and that minor
amounts of the metal-bridged species, WT-HSco1/Cu1(I)/
Cox172S-S and WT-HSco1/Cu2(I)/Cox172S-S, do occur, which are
probably the transient intermediates involved in the metal
transfer from Cu1(I)Cox172S-S to apoWT-HSco1. Such transient
interaction with Cox172S-S assists WT-HSco1 to pass from the
open to the closed state, which binds Cu(I) ions extremely
strongly (Fig. 4). The mutant P174L-HSco1 behaves differently:
the conformational disorder experienced by Cu(I)P174L-HSco1
indeed is associated with a weakly bound metal (Fig. 4), and
Cox172S-S is not able to assist the mutant P174L-HSco1 to form
the more compact state as it happens with WT-HSco1.
In conclusion, the P174L mutation in HSco1 decreases the
efficiency of both metal-binding and redox properties of HSco1,
which both are potentially involved in HSco1-mediated transfer of
the copper and electrons fromCox17 to theCuA site of COXII (16).
Methods
Protein Expression and Characterization. The pathogenic mutation
at the gene position C520T, corresponding to P174L amino acid
change, was made by using QuikChange mutagenesis kit (Strat-
agene, La Jolla, CA). WT-HSco1 protein and P174L-HSco1
pathogenic mutant were produced in E. coli BL21-Gold(DE3)
(Stratagene) following an already reported protocol (16). Por-
cine Cox17 was isolated from porcine intestine as fully oxidized
apo protein (Cox173S-S) and lyophilized (23).
The oxidation state of the cysteines of the WT- and P174L-
HSco1 proteins was evaluated through the selective reaction of
the free thiol groups with 4-acetamido-4-maleimidylstilbene-2,2-
disulfonic acid, which adds 500 Da per reactive thiol to the
total mass, thus shifting the mobility of the protein on a
SDS/PAGE denaturing gel. The metal content was determined
by inductively coupled plasma mass spectrometry. Far-UV CD
spectra (185–260 nm) were recorded on a Jasco J-810 spectropo-
larimeter on 10 M protein solutions in 20 mM phosphate
buffer, pH 7.2, at 298 K.
The melting temperatures of WT- and P174L-HSco1 proteins
in the apo state were determined through the fluorescence-
based thermal-shift assay (28). Fluorescence intensity was mea-
sured at different temperatures with excitation/emission wave-
lengths of 490 and 575 nm, respectively.
Redox equilibration between WT- or P174L-HSco1 and glu-
tathione was followed through the change of fluorescence
monitored on 5 M concentrations of protein samples previ-
ously incubated for at least 6 h under an N2 atmosphere, with
different reduced/oxidized glutathione (GSH/GSSG) ratios
(0.01 mM GSSG and varying concentrations of GSH, 0.1–200
mM) in 50 mM phosphate buffer, pH 7.2. The collection and
data analysis was performed by following a protocol previously
described for thioredoxins (29).
Preparation of Cox17, HSco1, and P174L-HSco1 Samples for MS Mea-
surements. ForMS experiments, purifiedWT- and P174L-HSco1
proteins containing one disulfide bond were brought into 50 mM
ammonium acetate, pH 7.5, by using HiPrep26/10 desalting
column (Amersham Biosciences, Uppsala, Sweden). Lyophilized
Cox173S-S was dissolved in argon-saturated 50 mM ammonium
acetate, pH 7.5, at 75 M concentration, and this stock solution
was used for further experiments. Cox172S-S was produced by
reduction of Cox173S-S with 1 mM DTT at 298 K (incubation
time 2 min), which leads to reduction of one most labile disulfide
bond in Cox173S-S. Fully reduced Cox17 was prepared by incu-
bation of Cox173S-S with 1 mM DTT at 45°C for 100 min.
MALDI-TOF and ESI-MS Protein Characterization. In MALDI-TOF
experiments, reduction of oxidized apoWT-HSco1 and
apoP174L-HSco1 (2 M protein concentration) by 1 mM DTT
was followed in 50 mM ammonium acetate buffer, pH 7.5, by
stopping the reduction with 5 mM iodoacetamide. Protein
adducts were identified by MALDI-TOF MS on a Voyager STR
instrument (Applied Biosystems, Foster City, CA).
In ESI-MS experiments, 0.8–4.8Mconcentrations of protein
samples or mixtures were infused by a syringe pump at 15 l/min
into an Ettan API ESI-TOF mass spectrometer (Amersham
Biosciences). Mass spectra were recorded during 2 to 3 min at a
capillary exit voltage of 150 V. HSco1 and P174L-HSco1 were
reduced with 1.0 mM DTT at 298 K. ESI-MS spectrum of
P174L-HSco1 also exposed two minor peaks corresponding to
incorrectly cleaved protein forms, which did not disturb mea-
surements. Reconstitution of HSco1 and Cox17 forms with
Fig. 4. The effect of the P174L-Sco1 mutation in the copper transfer with
Cox17. The pathogenic human Sco1 mutation P174L, next to the copper-
binding motif, determines a reduction of the efficiency of the copper transfer
from the mitochondrial metallochaperone Cox17 to Sco1.
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copper was conducted as follows. First, Cu(II) acetate was
dissolved at 150 M concentration in argon-saturated 50 mM
ammonium acetate, pH 7.5, and Cu(II) was reduced to Cu(I) by
addition of 1.0 mM DTT. Different equivalents of freshly
prepared Cu(I)DTT complex were added to HSco1 or Cox17
and incubated in buffer with 1.0 mM DTT, and the mixture was
incubated for additional 1 min at 25°C, and ESI-MS spectra were
recorded as described above. In Cox17/HSco1 titration experi-
ments, Cu1(I)Cox172S-S was prepared by addition of Cu(I) to
Cox172S-S, which subsequently was mixed with a sample of HSco1
protein. All buffers contained 1 mM DTT. The dissociation
constant of Cu1(I)Cox172S-S complex has been calculated as
previously reported (23).
NMR Protein Characterization. The fully copper-loaded state of the
Cu1(I)P174L-HSco1 NMR sample used for structure determi-
nation has been produced by adding 1.5 eq of
[Cu(I)(CH3CN)4]PF6 complex to reduced apo protein in 50 mM
phosphate buffer at pH 7.2 and in the absence of DTT. NMR
spectral assignment and structure determination of
Cu1(I)P174L-HSco1 were obtained through the experiments
listed in SI Table 1. The 1H, 13C, and 15N resonance assignments
of the Cu1(I)P174L-HSco1 are reported in SI Table 2. After
conversion of the NMR data in structural restraints, the struc-
ture was calculated by using the program DYANA. The relative
intensity of the split resonances was taken into account when
converting NOE volumes into distances. The best 30 conformers
of the DYANA family were subjected to restrained energy
minimization (REM) with AMBER 8.0, by using the metal force
field already applied for WT-HSco1 (16). The statistical analysis
of the REM family of Cu1(I)P174L-HSco1 structures is reported
in SI Table 3. The programs PROCHECK, PROCHECK-NMR
(30, 31), and WHATIF (32) were used in the evaluation of the
quality of the structures.More than 90% of residues were located
in the allowed regions of the Ramachandran plot.
Titrations of 15N-labeled apoHSco1 (0.1 mM) and apoP174L-
HSco1 (0.1 mM) with unlabelled Cu1(I)Cox172S-S or
[Cu(I)(CH3CN)4]PF6 were performed with NMR spectroscopy
following the 1H-15N spectral changes in HSQC spectra upon
addition of increasing amounts of the unlabelled protein partner
or copper(I) complex in the presence of 1 mM DTT. Aliquots
were added in a Coy chamber under nitrogen atmosphere at 298
K. The metalation state of WT-HSco1 and P174L-HSco1 pro-
teins was monitored along the NMR titration through a few
residues that are next to the copper(I) binding motif CXXXC
and therefore are experiencing chemical shifts sensitive to the
metalation state. In addition, their NHs are not overlapped in
the 1H-15N HSQC maps, thus they are easily integrated during
the titration steps to estimate the relative population of apo and
copper(I) loaded forms, which allows the estimation of the metal
affinity. The dissociation constant KD of Cu(I)P174L-HSco1 is
obtained according to the following scheme:
Cu(I)P174L-HScol  DTTN apoP174L-HScol
 Cu(I)DTT. [1]
The conditional dissociation constant for the Cu(I)DTT com-
plex, necessary for the above KD estimation, is 6.31  1012 M
at pH  7.4 and T  298 K (33).
R1 and R2 15N relaxation rates on 1:1 Cu1(I)Cox17/WT-HSco1
mixture were measured at 298 K on a Bruker (Billerica, MA)
Avance 500 spectrometer and then analyzed by using a standard
procedure (34). An estimate of the overall rotational correlation
time was derived from the measured R2/R1 ratio.
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Human Sco2 is a mitochondrial membrane-
bound protein involved in copper supply for
the assembly of cytochrome c oxidase in
eukaryotes. Its precise action is not yet under-
stood. We report here a structural and dynamic
characterization by NMR of the apo and cop-
per(I) forms of the soluble fragment. The struc-
tural and metal binding features of human
Cu(I)Sco2 are similar to the more often studied
Sco1 homolog, although the dynamic proper-
ties and the conformational disorder are quite
different when the apo forms and the cop-
per(I)-loaded forms of the two proteins are
compared separately. Such differences are
accounted for in terms of the different physico-
chemical properties in strategic protein loca-
tions. The misfunction of the known pathogenic
mutations is discussed on the basis of the
obtained structure.
INTRODUCTION
Cytochrome c oxidase (CcO) is the terminal enzyme of the
energy transducing respiratory chain in eukaryotes and
certain prokaryotes. The enzyme is embedded within the
inner membrane of the mitochondrion with a portion of
the molecule protruding into the intermembrane space
and a separate portion extending into the matrix (Tsuki-
hara et al., 1996). It catalyzes the reduction of molecular
oxygen and couples this reduction with proton transloca-
tion across the inner membrane (Ramirez et al., 1995;
Branden et al., 2006; Richter and Ludwig, 2003). In
eukaryotes, it consists of 12–13 subunits, with the three
subunits (Cox1–Cox3) that form the enzyme core being
encoded by the mitochondrial genome (Capaldi, 1990).
The remaining subunits are encoded by the nuclear
genome and consist of small polypeptides (ranging from
6 to 15 kDa) that surround the catalytic core. Catalytic
cofactors in CcO include copper ions and heme moieties
(Tsukihara et al., 1995). In particular, two copper ions exist
in a cysteine-bridged, binuclear, mixed valent center, des-
ignated CuA, located in Cox2. The domain of Cox2 con-
taining the CuA site protrudes into the inner membrane1132 Structure 15, 1132–1140, September 2007 ª2007 Elsevierspace with the CuA site 8 A˚ outside the membrane surface
(Tsukihara et al., 1995). In addition to the two copper ions
present in the CuA site, a mononuclear copper site inter-
acts with a heme moiety forming a heterobimetallic site
in Cox1. This metal center, designated heme a3-CuB, is
buried 13 A˚ below the membrane surface (Tsukihara
et al., 1995). Copper insertion into nascent Cox1 and
Cox2 chains is likely to occur in the intermembrane space,
as all of the thus far identified copper donor molecules,
Cox17, Sco1, Sco2, and Cox11, are localized within this
mitochondrial compartment (Khalimonchuk and Rodel,
2005; Cobine et al., 2006). Cox11 and Sco1 were pro-
posed to be the cometallochaperones assisting Cox17
in the metallation of the CuB and the CuA sites of CcO,
respectively (Carr and Winge, 2003). It has been shown
that Cox17 is capable of donating Cu(I) to both Sco1
and Cox11 (Horng et al., 2004; Banci et al., 2007) and
that the Sco1 protein forms a transient complex with
Cox2 in yeast (Lode et al., 2000). Sco2 is a protein highly
similar to Sco1 (Smits et al., 1994); indeed, both are teth-
ered to the inner membrane by a single transmembrane
helix, have a globular metal binding domain that protrudes
into the intermembrane space (Buchwald et al., 1991), and
are capable of binding copper ions in vitro and in vivo
(Beers et al., 2002; Nittis et al., 2001; Horng et al., 2005).
These features thus suggest the same or a very similar
function. Accordingly, both are proposed to be involved
in copper incorporation in the CuA site. However, whereas
sco1D yeast cells are respiratory deficient and are devoid
of CcO activity, sco2D yeast cells lack an obvious pheno-
type associated with respiration (Glerum et al., 1996).
Moreover, at variance with Sco2, Sco1 overexpression
fully restores respiratory growth in cox17D yeast cells,
whereas high levels of Sco2 fail to overcome the respira-
tory defects of sco1D yeast cells (Glerum et al., 1996). In
humans, patients with mutations in the Sco2 gene have
a clinical presentation distinct from that of Sco1 patients,
even if Sco1 and Sco2 are ubiquitously expressed and
exhibit a similar expression pattern in different human
tissues (Shoubridge, 2001). Studies with immortalized
fibroblasts from Sco1 and Sco2 patients suggest that
human Sco1 and Sco2 have nonoverlapping but cooper-
ative functions in CcO assembly (Leary et al., 2004).
Recently, it was shown that human Sco2 is also the down-
stream mediator of the balance between the utilization of
respiratory and glycolytic pathways (Matoba et al., 2006)
and has a regulatory role in the maintenance of cellularLtd All rights reserved
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Human Sco2 Cu(I) Domaincopper homeostasis (Leary et al., 2007). In particular, the
latter study suggests that both Sco1 and Sco2 might have
a role in regulating the cellular copper level, which is a
further phenotype independent from that of CcO assem-
bly. They are also proposing that Sco2 has a copper-level
signaling role and acts in conjunction with but upstream of
Sco1. Therefore, the role of the two distinct Scomolecules
in mammals is still debated, and the experimental
evidence available has not fully settled their functional
aspect.
In this work, we report a solution NMR investigation of
both the apo and metallated forms of human Sco2 (here-
after HSco2). The solution structure of Cu(I)HSco2 shows
that the protein has a thioredoxin fold, with one copper(I)
ion bound through a conserved CXXXC motif and a con-
served His, similar to what occurs in human Cu(I)Sco1
(hereafter Cu(I)HSco1). However, in Cu(I)HSco2, some
regions are more disordered than in Cu(I)HSco1, as a con-
sequence of the lack of long-range hydrogen bond/salt
bridge interactions. We also show that copper(I) binding
dramatically affects the dynamic properties of HSco2,
the apo form having a global dynamic tertiary structure
whereas copper(I) binding makes the protein more rigid,
even if a certain degree of global conformational motion
is still present in Cu(I)HSco2. Some changes from a disor-
dered apo protein to a compact metallated form upon
copper binding were also observed for HSco1 but, at var-
iance with HSco2, in HSco1 this effect is only restricted to
the metal binding region.
RESULTS AND DISCUSSION
Two truncated forms of the human Sco2 gene were engi-
neered, both lacking the N-terminal mitochondrial target-
ing sequence and the single transmembrane helix (see
Figure S1 in the Supplemental Data available with this arti-
cle online). The two truncated forms differ by a 21 amino
acid segment at the N terminus, which is predicted to be
unstructured, similar to what occurs in HSco1 (Banci
et al., 2006). Size-exclusion chromatography equipped
with multiangle light scattering showed that both
apoHSco2 constructs eluted in fractions corresponding
to a monomeric state for the protein (Figure S2). This
behavior differs from the corresponding constructs of
HSco1, being the longer HSco1 in a dimeric state and
the shorter HSco1 in a monomeric state (Banci et al.,
2006). In vivo studies have shown that this N-terminal
region is crucial for yeast Sco1 function and cannot be
replaced even by its Sco2 counterpart (Lode et al., 2002).
Our data support the hypothesis proposed by Lode et al.
(2002) that thisN-terminal region is important for the spatial
orientation of the C-terminal soluble domain and/or for
modulating the aggregation state of the proteins.
To investigate the structural and metal binding proper-
ties of HSco2, the shorter construct of 166 amino acids
was used (plus four residues corresponding to the TEV
protease recognition site [GSFT]; Figure S1), the first res-
idue being Gly100.Structure 15, 1132–1140,Reduced apoHSco2 is able to bind one equivalent of
either copper(I) or copper(II), similar to HSco1 (Horng
et al., 2005; Banci et al., 2006). UV/VIS and electron para-
magnetic resonance (EPR) spectra of Cu(II)HSco2
(Figure S3) are also similar to those recently reported for
HSco1 (Horng et al., 2005; Banci et al., 2006) as well as
those of bacterial Sco homologs (Balatri et al., 2003;
Andruzzi et al., 2005), suggesting that the copper(II) bind-
ing site is formed by the same ligands in both HSco1 and
HSco2 proteins.
The 1H-15N and 1H-13C heteronuclear single quantum
correlation (HSQC) spectra of apo and Cu(I)HSco2 show
well-dispersed resonances indicative essentially of
a folded protein in both states, according to similar circu-
lar dichroism spectra of the metallated and apo forms
(data not shown). However, only 84 out of the expected
160 15N backbone amide resonances were detected in
the 1H-15N HSQC spectrum of apoHSco2, whereas only
2 NHs are absent in the spectrum of Cu(I)HSco2 (Tables
S1 and S2). In apoHSco2, the backbone amide reso-
nances are missing for the regions containing the CXXXC
metal binding motif and the conserved His, and for their
closest surroundings (Figure 1). The signals detected in
the 1H-15N HSQC spectra of Cu(I)HSco2 and apoHSco2
have very similar chemical shifts (Figure S4), the DdNH dif-
ferences being smaller than 0.10 ppm. This indicates that
the observed region in apoHSco2 is not largely affected by
metal binding. Accordingly, chemical shift index analysis
of the residues detected in both apo and copper(I) forms
indicates the presence of the same secondary-structure
elements. Finally, a number of residues located at the
borderline between the regions of detected and unde-
tected NH resonances show double or multiple reso-
nances in the NMR spectra of the apo form (Figure 1),
whereas only a set of signals is present in Cu(I)HSco2.
In conclusion, the inability to detect many backbone NH
signals as well as the presence of double-backbone NH
resonances indicate that apoHSco2 in solution samples
multiple local conformational states exchanging with
each other on the intermediate or slow NMR timescale.
At variance with apoHSco1, the conformational heteroge-
neity involves not only the metal binding region but also
the b sheet and the surrounding a helices, which consti-
tute the protein core of HSco2 (Figure 1). Copper(I) binding
is, however, able to ‘‘freeze’’ the above regions in an
ordered, more rigid conformation, thus allowing its struc-
ture determination. The latter can, however, be deter-
mined only at 308K, as the majority of the NH signals
were too broad at lower temperatures to achieve a high-
resolution structure. Consistently, the number of observed
nuclear Overhauser effects (NOEs) is much larger than at
298K.
The overall fold of Cu(I)HSco2 contains four a helices
and nine b strands forming a central b sheet and two b hair-
pins, organized into a thioredoxin fold as found in the
Cu(I)HSco1 structure (Banci et al., 2006) (Figure 2). Cop-
per(I) is coordinated by the two cysteines of the CXXXC
conserved motif, located in loop 3 and helix a1, and by
the conserved His224 (Figure 2), located in a b hairpin.September 2007 ª2007 Elsevier Ltd All rights reserved 1133
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Human Sco2 Cu(I) DomainFigure 1. Detectability of the NMR Back-
bone NH Resonances between
ApoHSco1 and ApoHSco2
Backbone NH resonances not detected in
apoHSco1 or apoHSco2 are mapped in red
on Cu(I)HSco1 (left) and Cu(I)HSco2 (right)
solution structures. In apoHSco2, the back-
bone amide resonances are missing for resi-
dues located in the N terminus (100, 101,
102, 103), strand b1 (105, 107), 310-helix
(116), strand b3, loop 3, and helix a1 (127–
144), loop 5 (166–171), loop 7, helix a3, loop
8, and strand b6 (193–200, 202–231), and
strand b7 and loop 10 (237–244), according
to the secondary-structure elements observed
in Cu(I)HSco2. In apoHSco1, 36 backbone
amide resonances in strand b3 (164), loop 3
(166–173), helix a1 (175–180), loop 5 (202–
204), and loop 8 (244–264) are missing. Resi-
dues showing double or multiple conforma-
tions in NMR spectra of apoHSco2, located in
loop 1 (109), strand b2 (115), loop 2 (121),
strand b3 (125, 126), helix a1 (145, 146), strand
b4 (164, 165), loop 5 (172), and strand b5 (191
and 192), are mapped in blue. Copper(I) ions,
metal ligands, and proline residues are shown
in pink, yellow, and black, respectively.From 2J NH coupling-based 1H-15N HSQC experiments
(Figure 3), it appears that His224 binds copper(I) through
N32, whereas Nd1 is protonated. Copper(I) coordination
in HSco2 is the same as in Cu(I)HSco1 (Banci et al.,
2006). The Cu(I)HSco2 structure is also very close to that
of Cu(I)HSco1, the global root-mean-square deviation
(rmsd) between Cu(I)HSco1 and Cu(I)HSco2 being
1.27 A˚ for backbone atoms. No regions with rmsd’s
between the two mean minimized structures larger than
the sum of the rmsd’s of each family are found, indicating
no substantial structural differences within solution struc-
ture resolution.
The dynamic properties were mapped over the back-
bone of the copper(I)-bound protein based on 15N relaxa-
tion rates and heteronuclear 1H-15N NOEs. R1 and R21134 Structure 15, 1132–1140, September 2007 ª2007 Elseviervalues measured at two different protein concentrations
are similar, indicating that the aggregation state is not
changing upon dilution (Figure S5). Accordingly, upon
change of concentration, no meaningful variation in the
15N chemical shift (R0.05 ppm) is observed for any resi-
due of the protein. R1 values (Figure S5) measured at
500 MHz (0.2 mM protein) and 600 MHz (0.6 mM protein)
indicate that the protein reorients in solution as a mono-
mer. Indeed, these values at 298K (1.32 ± 0.17 s1) com-
pare well with those of proteins of similar size (human
Sco1, 1.38 ± 0.11 s1; Bacillus subtilis Sco, 1.40 ± 0.06
s1; monomeric superoxide dismutase (SOD), 1.41 ±
0.29 s1) (Balatri et al., 2003; Banci et al., 2000). Moreover,
R1 values of dimeric SOD (MW 32 kDa) (Banci et al., 2000)
are less than half of our data, confirming that Cu(I)HSco2 isFigure 2. Solution Structure of
Cu(I)HSco2
On the left side, the average structure of the
lowest-energy ensemble is shown. The sec-
ondary-structure elements are also reported.
The metal binding residues Cys133 and
Cys137 are shown in yellow, and His224 is
shown in blue. The copper(I) ion is depicted
as a pink sphere. On the right, the super-
imposition of 30 lower-energy structures of
Cu(I)HSco2 is represented as a tube whose
radius is proportional to backbone rmsd.
a helices and b strands are colored in red and
cyan, respectively.Ltd All rights reserved
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Human Sco2 Cu(I) DomainFigure 3. 1H-15N HSQC Spectrum Opti-
mized for the Detection of 2J NH of His
Rings, Recorded on Cu(I)HSco2
The spectra were collected at 308K and pH 7.2
on a spectrometer equipped with a cryoprobe
and operating at 500 MHz. A schematic dia-
gram showing the nomenclature used to
describe the imidazole atoms and the three
possible protonation states of the histidine
ring is presented. From 2J patterns, His224
has an a-type tautomeric state, His105,
His109, His185, and His257 have b-type tauto-
meric states, and His132 and His203 have
c-type tautomeric states.reorienting in solution as amonomer. The 1H-15N NOEs in-
dicate that there are no regions with local fluctuations on
the ps-ns timescale. However, the R2 mean value (25.9
± 4.5 s1 at 500 MHz and 298K on a 0.2 mM sample) of
Cu(I)HSco2 (Figure S5) is much higher than expected
(17.3 ± 0.7 s1 at 500 MHz as obtained from the
HYDRONMR program [Garcia de la Torre et al., 2000]
for themonomeric Cu(I)HSco2 structure). The unexpected
values of R2 can be ascribed to some degree of backbone
conformational fluctuations of the protein occurring along
the whole amino acid sequence on the NMR timescale
(103 s). Transverse crosscorrelated relaxation rates,
hxy, which are not affected by slow conformational
exchange (Tjandra et al., 1996), were measured to evalu-
ate whether exchange contributions are operative in
transverse relaxation rates. The average hxy value is
11.0 ± 1.8 s1 at 308K (Figure S6), which is significantly
lower than the average R2 value measured under the
same experimental conditions (26.4 ± 5.8 s1). From the
average hxy value, the effective tc was estimated (Lee
et al., 2006) assuming a uniform chemical shift anisotropy
of 160 ppm, q = 17, and rHN = 1.02 A˚. The effective tc is
10.7 ± 1.8 ns, equal to the overall tumbling time calculated
through HYDRONMR, which is 10.9 ns, thus confirming
the monomeric state of Cu(I)HSco2. The value of 10.7 ±
1.8 ns at 308K is also in agreement with that estimated
for HSco1 (having the same MW of 19.7 kDa), 14.5 ± 1.1
ns at 298K. If the values are extrapolated at the same tem-
perature they are the same within experimental uncer-
tainty, indicating the same monomeric state for both
proteins. According to the Redfield relaxation matrix
approach (Palmer, 2004), R2 values of a
15N nucleus of
an isolated 1H-15N dipole not affected by exchange contri-
butions for a protein tumbling at 10.7 ns should be in the
range of 14–15 s1. However, the average R2 of
Cu(I)HSco2 is much higher than that value, indicating
there is an exchange contribution to R2 (Akerud et al.,
2002). Therefore, HSco2 behaves in both apo and
copper(I) forms as a protein with a dramatic backbone
fluxionality, though to different extents in the two forms,
which is distinct from HSco1. This property can, therefore,Structure 15, 1132–1140,play a role in distinguishing the molecular functions of the
two human paralogs.
Comparison between the Structural and Dynamic
Properties of HSco1 and HSco2
In order to understand the factors determining the dif-
ferent behavior in solution between apoHSco1 and
apoHSco2, we analyzed the sequences of the solvent-
soluble domain of the two proteins. Only 51 residues are
different or weakly similar (Figure 4; sequence identity
51%; sequence homology 73%). By displaying them on
the structures of Cu(I)HSco2 and Cu(I)HSco1, the result
is that 29 residues are located in the secondary-structure
elements, while 22 are in loop regions. These residues are
mainly located on the protein surface, with the exception
of three residues which are largely buried in both
proteins. In HSco2 they are Ala201, Ala227, and Thr238,
which are replaced by longer hydrophobic side-chain res-
idues in HSco1 (Val237, Ile263, and Leu274, respectively).
The shorter side chains in these positions could determine
less compact hydrophobic contacts and therefore a less
tight hydrophobic core in apoHSco2 with respect to
apoHSco1, thus allowing the protein to sample multiple
local conformations. A similar correlation has indeed
been previously observed in the ferredoxin babbab fold,
where a mutation from a short residue (Ser or Ala) to a
longer hydrophobic residue (Val) in the hydrophobic core
stabilizes the tertiary structure of the protein in a single
conformation (Banci et al., 2003). According to this hy-
pothesis, position 201 (HSco2 numbering) (Figure 4) is
structurally important for orienting helix a3 with respect
to the b sheet, through hydrophobic interactions with sev-
eral hydrophobic residues conserved in both HSco1 and
HSco2 proteins (Phe104, Leu106, Phe128, and Ile165 in
HSco2): the shorter Ala201 chain present in HSco2 cannot
optimize the protein core packing as Val237 in HSco1 can
do. This single amino acid substitution could thus repre-
sent the structural basis for the conformational disorder
of helix a3 reflected in the undetectability of its backbone
NHs in apoHSco2 (Figure 1). Similarly, positions 227 and
238 (HSco2 numbering) (Figure 4) are involved inSeptember 2007 ª2007 Elsevier Ltd All rights reserved 1135
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Human Sco2 Cu(I) DomainFigure 4. Sequence Alignment of HSco1 and HSco2
Residues that are conserved, highly similar, or weakly similar are indicated, respectively, by *, :, and $ below the sequences. Secondary-structure
elements are also depicted at the top according to the Cu(I)HSco2 structure.hydrophobic interactions between strands b6, b7, and b3
interacting with residues conserved in both HSco1 and
HSco2 proteins (Trp123, Phe128, Tyr229, Leu230, and
Tyr240 in HSco2). The shorter Ala227 and Thr238 side
chains in HSco2 with respect to the Ile263 and Leu274
side chains in HSco1 could contribute to the conforma-
tional destabilization of strands b6 and b7, whose back-
bone NHs are indeed not detected in apoHSco2 as a con-
sequence of a less tight hydrophobic packing. Backbone
NHs of loop 8, which contains the His ligand, are also
missing in the 1H-15N HSQC map. Loop 8 is the junction
between helix a3 and strand b6, and the undetectability
of its signals is in agreement with the presence of local
conformational heterogeneity in this region of apoHSco2.
In conclusion, a single amino acid variation in key
positions of the sequence could significantly affect
the dynamic behavior of apoHSco2 with respect to
apoHSco1.
Upon copper(I) binding, all the unobserved backbone
NH signals of apoHSco2 (except for residues 196 and
237) become detectable, indicating that the metal ion is
capable of freezing one of the possible conformations
present in the apo form, that is, the one which appropri-
ately orients the ligands, Cys and His, to bind copper(I).
Still, the disorder in helices a3 and a4 and three loop
regions (loops 5, 8, and 10; Figure S7) in Cu(I)HSco2
(as estimated from the backbone rmsd among the con-
formers of the family) is higher than that found in the
corresponding regions of Cu(I)HSco1. Loops 5 and 81136 Structure 15, 1132–1140, September 2007 ª2007 Elseviershow the most striking differences in this conformational
disorder. In the Cu(I)HSco2 structure, loop 8 is highly
disordered in the solvent-exposed region, from residue
211 to 222, as medium- and long-range NOEs cannot
be detected for this stretch. On the contrary, in
Cu(I)HSco1, long-range NOEs are present between
loop 8 and loop 5 involving the side chains of Tyr256
(loop 8) and Glu206 (loop 5), which are indeed hydrogen
bonded. These interactions are absent in Cu(I)HSco2,
despite the residues in those positions being conserved
on both sides. Also, helix a3 shows an overall decreased
number of long-range NOEs with respect to those found
in Cu(I)HSco1 (five against eight long-range NOEs per
residue), thus determining a slight increase in backbone
rmsd in Cu(I)HSco2 (Figure S7). Positions 195 and 199
of this helix (Figure 4) are not involved in salt bridge
and hydrogen bond interactions, respectively, in
HSco2, at variance with what occurs for the correspond-
ing residues in HSco1 (Figure 5) (Banci et al., 2006;
Williams et al., 2005). Indeed, the residues in these posi-
tions change from Arg to Thr and from Asp to Ala,
respectively, thus making impossible the salt bridge
between Arg231 (helix a3) and Glu206 (loop 5) and the
hydrogen bond between Asp235 (helix a3) and Tyr245
(loop 8) observed in HSco1 (Figure 5). In conclusion,
the result is that some hydrogen bonds and charged in-
teractions connecting helix a3 and loops 5 and 8 in
HSco1 are not conserved in HSco2, accounting for the
lower rigidity of Cu(I)HSco2 with respect to Cu(I)HSco1.Ltd All rights reserved
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Human Sco2 Cu(I) DomainFigure 5. Network of Hydrogen Bond
and Salt Bridge Interactions in the Case
of HSco1 and HSco2
The salt bridge between Glu206 (in loop 5) and
Arg231 (in helix a3) is present in HSco1 (left) but
absent in HSco2 (right), where Arg231 is re-
placed by Thr195. Similarly, the hydrogen
bond between Od of Asp235 (in helix a3) and
OH of Tyr245 (in loop 8) is present in HSco1
(left) but missing in HSco2 (right), where
Asp235 is replaced by Ala199.Sco2 Point Mutations Causing Human
Mitochondrial Disease
Five known pathogenic missense mutations in the human
Sco2 gene have so far been identified: Cys133Ser (Tarno-
polsky et al., 2004), Glu140Lys (Papadopoulou et al.,
1999), Leu151Pro (Sacconi et al., 2003), Arg171Trp
(Jaksch et al., 2000), and Ser225Phe (Papadopoulou
et al., 1999). The Cys133Ser mutation eliminates the first
cysteine in the conserved metal binding CXXXC motif,
thus making the protein unable to bind copper and likely
determining a nonfunctional HSco2 protein. In the
Cu(I)HSco2 structure, Glu140, located in helix a1 and es-
sentially not solvent exposed, is involved in a salt bridge
with Lys143, which is disrupted in the Glu140Lys mutant.
In addition, the introduction of a longer side chain in a
buried region could locally destabilize side-chain packing
between helix a1 and the facing b sheet. Because Glu140
is relatively close to the copper binding Cys137, the pos-
sible structural rearrangements induced by the mutation
could affect both the copper binding properties and pro-
tein stability, factors which both influence protein function,
thus possibly rationalizing at the molecular level the
mutant misfunction. Similarly, the mutation of Ser225 to
Phe could affect the copper binding properties of
HSco2, destabilizing the copper(I) coordination of the
proximal His224 ligand. As copper(I) binding induces
a transition from an open apoHSco2 state to a compact
Cu(I)HSco2 state where His is metal coordinated, the
mutation could alter this conformational transition deter-
mining a weaker metal affinity, similar to what we recently
found for the Pro174Leu mutation in the HSco1 protein,
the mutated residue being similarly next to the Cys ligand
(Banci et al., 2007).
The mutation of Arg171Trp produces the loss of salt
bridges between Arg171 and the conserved charged
residues Asp168 and Glu170 in loop 5, whereas the muta-
tion of Leu151Pro could affect the hydrophobic packing,
as indeed Leu151 in helix a1 is involved in hydrophobic in-
teractions with Leu157 (loop 4), Val147 (helix a1), Val160
(strand b4), and Val254 (helix a4). Therefore, both patho-
genic mutations could likely destabilize the protein fold,
rendering the protein more susceptible to aggregation
and/or degradation, that is, increasing the turnover rate
of the protein.Structure 15, 1132–1140,Comparison between the Redox Properties
of ApoHSco1 and ApoHSco2
Similar to what occurs in apoHSco1 (Banci et al., 2006),
oxidized and reduced forms of apoHSco2 are character-
ized by different fluorescence spectra. The reduction
potential of the two cysteines in apoHSco2 at pH 7.2 is
lower than 0.3 V, which compares with 0.28 V in
HSco1 (Banci et al., 2007). Higher concentrations of gluta-
thione (GSH) (50 mM) are needed to reduce 90% of the
disulfide bond in apoHSco2, whereas in apoHSco1 the
complete reduction was obtained with 30 mM GSH. This
shows that the reduction potential is slightly lower for
HSco2 than for HSco1. In any case, the negative reduction
potential values of apoHSco2 and apoHSco1 suggest that
both need a reductant capable of reducing disulfide
bonds in order to bind the copper(I) ion. Mitochondrial
inner membrane space is indeed suggested to be more
oxidizing than cytosol, which has a redox potential
of 0.29 V (Koehler et al., 2006).
Biological Implications
Human Scos have essential, nonoverlapping functions in
the biogenesis of the CuA site that depend on their capa-
bility to bindCu(I) and/or Cu(II) and to interact in the protein
cascade of copper transfer (Horng et al., 2005; Leary et al.,
2004). Other additional molecular functions have been
suggested. Recently, both proteins have been suggested
to be involved in the maintenance of cell copper homeo-
stasis (Leary et al., 2007) or, limited to HSco2, as a down-
streammediator of theWarburg effect, as its expression is
regulated by p53 (Matoba et al., 2006). No other specific
functions for HSco1 and HSco2 have been proposed.
We have shown here that (1) HSco2 has a thioredoxin
fold similar to its human paralog HSco1 and that (2) the
metal binding and redox properties are similar. HSco2,
however, has an internal dynamic and conformational
disorder higher than that of HSco1, especially pronounced
in its apo form, where it samples more than one conforma-
tion. Despite the same overall structure, some key interac-
tions, whether hydrophobic or hydrogen bonds or salt
bridges, are dramatically different in the two proteins,
being less numerous in HSco2. The different dynamic
properties of HSco2 with respect to HSco1 can play an
important role in molecular recognition with differentSeptember 2007 ª2007 Elsevier Ltd All rights reserved 1137
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Human Sco2 Cu(I) Domainprotein partners. In particular, as HSco2, with respect to
HSco1, has been proposed to act upstream in the mainte-
nance of cellular copper homeostasis (Leary et al., 2007)
and is in addition involved in the p53-linked pathway
(Matoba et al., 2006), we can propose that the structural
malleability of HSco2, especially in its apo form, is an
essential requirement for taking part in various protein
pathway recognition. Indeed, amolecular featurecommonly
associated with protein interaction sites is structural
disorder, even if local (Ishima and Torchia, 2000).
EXPERIMENTAL PROCEDURES
Protein Preparation and Characterization
Long and short soluble domains of HSco2 (lacking the first 234 and 297
bp, respectively, corresponding to residues 1–78 and 1–99) were
amplified by polymerase chain reaction (PCR), cloned into the Gate-
way entry vector pENTR-tobacco etch virus-D-TOPO (Invitrogen),
and subcloned into pETG-30A (European Molecular Biology Labora-
tory Protein Expression and Purification Facility) by a Gateway LR
reaction to generate N-terminal, His-GST-fused proteins.
The proteins were expressed in Escherichia coli BL21-codon+ cells
(Stratagene), which were grown in Luria Bertani and minimal medium
([15NH4]2SO4 and/or [
13C]glucose) for the production of labeled sam-
ples. Protein expression was induced by adding 0.7 mM IPTG for
16 hr at 30C. Purification was performed by using a HiTrap chelating
HP column (Amersham Pharmacia Biosciences) charged with Zn(II).
The His-GST tag was cleaved with AcTEV protease (Invitrogen), and
separated from the C-terminal domain with a second purification
step. After this purification, the protein preparations showed a single
component by SDS-PAGE with <5% of copper bound to the protein,
as checked by inductively coupled plasma mass spectrometry (MS).
To investigate the aggregation state of HSco2, 0.5–1 mM protein
samples were run on a Superdex 75 HR-10/30 size-exclusion column
on an AKTA-FPLC system (Amersham Pharmacia Biosciences)
connected to a multiangle light-scattering system (DAWN-EOS; Wyatt
Technologies) equipped with quasielastic light-scattering detectors.
A mixture of protein standards (a, b, c, and d in Figure S2) of various
size were loaded to obtain a calibration line for the Supedex 75 col-
umn. Blue dextran was used in each mixture to determine the void
volume.
Dithiothreitol (DTT) was added to the apo protein at 10 mM concen-
tration to reduce the Cys residues of the CPXXCP motif before metal
reconstitution. Then, in the case of Cu(II) metallation, DTT was
completely removed through a PD-10 desalting column (Amersham
Pharmacia Biosciences) in an N2 atmosphere chamber, whereas 1
mM DTT was present in the case of Cu(I) metallation. The Cu(I) and
Cu(II) metallated forms were obtained by addition of stoichiometric
amounts of the metal ions, as (Cu[I][CH3CN]4)PF6 or CuSO4, to diluted
protein solutions in 50 mM phosphate buffer (pH 7.2), which were then
concentrated under nitrogen atmosphere. The metal content was then
determined by inductively coupled plasma MS.
Electronic spectra on Cu(II) derivatives were recorded on a Cary 50
spectrophotometer (Varian) at 298K. EPR spectra on Cu(II)HSco2 were
recorded at 180K on an Elexsys E500 spectrometer (Bruker) equipped
with an X-band microwave bridge (microwave frequency, 9.45 GHz)
and an ER 4131 VT unit for temperature control.
Redox equilibration between apoHSco2 and GSH was followed
through the change of fluorescence monitored on 5 mM protein sam-
ples previously incubated, for at least 6 hr under an N2 atmosphere,
with different GSH/GSSG (glutathione disulfide) ratios (0.1 mM
GSSG and varying concentrations of GSH, 10–200 mM) in 50 mM
phosphate buffer (pH 7.2). The collection and data analysis were
performed following a protocol previously described for HSco1 (Banci
et al., 2007).1138 Structure 15, 1132–1140, September 2007 ª2007 ElsevieNMR Experiments and Structure Calculations
NMR spectral assignment and structure determination of Cu(I)HSco2
were obtained through the experiments listed in Table S3, which
also indicates the magnetic fields at which they were collected. All
NMR spectra were acquired at 308K. Overall, the resonances of
96% of carbon atoms, 98% of nitrogen atoms, and 95% of protons
were assigned in Cu(I)HSco2 (Table S1; deposited in the BioMagRes-
Bank database). For the apo form, backbone assignment was per-
formed collecting triple-resonance experiments HNCA, HN(CO)CA,
and HNCO. The His ring protons of Cu(I)HSco2 were assigned through
a 1H-15N HSQC experiment tailored to the detection of 2J 1H-15N
couplings and from the analysis of 13C-NOESY-HSQC spectra. In
Cu(I)HSco2, all nonexchangeable protons of all His rings were
assigned. The exchangeable proton of the metal binding ligand,
His224, is also detected in Cu(I)HSco2. Proton-proton distance
constraints were derived from the analysis of 2D-NOESY (nuclear
Overhauser enhancement spectroscopy), 15N-NOESY-HSQC, 13C-
NOESY-HSQC, and 13C-NOESY-HSQC recorded on a D2O-
exchanged sample. In total, 2296 meaningful proton-proton distance
constraints together with 87 f and 89 c torsion angle constraints,
derived from chemical shift index analysis, were used in the structure
calculation of Cu(I)HSco2. The structure was calculated using the pro-
gram DYANA (Gu¨ntert et al., 1997). The copper ion was included in the
structure calculations by adding a new residue in the amino acid se-
quence, following an approach used for similar systems (Banci et al.,
2004). The sulfur atoms of the Cys ligands (Cys133 and Cys137) and
N32 of His224 were linked to the metal ion through upper distance
limits of 2.3 and 2.1 A˚, respectively. The best 30 structures of the
DYANA family were then subjected to restrained energy minimization
(REM) with AMBER 8.0 (Case et al., 2004). The force field parameters
for themetal ion were adapted from similar systems (Poger et al., 2005;
Banci et al., 1994). The statistical analysis of the REM family of the
Cu(I)HSco2 structure is reported in Table S4. The programs
PROCHECK, PROCHECK-NMR (Laskowski et al., 1993, 1996), and
WHAT IF (Vriend, 1990) were used in the evaluation of the quality of
the structures, and the results of this analysis are reported in Table
S4. More than 90% of residues were located in the allowed regions
of the Ramachandran plot.
Relaxation Measurements and Analysis of Cu(I)HSco2
15N R1, R2, and steady-state heteronuclear
1H-15N NOEs were mea-
sured on 0.6 mM Cu(I)HSco2 at 600 MHz (308K) and on 0.2 mM or
0.6mMCu(I)HSco2 at 500MHz (298K and 308K) equippedwith a cryo-
probe using standard pulse sequences (Table S3). Relaxation rates R1
and R2 were determined by fitting the crosspeak heights, obtained
through the standard routine of the Sparky program (T.D. Goddard
and D.G. Kneller, SPARKY 3, University of California, San Francisco),
measured as a function of the delay within the pulse sequence to a sin-
gle-exponential decay. The heteronuclear NOE values were obtained
from the ratio of the peak height for 1H-saturated and unsaturated
spectra. The heteronuclear NOE values and their errors were esti-
mated by calculating the mean ratio and the standard error from the
available data sets. Reliable 15N R1, R2, and
1H-15N NOE values
were obtained for 107 out of the 160 assigned backbone NH
resonances. The others were too weak, or were overlapped, to be
accurately analyzed. Transverse crosscorrelated relaxation rates, hxy,
weremeasured on a 0.6mM sample at 600MHz (308K) using the pulse
sequences of Tjandra et al. (1996) with a dephasing period 2D = 14ms.
The effective tc value was estimated using the equations described in
Lee et al. (2006).
HYDRONMR Calculations
Theoretical prediction of the rotational properties of Cu(I)HSco2 was
calculated by using the ‘‘shell modeling’’ strategy implemented in
HYDRONMR software (Garcia de la Torre et al., 2000). The calculation
was performed by using a viscosity of water at 308K of 0.71 Ns/m2. The
value of the atomic element radius was set to 3.2 A˚ according to ther Ltd All rights reserved
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Human Sco2 Cu(I) Domainaverage value determined previously on a set of different proteins (Gar-
cia de la Torre, 2001).
Supplemental Data
Supplemental Data include seven figures and four tables and can be
found with this article online at http://www.structure.org/cgi/content/
full/15/9/1132/DC1/.
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Introduction 
Hyp1 protein has been suggested to have a role of copper trafficking in prokaryotes, 
as predicted from genomic contexts analysis [1]. The latter is a soluble protein mostly 
occurring in the periplasm of Gram-negative bacteria, and consisting of about 150 amino 
acids. Recently, the first structure of Hyp1 protein from Deinococcus radiodurans 
(DR1885) showed that the fold of this class of proteins organizes in cupredoxin-like fold [2], 
which is similar to more studied protein CopC, involved in copper homeostasis. All Hyp1 
sequences share a conserved Hx14Mx21HxM consensus motif, which could bind copper(I) 
ion. By analyzing the neighborhood of Hyp1 gene, it is suggested that Hyp1 protein has a 
possible relationship with Sco protein, which is proposed to be involved in copper ion 
delivery to the CuA center of cytochrome c oxidase (CcO) complex[1]. Although a large 
number of data have already established that Sco proteins are involved the assembly of 
CcO, precise function of these proteins are still unknown and, indeed, might be different 
from organism to organism [3-5] . Based on the previous observations, three basic models 
are widely proposed: 1) Sco is a copper(I) chaperone, which transfer copper(I) ion to CuA 
site; 2) recent resolved structures of Sco proteins in different organisms show that Sco 
proteins adopt a thioredoxin-like fold, thus Sco could reduce the cysteines in the CuA center 
for copper binding; 3) on the basis of extreme sensitivity to hydrogen peroxide, the Sco 
proteins have also been proposed to function as copper-dependent redox switches in 
signaling. In this model, bound copper(I) ion is oxidized to copper(II) and released. Based 
on our investigation on hSco1, it was indicated that Sco protein could have a dual function 
role of combination of two of the three above points.  
Since Sco proteins show great variance, it is likely that Hyp1 proteins have different 
functions in different organisms, i.e., Hyp1 proteins could be copper(I) donor upstream of 
Sco protein or Hyp1 transfer copper(I) directly to CuA site.  
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In order to understand the function of Hyp1 protein in different organisms, the 
solution structures of Hyp1 protein in T. Thermophillus, the gene product of TTHA1943, 
were solved by NMR in both apo and copper(I) binding forms. Copper binding affinity was 
also determined by competition experiments, showing a dissociation constant of KD=2.2 ± 
0.6×10-13M-1. Protein-protein interactions with Sco protein of T. Thermophillus (TTSco 
hereafter) and CoxII have been also performed. From the structure, dynamic and protein-
protein interaction data, a possible copper transfer mechanism for copper assembly of CuA 
site was suggested for this bacterium. Instead of being copper donor to TTSco, TTHA1943 
is more likely a protein transferring Cu(I) ion directly to CuA site of CcO. The functional 
role of TTSco is either a copper(II) translocation protein or thioredoxin or the combination 
of the two. 
Result 
 
Assignment and structural heterogeneity of TTHA1943 ---- TTHA1943 Protein 
was expressed according to the description in materials and methods section. NMR 
samples were 1.0 mM in protein concentration in 50 mM potassium phosphate buffer (pH 
7.2) containing 10% D2O. Copper(I) metalation was followed by using NMR: 1H-15N 
HSQC spectra were acquired at increasing copper(I) ion concentrations and no more 
spectra change were observed when copper(I)/TTHA1943 ratio was beyond 1:1. The 1H-
15N and 1H-13C HSQC spectra of apoTTHA1943 and Cu(I)TTHA1943 show well-
dispersed resonances indicative of an essentially folded protein in both states. The 
backbone and side chain assignments were performed by using standard triple resonance 
experiments. All the resonances are detected through the whole peptide sequence except 
for the residues 80 and 107 in both apo and Cu(I) form. 23 and 24 residues show two sets 
of amide resonaces in apoTTHA1943 and Cu(I)TTHA1943, respectively. The two species 
are present in a molar ratio of 65:35 in both apo and Cu(I) form. Since MS spectra shows 
one species with the correct molecular weight, the heterogeneity should arise from 
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conformational variability of the protein backbone. The chemical shift difference between 
Cβ and Cγ of P14 and NOE’s patterns of P14 and G13 indicate that structure heterogeneity 
is originated from trans/cis isomerization of peptide bond preceding P14 (Xaa-P14). The 
major species belong to the cis conformation. 
Structures of apoTTHA1943 and Cu(I)TTHA1943 ---- The solution structures of 
apoTTHA1943 and Cu(I)TTHA1943 were determined by using distance and angle 
restraints as obtained from 2D and 3D heteronuclear NMR experiments. Trans and cis 
conformations were considered separately according to different short and long range NOE 
partterns. Therefore, four conformations were totally obtained from structure calculations 
(apoTTHA1943 with trans form Xaa-P14, apoTTHA1943 with cis form Xaa-P14, 
Cu(I)TTHA1943 with trans form Xaa-P14 and Cu(I)TTHA1943 with cis form Xaa-P14). 
Fig 1. shows the structure of Cu(I) TTHA1943 with trans form Xaa-P14 as an example of 
the four structures. About 1700 restraints are used in the calculation of each of the four 
conformations. Backbone RMSD values were in all cases around 0.70 ± 0.10 Å. The 
structure difference induced by trans/cis isomerization is only localized at loop 1 and loop 
8. No regions with RMSD between the mean minimized structures of apo and Cu(I) forms 
larger than the sum of the RMSDs of each family are indeed found, indicating no 
substantial structural differences between apo and copper forms. 
The overall structure of TTHA1943 contains the cupredoxin-like fold, constituted by 
two β sheets forming a Greek key β-barral motif that involves ten β strands, two of which 
is parallel and the others are anti-parallel. Different from a typical cupredoxin-like fold, 
strand β4 and strand β5 form an extended and solvent exposed β heparin. Cu(I) ion is 
bound to two Met and two His of the conserved Hx14Mx21HxM motif, also confirming by 
combined chemical shift variation. The copper ion coordinated in a tetrahedral arrangement 
and the metal ligand atoms are sulfur atoms of Met 61 and Met 85, Nδ1 of His 46 and Nε2 
of His 85. 
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Measuring Cu(I) binding affinity ---- The copper binding affinity of 
Cu(I)TTHA1943 was investigated by titrating the 15N Cu(I)TTHA1943 with DTT. The 
process was followed through 1H-15N HSQC spectra. No variation in the chemical shifts of 
the amide signals in Cu(I)TTHA1943 could be observed at any stage of the titration. 
Instead, the intensities of Cu(I) protein signals decreased with increasing DTT 
concentration. Thus the equilibrium constant between Cu(I)TTHA1943 and DTT was 
detected by the relative intensity of peaks of apo and Cu(I) species (Fig 2). The molar 
fraction of apo and Cu(I)-TTHA1943, when plotted as a function of the DTT:TTHA1943 
molar ratio, can be fitted with an equilibrium constant of (3.45 ± 0.18)×10-2 for the 
transfer of copper(I) ion from TTHA1943 to DTT. Thus the dissociation constant for 
Cu(I)TTHA1943 can be obtained as KD= (2.17± 0.10) ×10-13 M, considering KD of DTT 
is 6.31 × 10-12 M. 
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Fig 1. The minimized mean structure of 
Cu(I)TTHA1943  with trans form Xaa-P14 
Copper(I) binding ligands are shown in 
pink color; copper(I) sphere is shown in 
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Fig 2. Fitting curve of measuring KD value 
of Cu(I)TTHA1943 
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Protein dynamics ---- The 15N relaxation parameters of apoTTHA and Cu(I)TTHA 
were measured as described in materials and methods section. The correlation times for 
molecule reorientation of apo- and Cu(I)TTHA1943 is 9.0 ± 0.2 and 9.2 ± 0.3 ns, 
respectively, as expected for a protein of this size in a monomeric state[2]. Although these 
values are consistent with a molecule of 120 amino acids, use of an isotropic rotational 
diffusion model is statistically rejected in TENSOR2 program. This is not surprising in 
view of the anisotropic nature of the inertia tensor. A fully analysis of the diffusion tensor 
was therefore undertanken. The rotational diffusion tensor of Cu(I)TTHA1943 has axes 
Dxx = (1.545±0.033) × 10-7 s-1, Dyy = (1.765±0.035) × 10-7 s-1 and Dzz= (2.109±0.033) 
× 10-7 s-1, suggesting a significantly rhombic tensor. The angles between inertia tensor 
and diffusion tensor were also calculated and three main axes are almost collinear with the 
values no more than 200. The anisotropic rotational diffusion tensors were then used to 
determine the internal mobility of the TTHA1943 molecules in solution, according to 
model-free approach.  
Overall, the TTHA1943 molecules are rather rigid as shown by the average order 
parameter S2 values are 0.84±0.10 and 0.83±0.12 for the residues without splitting on 1H-
15N HSQC. 1H-15N NOE values of residues 53-58, located in the solvent exposed β strands 
and the according β-turn, are lower than 0.55 and, as a consequence, S2 values of those 
residues are much lower than overall average values, showing the presence of fast motion 
in ps-ns time scale. Residue 22, located in the link between β2a and β2b, and residue 109, 
located in the turn of β9 and β10 are also tumbling faster than overall tumbling rate. 
Residues 7 and 112 show motion in us-ms time scale with exchange rate around 5s-1 and 
1s-1, respectively.  
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The relaxation parameters for the residues showing double conformation are quite 
different. For the resonances belong to the trans form of Xaa-14, relaxation data of 
residues 11, 91 and 120 suggest fast motion. Residues 86 and 119 show slow motion. 
Residue 13 has both a very fast and very slow motion. The rest of residues showing double 
conformations are rigid. In the cis conformation, on the contrary, residues 11 and 13 are 
rigid, as shown by the 1H-15N NOEs and S2 data. This data suggested that in addition to the 
structure variations, trans/cis isomerition of peptide bond preceding P14 (Xaa-P14) induce 
different local dynamic properties between trans and cis conformation. The trans 
conformation is overall rigid but with a flexible loop 1, while the cis conformation forms a 
rigid loop1. 
 
Temperature dependent HSQC ---- Considering that the optimal growth of T. 
Thermophillus is 65oC, the 1H-15N HSQC spectra were collected stepwise up to 70 oC. The 
spectra are still well dispersed in high temperature (70 oC), suggesting that the overall fold 
of TTHA1943 doesn’t alter significantly in different temperature. The equilibrium between 
trans and cis Xaa-P14 is not significantly changing as well, indicating that structure 
heterogeneity of TTHA1943 is still present in physiological condition. No collapse of two 
forms at higher temperature was detected, indicating a very slow process on the exchange 
rate between the two states (kex > 500 ms). The majority of resonances shifted along the 
same direction with increasing of temperature, with exception of residues 52-58, 119, 120, 
which are detected fast motion in 25 oC. The line widths of latter residues also turn boarder 
at temperature higher than 60 oC. Thus, it is reasonable to believe that the solvent exposed 
and extended β−heparin, composed by strands β4 and strands β5, could be highly flexible 
in the physiological conditions. Moreover, one of the copper binding ligands, sulfur atom 
of Met 61, is also located on β4. Thus, it is also predictable that, at physiological 
  
 
79 
conditions, this residue is flexible and can easily adapt to structural changes induced by the 
presence of the Cu(I) ion. 
Interaction with Sco and CuA ---- Previous studies has already suggested that 
proteins of Hyp1 family are potential copper transporter in prokaryotes. Moreover, genes 
of Hyp1 are close to genes of Sco, the product of which are known to be involved in the 
copper assembly of CuA site of CcO. Thus Hyp1 proteins could have potential roles in 
copper trafficking to CcO. In order to investigate these points, the interaction of Sco and 
CuA with TTHA1943 is also studied by titrating the 15N-Cu(I)TTHA1943 with unlabelled 
apoSco and unlabelled apoCuA, respectively. The process was followed through 1H-15N 
HSQC spectra and 1mM acrobatic acid was added into the mixture to keep the copper(I) in 
the reduced state. In the titration between 15N-Cu(I)TTHA1943 and apoTTSco, no copper 
transfer occurs from Cu(I)TTHA1943 to apoTTSco, even when more than two equivalents 
of apoTTSco were added. This data suggested that TTHA1943 has much higher affinity 
than TTSco. Indeed, TTSco is unable to bind copper(I) ion in the presence of equal 
equivalent DTT, differently from human Sco1 (data not shown). Considering that KD value 
of Cu(I)DTT is 6.31 × 10-12 M, KD value of Cu(I)Sco could be estimated higher than 10-10 
M. 
Differently, when 0.5 equivalent apoCuA is added to Cu(I)TTHA1943 solution, 100% 
copper(I) has already been transferred from TTHA1943 to CuA. In this process, no 
variation in the chemical shifts of the amide signals in TTHA1943 could be observed at 
any stage of the titration. Instead, the intensities of Cu(I)TTHA1943 signals decreased with 
increasing apoCuA concentration and, concomitantly, apoTTHA1943 signals appeared with 
increasing intensities along the titration. This data indicated that one apoCuA is capable of 
receiving two copper(I) ions from two Cu(I)TTHA1943 molecules, forming the binuclear 
center. A constant of 102 can be estimated as lower limit for the following equilibrium.  
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Discussion: 
 
Potential function role of TTHA1943 — The overall fold of TTHA1943 is 
organized into cupredoxin fold. Similar fold is shared by other proteins with different 
functions, i.e., immunoglobulin receptors (PDB ID codes 1IAR and 1F42), cellular 
adhesion molecules (1ZXQ and 1VCA), blue oxidases (1BGL and 1AOZ), plastocyanin 
(1PLC), hemocyanin (1LLA), cytochrome f (1HCZ), and the superoxide dismutase copper 
chaperone (1QUP). Notably, the CuA domain of CcO in T. Thermophillus also adopts 
similar fold[6]. Different from other proteins sharing similar cupredoxin fold, a solvent 
exposed and extended β-heparin was detected at 25 0C. When temperature is increasing to 
the physiological condition of T. thermopiles, the resonances of residues located on this β-
heparin (residues 52-58) turn melting, indicating a conversion into a highly flexible loop at 
high temperature. One of the binding ligands is close to this region, suggesting the 
possibility of a partner protein to access the metal site by means of conformational changes 
and coordination of an incoming side chain. More than twenty residues show double 
conformations, which are induced by trans/cis isomerization of Xaa-P14. Interestingly, a 
similar behavior was also detected in CuA site of T. Thermophillus. Moreover, interaction 
studies between Cu(I)TTHA1943 and apoCuA showed that copper could be quantitatively 
transferred from TTHA1943 to CuA. On the basis of these finding, we can propose the 
copper chaperone role of TTHA1943, involved the supply of the copper cargo to the CuA 
site of CcO.  
Potential function role of Sco protein of T. Thermophillus ---- The Sco proteins 
have been proposed to function as thiol:disulfide oxidoreductases, redox signaling proteins, 
copper trafficking proteins, or some combination thereof. Genomic analysis reveals a co-
expression relationship of TTSco and TTHA1943, indicating that two proteins are 
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functional related. Based on our finding, TTSco has much lower affinity to copper(I) ion 
compared to TTHA1943 (KD value of Cu(I)TTHA1943 is  (2.17± 0.10) ×10-13 M-1 and 
that value of Cu(I)TTSco is estimated as ~ 10-10M-1). Assuming a similar expression level 
and turn over rates of these two proteins, TTSco is unlikely to bind copper(I) ion in the 
presence of TTHA1943. Thus the functional role of copper(I) chaperone for CuA site can 
not be supported. To the same reason, redox signaling protein role of TTSco could be also 
ruled out.  
Therefore, the TTSco function as a reductase seems reasonable, which reduces CuA 
Cys residues prior to copper insertion. The overall fold of Sco family is organized into 
thioredoxin fold, as shown by solution and crystal structures of resolved homologies. In 
particular, from crystal structure of BS Sco, a disulphide switch was detected, thus 
supporting the thioredoxin functional role of bacterie Sco proteins[7]. In addition to the 
three typical function roles, TTSco might also be a copper(II) chaperone. A number of 
studies have already shown that Sco proteins, in both eukaryotic and prokaryotic organisms, 
are able to specificly bind copper(II) ion in a 1:1 stoichiometry. And copper(II) ion is also 
available in the periplasm, being much oxidizing environment than cytoplasm of 
prokaryotic cell. In our study, it was found that TTSco binds copper(II) ions stronger than 
copper(I) and it is able to interact with CuA, exchanging copper(II) ions (data not shown).  
According to our observations, two potential mechanisms of copper supply to CuA site 
of T. Thermophillus could be proposed. 1) TTSco is a solely thioredoxin function, which 
reduces the Cys residues of CuA site. Cu(I)TTHA1943 supply two copper(I) ions to CuA 
site after reduction. 2) TTSco has a dual function as thioredoxin and copper(II) chaperone. 
Reduced TTSco receives one copper(II) ion from other proteins; Cu(II)TTSco reduces the 
Cys residues of CuA site, at that stage, copper(II) ion is still bound by oxidized TTSco; 
Cu(I)TTHA1943 and Cu(II)TTSco transfer copper(I) and copper(II) simultaneously to CuA 
site, forming a mixed-valence [Cu(1.5)... Cu(1.5)] center; oxidized TTSco is reduced by 
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other proteins, such as other thioredoxin proteins or cytochrome c, to be ready for next 
metal transfer. 
Materials and Method: 
 
Sample preparation ---- STRING program (http://string.embl.de) was used to 
identify the Thermus Thermophillus Sco neighboring genes. TTHA1943 was expressed in 
E. coli BL21-Gold (DE3) cells (Stratagene), which were grown in LB and minimal 
medium [(15NH4)2SO4 and/or [13C]-glucose] for the production of labeled samples. 
Purification was performed by using a HiTrap chelating HP column (Amersham Pharmacia 
Biosciences) charged with Ni(II). His-GST tag was cleaved with AcTEV, and separated 
from the C-terminal domain with a second purification step. After this purification, the 
protein preparations showed a single component by SDS-PAGE, as checked through ESI-
MS spectrometry.  
The Cu(I) metallated form was obtained by addition of stoichiometric amounts of the 
metal ion, (Cu(I)(CH3CN)4)PF6) to diluted protein solutions in 50mMphosphate buffer at 
pH 7.2, followed by protein concentration under nitrogen atmosphere.  
Solution structure determination 
NMR spectral assignment and structure determination were obtained through the 
classical triple resonance experiments. Back bone assignments were done through HNCA, 
HN(CO)CA, CBCA(CO)NH, HNCACB and HNCO spectra. Side chain were assigned 
through 3D (h)CCH-TOCSY together with 13C-NOESY-HSQC and 15N-NOESY HSQC. 
The His ring protons were assigned through a 1H-15N HSQC experiment tailored to the 
detection of 2J 1H-15N couplings and from the analysis of the 13C-NOESY-HSQC spectra. 
Proton-proton distance constrains were derived from the analysis of 2D-NOESY, 15N-
NOESY-HSQC and 13C-NOESY-HSQC. The relative intensity of the split resonances was 
taken into account when converting NOE volumes into distances. The secondary structure 
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elements were predicted from the chemical shift index and angle constrains were derived 
accordingly. Trans and cis conformation of peptide bonds preceding Prolines are identified 
according to chemical shift difference between Cβ and Cγ as described in Schubert et al 
[8]
. The structures were calculated using the program CYANA-2.0. The best 30 structures 
of the CYANA family were then subjected to restrained energy minimization (REM) with 
AMBER 8.0[9]. The force field parameters were adapted from similar systems[10]. The 
programs PROCHECK, PROCHECK-NMR[11] and WHATIF[12]  were used in the 
evaluation of the quality of the structures. More than 90% of residues were located in the 
allowed regions of the Ramachandran plot for solved structures. 
Relaxation parameters measurement and data analysis  
15N R1, R2, and steady-state heteronuclear 1H–15N NOEs were measured on at 400 
MHz 298K using standard pulse sequences. Relaxation rates R1 and R2 were determined by 
fitting the cross-peak heights, obtained through the standard routine of Sparky program, 
measured as a function of the delay within the pulse sequence, to a single-exponential 
decay. The heteronuclear NOE values were obtained from the ratio of the peak height for 
1H-saturated and unsaturated spectra. The heteronuclear NOE values and their errors were 
estimated by calculating the mean ratio and the standard error from the available data sets.  
Measuring dissociation constant of Cu(I)TTHA1943 
Titrations of 15N-labeled Cu(I)TTHA1943 (0.2 mM) and DTT were performed with 
NMR spectroscopy following the 1H–15N spectral changes in HSQC spectra upon addition 
of increasing amounts of DTT. The metalation state of Cu(I)TTHA1943 was monitored 
along the NMR titration through a few residues that are next to the copper(I) binding motif. 
In addition, the NHs of these resonances are not overlapped in the 1H–15N HSQC maps, 
thus they are easily integrated during the titration steps to estimate the relative population 
of apo and copper(I) loaded forms, which allows the estimation of the metal affinity. The 
dissociation constant KD of Cu(I)TTHA1943 is obtained according to the following scheme:  
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The conditional dissociation constant for the Cu(I)DTT complex, necessary for the 
above KD estimation, is 6.31 × 10-12 M[13] at pH 7.4 and T 298 K. 
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4 
CONCLUSIONS AND 
PERSPECTIVE 
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Structural biology provides a detailed analysis of the structure of biological 
macromolecules at atomic level. From solved structures, the relationship between structure 
and function could be investigated. Metalloproteins, which comprise a significant share of 
the proteome, contain biologically relevant metal ions which can have one or more 
accessible oxidation states. In recent years, the investigation of mechanisms how metals are 
transported and inserted into diverse protein locations is an emerging field in the scientific 
world. Therefore structural characterization of metalloproteins is an important aspect of 
post-genomic research. Our activity is integrated into this framework and intends to 
contribute to the coverage of metalloprotein structures and to pursue functional studies 
aiming to elucidate the role of metal cofactors, their redox properties, and implications in 
protein-protein interactions. 
Moreover, several metalloproteins are involved in diseases, and often they contain 
copper. The alteration of copper homeostasis leads to errors of metabolism and damage to 
cells, resulting in pathological conditions. Among the factors required to achieve copper 
ion homeostasis are the metallochaperones, which specifically traffic copper to 
cuproenzymes. During the PhD course my attention was focused on the structure 
determination of three copper proteins, MNK6, HSco1 and HSco2.  
 
MNK6 is the sixth copper(I) binding domain of Menkes protein, where the disease 
causing A629P mutation occurs. On the basis of our investigation on protein structures, 
dynamic properties, and interaction with its copper donor, HAH1, it was unraveled that 
protein structures don’t alter significantly but the dynamic properties are affected by the 
mutation. Comparing H/D exchange rates between wild type and mutant MNK6, it can be 
concluded that for the mutant protein the equilibria between folded and unfolded 
conformations are shifted towards the unfolded state(s), i.e. the β-sheet is more often 
transiently exposed to the bulk solvent, being more susceptible to degradation. This 
proposal could agree also with some other pathogenic mutation detected from Wilson and 
Menkes disease, i.e. H1069Q and Y532H in Wilson disease. Next step, we will 
characterize the Y532H localized on the copper(I) binding domain 5 of Wilson protein.  
 
Many experimental evidences support the hypothesis that HSco1 and HSco2 are 
involved in the copper insertion into CuA site of Cox2 subunit. However, the precise 
function of these two proteins is not clear yet. In order to understand the mechanism of 
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Sco-mediated copper insertion into CcO, we have determined the solution structures of 
apoHSco1, Cu(I)HSco1, Ni(II)HSco1 and Cu(I)HSco2. The structures indicate that the 
metal ion is bound by two Cys residues of CXXXCP motif and one highly conserved His 
residue. Upon metal binding, proteins pass from an open and flexible state to a close and 
rigid state, as confirmed also by ESI-MS studies. We obtained crystals of Ni(II)HSco1, and 
the relative X-ray structure suggest the binding of the metal ion to the oxidized form of 
HSco1. The species, described from the above mentioned structure, may be represent a 
transition state of the copper transfer from HSco1 to the CuA site of Cox2. It may represent 
a missing link, which integrates the metal transfer and thioredoxin functions already 
proposed for this fascinating protein. 
Structure of HSco2 is similar to HSco1. But the dynamic properties are quite different 
between two proteins in both apo and copper(I) loaded form. In apo form, 84 out of 160 
HN signals are missing in HSco2 protein, while only 20 in HSco1 protein. This indicates 
that HSco2 are more flexible than HSco1 in apo form. Although, upon copper binding, 
HSco2 protein turns more rigid and only 2 of the missing signals are still undetected, some 
degree of flexibility is still present among the whole peptide sequence. Since the function 
roles are quite relevant to the dynamic properties of protein, it is reasonable to believe that 
the partners of these two proteins are different.  
The solution structure of P174L-HSco1 mutant showed that the mutation significantly 
affects the metal binding properties of HSco1 protein. Structurally, the mutation produces 
the lack of well-organized hydrophobic contacts and a structural heterogenity in the 
vicinity of the metal binding region. The local structural changes induced by the point 
mutation decrease the copper(I) affinity of the mutant, thus negatively affecting the 
metallochaperone function of HSco1. ESI-MS and NMR interaction studies between 
HSco1 and HCox17 demonstrate that Cu1(I)-HCox172S-S, is capable of transferring 
efficiently Cu(I) to apoWT-HSco1, but not to apoP174L-HSco1. 
 
Although we have got some hints for the function of HSco1 and HSco2 and the 
pathological mechanism by which P174L mutant induces severe CcO deficiency disease 
has been proposed, a number of questions are still open for this topic and will be 
investigated. For example, 1) HSco1 and HSco2 are membrane bound protein, and indeed, 
are homodimer in physiological conditions. However, the proteins we expressed here were 
only soluble domains. In result section 3.2, we reported another HSco1 construct, called 
long HSco1, where 14 more residues were expressed on N-terminal. From gel filtration 
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data, it is indicated this long HSco1 construct could form a dimmer or the monomer-
dimmer equilbra is present in this system. Therefore, the next step will be the investigation 
of interface of homodimer. 2) From the crystal structure of Ni(II)HSco1, it is indicated that 
the two Cys residues of CXXXCP conserved motif are oxidized when copper(I) is 
transferred to CuA site. But nothing is known at the moment about how the two cysteines 
of CXXXC conserved motif of HSco1/2 are reduced prior to copper transfer from Cox17. 
Therefore interaction studies between HSco1/HSco2 and HCox17 in both reducing and 
oxidizing environment will be performed. 
